INTERNATIONAL REVIEW OF
Neurobiology VOLUME 13
Associate Editors
W. Ross ADEY
H. J. EYSENCK
D. BOVET
G. HARRIS
...
25 downloads
1377 Views
23MB Size
Report
This content was uploaded by our users and we assume good faith they have the permission to share this book. If you own the copyright to this book and it is wrongfully on our website, we offer a simple DMCA procedure to remove your content from our site. Start by pressing the button below!
Report copyright / DMCA form
INTERNATIONAL REVIEW OF
Neurobiology VOLUME 13
Associate Editors
W. Ross ADEY
H. J. EYSENCK
D. BOVET
G. HARRIS
Josh DELGADO
C. HEBB
SIR JOHN ECCLE~
0. ZANGWIU
Consultant Editors
V. A m s m
K. KILLAM
MURRAYB. BORNSTEIN
C. KORNETSKY
F. TH. BRUCKE
A. LAJTHA
P. DELL
B. LEBEDEV
J. ELKES
SIR AUBREYLEWIS
W. GREYWALTER
VINCENZOLONGO
R. G. HEATH
D. M. MACKAY
B. HOLMSTEDT
STENMARTENS
P. A. J.
F. MORRELL
s. KETY
JANSSEN
H. OSMOND STEPHENSZARA
INTERNATIONAL REVIEW OF
Neurobioloav Edited by CARL C. PFEIFFER New Jersey Neuropsychiatric Institute Princeton, New Jersey
JOHN R. SMYTHIES Department of Psychiatry University of Edinburgh, Edinburgh, Scotland
VOLUME 13
1970
ACADEMIC PRESS
New York
San Francisco
A Subsidiary of Harcourt Brace Jovanovich, Publishers
London
COPY RIG^ @ 1970,
BY
ACADEMICPRESS,INC.
ALL RIGHTS RESERVED NO PART OF THIS BOOK MAY BE REPRODUCED IN ANY FORM, BY PHOTOSTAT, MICROFILM, RETRIEVAL SYSTEM, OR ANY OTHER MEANS, WITHOUT WRITTEN PERMISSION FROM THE PUBLISHERS.
ACADEMIC PRESS, INC. 111 Fifth Avenue, New York, New York 10003
United Kingdom Edition published b y ACADEMIC PRESS INC. (LONDON) LTD. 24/28 Oval Road, Londonf N W 1
LIBRARY OF CONGRESS CATALOG CARDNUMBER:59-13822
PRINTED IN THE UNITED STATES OF AMERICA
CONTENTS CONTHBUTORS .
.
.
.
.
.
.
.
.
.
.
.
.
.
ix
. . .
. . .
. . .
1 4 12 23 24
Of Pattern and Place in Dendrites MADGEE . SCHEIBELAND ARNOLDB. SCHEIEEL
I. I1. I11. IV .
Historical Introduction . . . . Specific Patterning in Dendritic Domains Specificity of Synaptic Position . . Conclusions . . . . . . References . . . . . .
. . .
. .
. . .
. .
. . .
. .
. . .
. .
. .
. .
. .
The Fine Structural Localization of Biogenic Monoamines in Nervous Tissue
FLOYD E . BLOOM I. Introduction . . . . . . . . . . . I1. Model Tissue Experiments and the “Ideal Localizing Paradigm” I11. The Binding of Biogenic Monoamines to Cellular Organelles . IV . Localization of Monoamines in Nervous Tissue . . . V . Conclusions . . . . . . . . . . . References . . . . . . . . . . .
.
.
.
.
. .
27 28 39 41 61 62
Brain Lesions and Amine Metabolism
ROBERTY . MOORE
I. Introduction . . . . . . . . I1. Subcortical Lesions and Brain Amine Levels . I11. Interpretation of Lesion Effects on Brain Amines IV . Conclusions . . . . . . . . References . . . . . . . .
. . . . .
. . . . .
.
. .
.
.
.
. .
.
.
67 69 72 88
89
Morphological and Functional Aspects of Central Monoamine Neurons
KJELL FUXE.TOMAS HOKFELT.AND URBANUNCERSTEDT I. Morphology of Central Monoamine Neurons I1. Function of Central Monoamine Neurons . I11. Some Conclusions . . . . . . References . . . . . . . V
. . . .
. . . .
. . . .
. . . .
. . . .
93 104 119 121
vi
CONTENTS
Uptake and Subcellular Localization of Neurotransmitters in the Brain
SOLOMONH . SNYDER.MICHAELJ . KUHAR. ALAN I . GREEN. JOSEPH T . COYLE. AND EDWARD G. SHASKAN
.
I Introduction . . . . . . . . . . . I1. Catecholamine Uptake . . . . . . . . . I11. Serotonin Uptake . . . . . . . . . . IV . Amino Acid Uptake and Subcellular Localization . . . V . Separation of Catecholamine-Storing Synaptosomes in Different Brain Regions . . . . . . . . . . VI . Separation of Synaptosomes Storing Different Transmitters . VII Conclusions . . . . . . . . . . . References . . . . . . . . . . .
.
. .
. .
.
.
.
127 128 139 143
. . . .
. . . .
146 149 156 156
160 166 171 178
.
Chemical Mechanisms of Transmitter-Receptor Interaction JOHN
T. GARLANDAND
JACK
DURELL
I. Studies to Elucidate the Chemical Nature of the Receptor I1. Biochemical Effects of the Transmitters . . . . I11. Theories of Transmitter-Receptor Interaction . . . References . . . . . . . . . .
.
.
.
.
.
.
.
.
.
.
.
.
The Chemical Nature of the Receptor Site
A Study in the Stereochemistry of Synaptic Mechanisms J . R SMYTHIES
.
I. I1. I11. IV
.
V.
VI . VII. VIII IX
. . X. XI.
Introduction . . . . . . . . . . . Possible Role of RNA in Excitable Membrane . . . . Prostaglandin-Ribonucleoprotein Complex . . . . . Specification of the Cholinergic Receptor . . . . . Specification of the Catecholamine Receptors . . . . Specification of the Serotonin Receptors . . . . . Amino Acid Transmitters . . . . . . . . The Disulfide Bond . . . . . . . . . Miscellaneous Compounds . . . . . . . . Some Stereochemical Relations between Membrane-Active Drugs and Antibiotics . . . . . . . . . . RNA and the Sodium Pump Mechanism . . . . . References . . . . . . . . . . . Note added in proof . . . . . . . . .
.
.
. .
. .
.
.
.
.
.
.
. .
. .
181 184 189 192 201 202 207 210 212 215 217 220 221
Molecular Mechanisms in Information Processing
GEORCESUNCAR
I. Introduction . . . . . I1. Neural Coding . . . . I11. Evidence for Molecular Mechanisms IV . Molecular Hypotheses . . .
.
.
. .
.
.
. .
.
.
. .
.
.
. .
.
.
. .
.
.
. .
.
.
. .
.
.
. .
223 227 231 242
vii
CONTENTS
V . Concluding Remarks References
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
.
248 250
. .
. .
.
. . . .
255 256 268 279 280 288
. . . . . . .
289 290 296 313 316 319 321
325 327 333 335 338 339 340
.
.
The Effect of Increased Functional Activity on the Protein Metabolism of the Nervous System
.
B. JAKOUBEK AND B SEMIGINOVSK~
I. Introduction . . . . . . . . . . . I1. Studies Performed at the Tissue Level . . . . . I11. Protein and Nucleic Acid Metabolism in Neurons and Glial Cells IV . Conclusions . . . . . . . . . . . References . . . . . . . . . . . Note added in proof . . . . . . . . .
. . .
Protein Transport in Neurons
RAYMOND J . LASEK I. I1. I11. IV . V. VI .
Introduction . . . . . . . . . . . . Site of Neuronal Protein Synthesis . . . . . . . Axonal Transport . . . . . . . . . . . Physiological and Pathological Changes which Effect Axonal Transport Possible Mechanisms Underlying Axonal Transport . . . . Conclusions . . . . . . . . . . . . References . . . . . . . . . . . . Neurochemical Correlates of Behavior
M . H . APRISONAND J . N . HINCTGEN I. Introduction . . . . . . . . . . I1. Behavioral Depression and Increases in Brain Serotonin . I11. Behavioral Depression and Decreases in Brain Serotonin . IV . Behavioral Excitation and Decreases in Brain Acetylcholine V. Methodological Problems . . . . . . . VI . summary . . . . . . . . . . References . . . . . . . . . .
.
.
.
.
.
.
. .
. .
. .
. .
.
. .
.
. .
.
Some Guidelines from System Science for Studying Neural Information Processing
.
.
DONALD0 WALTERAND MARTINF GARDINER I. Basic Concepts . . . . . . . . . . I1. New Insights Arising from the Information Systems Viewpoint 111 Summary and Prospect . . . . . . . . . . References . . . . . . . . . . .
.
AUTHORINDEX.
. .
. .
. .
. SUBJECTINDEX. . CONTENTS OF PREVIOUS VOLUMES.
. . .
. . .
. . .
. . .
. . .
. . .
. . .
.
.
. . .
.
.
.
. . .
. . .
343 356 369 372 375 392 399
This Page Intentionally Left Blank
CONTRlB UTORS Numbers in parentheses refer to the pages on which the authors’ contributions begin.
M. H. APRISON,Section of Neurobiology, The Institute of Psychiatric Research and Departments of Psychiatry and Biochemistry, Indiana University Medical Center, Indianapolis, Indiana ( 325) FLOYDE. BLOOM,Laboratory of Neuropharmacology, Division of Special Mental Health Research, National Institute ~f Mental Health, Saint Elizabeths Hospital, Waslzington, D. C . (27)
T. C O Y L E ,Departments ~ of Pharmacology and Experimental Therapeutics and Psychiatry and the Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland ( 127)
JOSEPH
JACK
DURELL, Section on Membrane Chemistry, Laboratory of Cerebral Metabolism, National Institute of Mental Health, Bethesda, iMaqland, and Center for the Study of Behavioral Biology, Psychiatric Institute Foundation, Washington, D. C . (159)
K JELL FUXE,Department of Histology, Karolinska Institutet, Stockholm, Sweden (93)
T. GARLAND,+ Section on Membrane Chemistry, Laboratory of Cerebral Metabolism, National Institute of Mental Health, Bethesda, Maryland, and Center for the Study of Behavioral Biology, Psychiatric Institute Foundation, Washington, D. C. (159)
JOHN
MARTINF. GARDINER, Departments of Physiology and Anatomy, Brain Research Institute, University of California, Los Angeles, California ( 343 ) ALANI. GREEN,Departments of Pharmacology and Experimental Therapeutics and Psychiatry and the Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland (127) J. N. HINGTGEN, Section of Neurobiology, The Institute of Psychiatric Research and Departments of Psychiatry and Biochemistry, Indiana University Medical Center, Indianapolis, Indiana ( 325)
TOMASHOKFELT,Department of Histology, Karolinska Institutet, Stockholm, Sweden (93)
* Present address: Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland f Present address: Washington University School of Medicine, Department of Internal Medicine, Metabolism Division, St. Louis, Missouri. ix
X
CONTRIBUTORS
B. JAKOUBEK, Institute of Physiology, Czechoslovak Academy of Sciences, Prague, Czechoslovakia and Institute of Pathophysiology, Medical Faculty of Charles University, Pizen, Czechoslovakia ( 255) MICHAELJ. KUHAR, Departments of Pharmacology and Experimental Therapeutics and Psychiatry and the Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland ( 127)
RAYMOND J. LASEK,*Department of Neurosciences, University of California San Diego, La Jolla, California (289) ROBERTY. MOORE,Department of Pediatrics and Medicine (Neurology) and the Joseph P . Kennedy, Jr. Mental Retardation Research Center, The University of Chicago, Chicago, Illinois (67) ARNOLDB. SCHEIBEL, Departments of Anatomy and Psychiatry and Brain Research Institute, U.C.L.A. Center for the "Health Sciences, Los Angeles, California (1) MADGEE. SCHEIBEL, Departments of Anatomy and Psychiatry and Brain Research Institute, U.C.L.A. Center for the Health Sciences, Los Angeles, California ( 1 ) B. SEMIGINOVSK+, Institute of Physiology, Czechoslovak Academy of Sciences, Prague, Czechoslovakia, and Institute of Pathophysiology, Medical Faculty of Charles University, Pizen, Czechoslovakia ( 255) EDWARD G. SHASKAN, Departments of Pharmacology and Experimental Therapeutics and Psychiatry and the Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland ( 217)
J. R. SMYTHIES,Department of Psychiaty, University of Edinburgh, Edinburgh, Scotland ( 181) SOLOMON H. SNYDER,Departments of Pharmacology and Experimental Therapeutics and Psychiatry and the Behavioral Sciences, The Johns Hopkins University School of Medicine, Baltimore, Maryland ( 127) GEORGES UNGAR,Baylor College of Medicine, Houston, Texas (223) URBAN UNGERSTEDT, Department of Histology, Karolinska Institutet, Stockholm, Sweden (93) DONALD 0. WALTER,Departments of Physiology and Anatomy, Brain Research Institute, University of California, Los Angeles, California (343) * Present address: Department of Anatomy, School of Medicine, Case Western Reserve University, Cleveland, Ohio.
OF PATTERN AND PLACE IN DENDRITES1f2 By Madge E. Scheibel and Arnold 8. Scheibel Departments of Anatomy and Psychiotry and Brain Research Institute, U.C.L.A. Center for the Health Sciences, Lor Angeles, California
. . . . . . . . . . .
I. Historical Introduction 11. Specific Patterning in Dendritic Domains . . . . . . . A. Straight, Unbranched Pattern . . . . . . . . . B. Convoluted, Field-Specific Patterns . . . . . . . . C. Some Thoughts on Dendrite Patterning . . . . . . . 111. Specificity of Synaptic Position A. Dendrites as Monoreceptive Elements . . . . . . . B. Dendrites as Polyreceptive Elements . . . . . . . C. Some Though6 on the Significance of Synaptic Position in Complex Cortical Systems i . . . IV. Conclusions References
I 4 5
. . . . . . . . .
7 11 12 13 16
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
21 23 24
I. Historical Introduction
The dendritic extensions of neurons have come to occupy a central role in all considerations of synaptic activity and integrative operations undertaken by nerve cells. Such consideration is not inappropriate in view of the extensive receptive surface provided to inccming volleys and the very large proportion of total neural tissue mass made up by these structures ( Aitken and Bridger, 1961). It is almost exactly a century since their existence was first reported by Gerlach in carmine stains (Gerlach, 1871), and present knowledge of the intrinsic structure and physiological properties peculiar to these elements may hardly seem commensurate to the period during which they have been hown. It is our purpose to review briefly the more significant contributions in this area and to present several bodies of data relevant to organization of the dendrite mass and to the arrangement of presynaptic ensembles along their surfaces. The epochal quality of Gerlach's discovery was mitigated by his assumption that the processes which he could see leaving the cell bodies 'Based in part on the twelfth George H. Bishop Lecture in Experimental Neurology delivered at Washington University School of Medicine, St. Louis, Missouri, April 14, 1967. 'Experimental studies of the authors were supported by the U. S. Public Health Service, grants NB-01063 and HD-00972.
1
2
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEX
reunited to form a net or reticulum marked by protoplasmic fusion. Camillo Golgi's use of chrome silver techniques established the free nature of dendritic terminals (Golgi, 1903) and set a cornerstone for the neuron theory eyen though he was later to err in maintaining reticularism as a general theory of neuronal organization, and nutrition as the specific role of the dendrites. Cajal's studies of the nervous system, using the impregnation methods of Golgi and ancillary techniques, capped the initial phases of dendrite studies with the discovery of spines, and the conclusion that, in the dynamically polarized neuron, dendrites received afferent volleys and conducted them toward soma and axon. A number of dendrite patterns were described by Cajal (1909, 1911) at various levels of the nervous system, but the first attempt to provide a reasonable set of physiological consequences for some of these pattern variations was that of Lorente de Nb (1939, 1947). In advancing the theses of open and closed fields, he related dendritic morphology to the probable distribution paths of current and suggested possible effects on adjacent neuronal ensembles. Elaboration and further applications of these ideas can be found in more recent studies by Mannen (1966), Leontovitch and Zhukova ( 1963), Ram6n-Molinar and Nauta ( 1966), and ourselves (Scheibel and Scheibel, 1958a). The majority of these workers relate pattern to the phylogenetic age of the neural subsystem, long radiating and unramified dendrite systems being equated with more archaic mechanisms. However, we have pointed to the relatively high degree of structural complexity in pre- and postsynaptic morphology present even in invertebrate forms of great antiquity (Scheibel and Scheibel, 1962). We prefer to consider the structural characteristics of dendrite systems rather as a function of the morphology of the presynaptic components, and as an expression of postsynaptic integrative mechanisms peculiar to those neural elements. We shall examine this problem in some detail below. The semiquantitative approach of Sholl (1956) to the problem of cortical dendritic organization and pre- and postsynaptic relations was predicated on the statistical irrelevance of individual connections. His studies set a trend in establishing possibilities for a mathematically more rigorous approach, At the same time, the possible importance of circuit patterns and place-specific effects was deemphasized. In light of more recent studies, this research orientation has not seemed entirely justified. Among the attempts to develop conceptual models of dendritic systems, the studies of Rall ( 1962, 1964, 1967) bear special mention. Expanding on the dendrite segment counting techniques first suggested by Bok (1959) and Sholl (1956), Rall developed a theoretical treatment, drawing on geometric properties and potential theory to enable certain predictions
OF PATTERN AND PLACE IN DENDRITES
3
about mechanisms operating along dendrites to be made. His studies have led to the theoretical prediction of functional distinctions between somatic and dendritic synapses. The latter would be expected to dominate slow changes in the background level of excitation, while somatic synapses would be best situated for triggering of impulses. These predictions have proven reasonably congruent with data available from microphysiological studies by a number of workers. However, a number of features of the relatively passive, cable-like dendrites, which Rall invokes to facilitate model building, are clearly oversimplifications. More recent studies of membrane impedance changes that accompany development of excitatory and inhibitory postsynaptic potentials have provided documentation for a characteristically somatic position for inhibitory nerve endings--in spinal cord at least (Smith et al., 1967). Electron microscopy has added an important dimension of data to dendrite studies, with enhancement of resolution of visible detail, often by several orders of magnitude, though at the price of all sense of relative position and orientation. Aside from the dense covering of synaptic terminals and glial processes extending to the dendrite tips, a finding already indicated by Golgi impregnation studies, perhaps the greatest surprise has been the increasingly homogeneous, electron-transparent nature of the endoplasm in areas progressively further from the cell body. While granule-rich silhouettes of endoplasmic reticulum extend out limited distances from the soma-dendrite junction, these soon disappear, leaving only the smooth contours of occasional nongranular endoplasmic bodies and the ubiquitous longitudinally running dendritic tubules. Whether these tubelike profiles, 100A or less in diameter, actually serve a conduit function, or rather represent structural skeleton, or even fixation artifact, is still uncertain (Gray, 1964). The discovery of dendritic projections or spines (thorns, gemmules) by Cajal (1909) using rapid Golgi and methylene blue techniques has been supported by subsequent studies (Fox and Barnard, 1957; Scheibel and Scheibel, 1955; and others) and only recently confirmed by electron microscopic analysis (Gray, 1959). The function of these small ( 1 3 p ) substructures remains enigmatic, but it now seems likely that they serve purposes beyond that of simply increasing dendritic surface area (Colonnier, 1967). The discovery by Gray ( 1959) of intraspinous coiled canalicular structures would suggest functions of a more specific nature. More recently, Colonnier (1964) has demonstrated their dependence on the presynaptic influx by showing their degeneration following loss of the terminal boutons synapsing upon them. Furthermore, studies of Walberg (1963) suggest that the spines ingest such terminal bouton fragments, perhaps by a pinocytotic-like mechanism, prior to their own
4
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
degeneration. We have used this close relationship between pre- and postsynaptic structures in exploring terminal presynaptic topography in a complex environment such as cerebral cortex, as will be described later. Although it does not seem appropriate at this time to review developments in dendritic physiology over the past thirty years, several contributions should be mentioned as pertinent to our own consideration. Bishop and Clare (1852, 1953) were among the first to suggest the additive, nonpropagating nature of dendritic potentials and their possible relation to the electroencephalograph on the one hand, and to modulation of the firing threshold of the soma1 trigger zone on the other. Such suggestions reflected empirical development of earlier notions of Gesell and his co-workers (1954) on the dynamic polarization of neurons and the effects of current flow between dendrite and soma. Experiments with neurons in tissue culture raised some questions as to whether decremental conduction actually characterizes the total repertoire of dendritic responses (Hild and Tasaki, 19.62). In any case, the ideas of Bishop and Clare have done much to enrich our concepts of the neuronal model and free it from the confines of all-or-nothing physiology. Dendritic excitation has been attributed exclusively to chemogenic processes by some workers ( Grundfest, 1957). Recent information has necessitated alterations in so monistic a view. Data from several sources stresses the uniqueness of the subsynaptic patch as the unit of functional activity along the dendritic membrane, determining the actual effect of the presynaptically released transmitter. The same transmitter substance may have different effects on different membrane patches (Tauc and Gerschenfeld, 1961; Kandel et al., 1967). Thus it remains possible to operate within the confines of Dale’s hypothesis (1935) (all terminals of all branches of a single neuronal axon release the same transmitter substance) and still obtain contrasting effects from different terminals of an axon synapsing upon different neuron systems. We have recently identified such a situation in cat spinal cord, where branches of a single primary afferent collateral supply both extensor and flexor motoneuron pools without intercalated internuncials ( Scheibel and Scheibel, 1969). II. Specific Patterning in Dendritic Domains
If it is assumed that structure reflects function, the opulence of dendritic patterns in neurons of the vertebrate nervous system bears witness to the range of operations subserved by dendritic membrane. While it seems safe to assume that reception and/or integration of presynaptic impulses (with the added possibility of spike generation in some dendrite systems under certain conditions) represent the principal dendritic role, specific problems of local topography and physiological dynamics vary widely.
OF PATTERN AND PLACE IN DENDRITES
5
Figure 1 illustrates a few dendritic patterns found in the brainstem. The most significant variations exist in (1) the amount of branching of the individual dendrite shaft, ( 2 ) the course of the individual element, and ( 3 ) the size and shape of the total dendrite domain. Meaningful interpretation of these variables requires correlative information about the presynaptic input systems and, if possible, the nature of the information involved in the synaptic transaction. A. STRAIGHT,UNBRANCHED PATI-ERNS Those cells making up the greater part of the reticular core of the brainstem are characterized by limited numbers of long, relatively straight and poorly ramified dendrite shafts. The individual shaft may have as few as 2 or as many as 6 or 7 branch points aIong its course, and extend for as much as 500 to 7 5 0 p from the cell body of origin. The total diameter of the dendritic domain may accordingly exceed 1 mm, and we have calculated that between 4000 and 5000 similar nerve cell bodies may lie in such a tissue volume (Scheibel and Scheibel, 195813).
'
B A / \
C
D
FIG.1. Dendrite patterns of a group of neurons in the brainstem. A: Neuron of the kitten axial core (reticular formation) showing straight, relatively unbranched dendrite shafts; B: neuron of the kitten ventrobasal nucleus of the thalamus showing multiple, richly branched dendrites producing a tufted appearance; C: neuron of the inferior olive in an infant with branched and convoluted dendrites forming a dense spherical domain; D: four neurons of the medial portion of the superior olive in a kitten showing paired dendrite domains of limited extent. Drawn from Golgi-stained preparations at varying magnifications.
6
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
Several statements of fact can be made about the nature of this dendrite pattern, and several questions should be raised as to the nature of their functional role. Histological studies clearly show that the presynaptic influx to this type of dendrite system consists of axonal preterminal segments of varying lengths which run along the dendrites, often for appreciable distances, establishing repetitive terminal synaptic contacts along the way. This parallel apposition of pre- and postsynaptic components appears characteristic of the linear, poorly ramified dendrite shaft in most locations ( Scheibel and Scheibel, 19%). In most cases, these elements receive a number of synaptic inputs, not only from different presynaptic preterminal fibers, but also from different fiber systems, thereby resulting in appreciable convergence of heterogeneous afferent information along the soma-dendrite membrane of the individual cell (Scheibel et al., 195.5). The nature of the ensuing integrative process has been examined both theoretically and experimentally. For spinal motoneurons, at least (Smith et al., 1967; Burke, 1967; Rall, 1967; Rall et al., 1967), it may be sufficient to consider the dendrites as essentially passive conductors, The excitatory process which then develops in the region of the somal trigger zone is a moment-tomoment function of the size, geographical position, and sign of the multiple discreet local disturbance (postsynaptic potentials, PSPs ) along the entire domain membrane system. PSPs generated near the dendrite tips may be “invisible” to the intrasomal microelectrode but may still exert tonic shaping effects of some magnitude on somal output. Dendritic locations increasingly close to the soma presumably produce PSPs of progressively greater amplitude, decreased temporal distortion, and enhanced effectiveness in programming spike activities at the trigger zone. This quasi-linear model may represent an oversimplification of the behavior of reticular neurons where dendrites penetrate through adjacent nuclei and tracts of diverse function. Unpublished data (Scheibel et al., 1961) suggest that in this case, the locus of spike generation may wander along the soma-dendrite membrane, thereby raising the question of independent spike induction in dendrites. The penetration of long dendrite shafts through diverse nuclei and tracts brings up another variable of still largely unknown dimensions, i.e., the effect of variations in Iocal field potentials upon a passing dendrite element. It is known that potentials of the order of 1 millivolt can be measured in the immediate surround of an activated spinaI motoneuron (Nelson and Frank, 1964) and that closely adjacent motoneurons
OF PATTERN AND PLACE IN DENDRITES
7
can show consequent threshold variations of the order of 10 to 30%(Nelson, 1966). There are, as yet, no corresponding measurements for reticular neurons, but it seems reasonable to assume qualitatively similar effects in this locale. We can, therefore, conceive of the widely spreading, linear dendrite system of the reticular formation as a pattern suited to sampling information from heterogeneous and diversely situated afferent sources, directly through synaptic interaction, and more indirectly through impingement of local standing or evoked field potential phenomena imposed via nonsynaptic (ephaptic) means.
B. CONVOLUTED, FIELD-SPECIFIC PATTERNS In contrast with the unramified structure of axial reticular dendrite systems, a number of examples of highly convoluted, densely branched and/ or tufted, or otherwise uniquely configured dendrite domains can be cited. Some of the most striking of these can be found in sensory “relay” nuclei such as the ventrobasal complex of the thalamus and the superior olive of the upper medulla. Equally unique examples are seen in inferior olive and cerebellar cortex, related structures of more ambiguous functional significance. The ganglion cells of the retina differ from all of these in having a range of dendrite domain patterns, to each of which a putative function has recently been assigned. 1. Neurons of the Ventrobasal (Somatic Sensory) Thalamus Thalamic ventrobasal cells (Fig. 1B) are representative of neurons in sensory transmission systems, where a significant measure of mode and/or locus specificity is maintained ( Mountcastle, 1961). The dendrites are relatively thick and short, and quickly break up into dense masses of secondary branchlets forming tufts or brushes [the bzcschzellen or cellules en buisson of Cajal (1911)l. The rather small, densely configured domain resulting from this structural design overlaps and partially interpenetrates a group of immediately adjacent dendrite fields. Superimposed upon this matrix of interlocking postsynaptic elements is a group of presynaptic axonal systems, each forming a neuropil plexus of unique configuration. Of these, the medial lemniscus, carrying sensory information from the periphery, terminates in a set of conical arbors, also partly overlapped. In concert, the pre- and postsynaptic structures form a complex substrate well adapted to ensure maximal security and adequate fidelity of transmission (Purpura and Cohen, 1962). Unquestionably, the limited spread and elaborate branching of the dendrite systems of these cells ensures activation of the soma1 trigger zone
8
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
consequent to volleys arriving at a highly restricted portion of the ventrobasal field (Scheibel and Scheibel, 1966a).
2. Neurons of the Superior Olive Superior olive neurons bear dendrite patterns which are appreciably different from ventrobasal elements, but equally well adapted to their functional role. The cells are aligned, long axes parallel, around the periphery of the nuclear sac, each neuron being essentially bipolar, and carrying one main central and one peripheral-pointing dendritic shaft. These immediately generate a group of secondary branches, limited in number and extent, forming oval dendritic fields flanking each neuron soma ( Cajal, 1909). These dendritic domains are immersed in elongated, cone-shaped, terminal afferent fields, apparently tagged for several auditory variables including pitch. The highly restricted lateral dimensions of each dendritic field presumably restrict the frequency range monitored by each cell. A further, and even more dramatic specialization exists in the medial superior olive (Fig. 1D) in that the two major dendritic domains of each neuron sample inputs from opposite sides ( Goldberg and Brown, 1969). Several groups of physiological responses appear in response to high frequency binaural stimuli including excitatory-excitatory ( EE ), and excitatory-inhibitory ( EI ) effects. In addition, the same, or similar cells discharge in periodic or phase-linked manner to low frequency stimulation of either ear. In this case, discharge rate and degree of phase-locking are determined by the relative timing of the stimuli arriving from the two ears. Thus, the double dendritic domain of each superior olive neuron appears to serve as substrate to paired neural mechanisms participating in sound localization.
3. Neurons of the Inferior Olive Another type of highly developed dendritic domain is that of the inferior olive neuron (Fig. 1C). Here a number of main dendrites from each cell are multiply branched and convoluted around the soma, forming a dense, spherical field of impressive complexity. This very obvious attempt to limit the geographical range of the postsynaptic membrane is matched by presynaptic conical arbors of equal structural elegance. As in the case of the ventrobasal complex, the dendritic domains are partially overlapped and interpenetrating, thereby forming a dense postsynaptic matrix upon which presynaptic terminal neuropil of several patterns ( Scheibel and Scheibel, 1955) delimits secondary domains. Despite its obvious size and prominence as a brainstem landmark, the function of the inferior olive remains enigmatic, thereby seriously compromising any attempt to relate structure to function.
OF PATTERN AND PLACE IN DENDRITES
9
4. The Purkinje Neuron of the Cerebellum The Purkinje cell offers another example of a dendritic field of unique shape and dimension, configured to a specific relationship with the presynaptic influx. As Fig. 2 shows, the Purkinje dendrite domain develops from one side of the cell body, while the axon develops from the other (or from a primary dendrite branch). In the mammalian vertebrate, the dendrite system is made up of a series of primary, secondary, and tertiary branchlets compressed into a bidimensional domain placed perpendicular to one of the two major cerebellar inputs, the parallel fiber system. The surface area of tertiary branchlets together with the spines which they bear (as many as 120,000 per domain) far exceed that of primary and secondary systems together, and provide a veritable screen or filter system through which information in the parallel fiber ensemble must percolate (Cajal, 1911; Fox et aZ., 1967). The Purkinje dendrite domains of nonmammalian vertebrate brains show a basic pattern which is similar to that of mammals, but with certain obvious simplifications ( Fig. 2 ) . The distinction between primary, secondary, and tertiary components, while still recognizable in birds, can no longer be made out in fish where spines have become difficult
FIG.2. Varying dendrite patterns in cerebellar Purkinje cells of various vertebrate species, A: sturgeon; B: perch; C: turtle; D: pigeon; E: man. In the last, 1, 2, and 3 refer to primary, secondary, and tertiary dendrites respectively. Based on Golgi-stained sections drawn at varying magnifications.
10
MADGE E. SCHEIBEL AND ARNOLD B. SCHEJBEL
to identify, or have disappeared entirely. The number of branches, and consequently of branch points, has also noticeably diminished in these forms, presumably decreasing the range of possible dendritic operations. Nonetheless, even in cerebellar forms relatively as simple as that of the sturgeon, the restricted number of dendrite shafts characterizing these Purkinje cells form a domain whose orientation and silhouette do not differ greatly from that of man (Fig. 2A,E), In each case, the shaping factor would appear to be the presence of a system of parallel fibers crossing the sequence of Purkinje domains at right angles. Although a number of attempts have been made to interpret the meaning of this synaptic configuration ( Eccles et al., 1967), no definitive conclusions are yet possible save that it clearly represents an efficient mode of spreading information over very large numbers of similar cells in sequence. The success of this structural paradigm is attested by the similarity of the circuit throughout the vertebrate line despite interspecies variation in detail.
5. Ganglion Cells of the Retina Neurons of the ganglion cell layer of the retina deserve consideration at this point because of a group of physiological correlations which have tentatively been established with the varied dendritic domains which they show. The inclusion of these cells is appropriate since the retina, though thought of as part of the peripheral nervous system, is embryologically a derivative of the diencephalic vesicle (thalamus) from which it emigrated at an early stage in ontogenetic development. In the frog, five major dendritic patterns were described by Cajal (1894) and are illustrated in Fig. 3. These include ( a ) small cells with very constricted dendritic ramifications spread out in a single bushy slab at an inner level of the plexiform layer (Fig. 3C); ( b ) large cells with a single, very extensive planar domain spread along the outer margin of the plexiform layer (Fig. 3D); ( c ) large cells with multilevel “ H type
A
B
C
D
E
FIG.3. Different forms of retinal ganglion cells of the frog. A: An “ H cell with extensive multilevel dendrite domain; B: an “E” cell with multilevel and parcellated dendritic domain; C: small cells with constricted, one-level domains; D: large (parasol type) cell with extensive one-level dendrite domain; E: large cell with diffuse dendrite domain. Based on drawings of Cajal (1894) from Golgi-stained material.
OF PATI’ERN AND PLACE IN DENDRITES
11
distribution of dendritic masses (Fig. 3A); ( d ) cells with multilevel “E” type distribution of dendritic fields (Fig. 3B); and ( e ) cells with a diffuse, nonplanar dendritic domain (Fig. 3E). These dendrite systems receive information from the immediately overlying bipolar cells, The horizontal spread of these ganglionar dendrite systems and their position in the lamina largely determine the number and identity of bipolar cells with which they connect. Lettvin and co-workers (1961) have attempted to correlate these patterns with a group of physiological properties which they have isolated in optic nerve fibers of the frog visual system. The small, onelevel constricted elements are assigned a role in boundary detection where the receptive field extends over no more than 2 to 4 degrees. The large cells with extensive, single-layer dendritic domains are interpreted as dimming detectors (off fibers), Here, spatial resolution is poor, and relative rather than absolute values of illumination are apparently involved. The multilevel “ H type domain cell is conceived as primarily sensitive to “contrast, movement, and change” ( on-off detectors), functioning as a detector of events signalled by any combination of changes in distribution of light and boundaries over its surface. The multilevel “ E type domain neuron is associated with “movement-gated, dark convex boundary detection.” The multiple compartmentation of the horizontal fields is thought to provide a number of small receptive segments capable of determining the degree of dimming in any one such area combined with the amount of boundary in that area. Thus the “ E type is seen as combining a group of “H’ functions with a higher degree of spatial (boundary) resolution. Finally, the diffuse dendritic type is matched, by exclusion, with general light level measuring properties. The correlations suggested by Lettvin and his associates, though intuitive and conceptually satisfying, cannot yet be considered as proven. Nevertheless, they underline the possibility, also demonstrated in studies by Hubel and Wiesel (1959) on mammalian visual cortex, that various neural elements are preprogrammed for certain varieties of input which, in combination, may represent potentially meaningful environmental happenings. Their relevance to this review lies in the fact that the various dendrite patterns involved apparently determine those characteristics of visual input to which each cell will respond, and thereby represent a putative link between neural structure and epistemology.
C. SOMETHOUGHTS ON DENDRITE PATTERNING In examining a selected group of dendrite patterns, we obviously have omitted many others. Those selected illustrate a range of domain
12
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
patterns from the multipolar, long, straight, relatively unbranched systems characteristic of the brainstem reticular core, through the highly branched, convoluted and/ or tufted elements of the ventrobasal thalamus and inferior olive, to the consistently stylized, bidimensional fields of cerebellar Purkinje cells and the complex geometry of retinal ganglion cells. Some workers ( Ram6n-Molinar and Nauta, 1966) have stressed the existence of a pattern continuum linking the unramified “reticular” dendrite pattern of the “isodendritic core” of the brainstem through a heterogeneous group of domains of varying complexity ( allodendritic patterns) to the most highly specialized patterns such as those of the inferior olive and sensory thalamic fields (idiodendritic patterns). There are, unquestionably, appealing features to this mode of categorization. However, it would also appear to have certain limitations, such as the difficulty of including cortical cells-cerebral, cerebellar, or hippocampal-in the sequence. There is also the implication that reticular (isodendritic) cells represent the most primitive (i.e., least developed) dendrite pattern, a notion that does not seem justified when they are compared with phylogenetically more primitive neuron patterns in many nonvertebrate forms. In another attempt to bring some degree of functional relevance to dendrite patterning, Lorente de N6 (1939, 1947) introduced the concepts of open and closed nuclei, based on dendrite patterning and the consequent distribution of electrical sources and sinks. Although this classification may have some predictive value in the analysis of potential fields, it would appear to represent an oversimplification of the data. The limited roster of dendrites shown by any Golgi stain does not exist in vacuo, nor do they more than epitomize some of the patterns etched by the far greater numbers left unstained. Furthermore, the number and complexity of membrane profiles which pack the interdendritic space make any prediction as to field shape and current distribution, at best, an approximation. Ill. Specificity of Synaptic Position
The significance of synaptic position along the soma-dendrite membrane has become increasingly clear over the last few decades as the dynamics of membrane and field have been elucidated. WhiIe the properties of dendrites remain largely enigmatic, our models can no longer be fully satisfied by the assumption that they are passive, undifferentiated samplers of synaptic drive on the one hand, and extensions of the soma1 membrane for ion flux (source-sink) operations on the other. The hierarchical aspects of dendrite membrane organization and the contrasting roles of proximal and distal portions emphasize the impor-
OF PATTERN AND PLACE IN DENDRITES
13
tance of synaptic locus. Position becomes even more significant as the role of branch points along each dendrite shaft comes under increasing scrutiny. Are they points of potential block for membrane disturbances; or do they perhaps operate as valves, allowing transmission in one direction only? Alternatively; might they function as selective loci for spike initiation along the dendrites, or conceivably, even as integrators and/ or differentiators of the totality of local disturbances ( PSPs) generated distally? Clearly, if any of these putative roles could be proven, one more reason would be added to a rapidly growing roster for developing the fullest possible acquaintance with patterns of synaptic topography on various neurons.
A. DENDRITES AS MONORECEPTIVE ELEMENTS With the exception of a few nuclear pools, most cells located in the axial core of the central nervous system tend to show a comparatively simple pattern of synaptic localization along the soma-dendrite membrane. Most commonly, an entire dendrite or segment of dendritic domain tends to be dedicated to a certain type of input, suggesting (though not necessitating) a relatively uniform functional role for certain shafts, with the final integrative processes presumably occurring in the area of the soma1 trigger zone.
1. Neurons of the Brainstem Reticular Core Despite the complex organization of the brainstem reticular formation with its densely intermixed fields of cells, local fiber systems, and tracts, we are convinced that dendrite systems in large numbers of reticular cells are organized to receive certain inputs in relatively pure culture. As an example, we will cite reticular neurons located in Olszewski’s ventral subnucleus of the nucleus medullae oblongatae centralis ( Olszewski, 1954). As we have shown elsewhere, such cells may spread their dendrites over % to % of the cross-sectional area of the brainstem, as seen in transverse sections, while showing little development along the rostrocaudal axis, leading to a two-dimensional or chip-shaped domain module ( Scheibel and Scheibel, 1958b, 196813). Careful examination of shaft organization and impinging presynaptic afferent systems suggests definite concentrations of certain inputs on certain shafts (Fig. 4). Ventrally directed shafts appear preferentially loaded with terminals from pyramidal tract collaterals while ventrolateral projecting branches receive, in the main, collaterals streaming in from the spinothalamic bundles and their associated tract nuclei, the so-called lateral reticular nucleus. Dorsolateral ranging shafts appear to receive axonal termina-
14
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
FIG.4. Slightly schematized drawing showing the relation of specific presynaptic afferents to the monoreceptive dendrite system of a neuron of the brainstem reticular core. Left side: afferent terminals pictured here include (1) collaterals from vestibular nuclear complex, ( 2 ) collaterals and terminals of the descending root of the fifth nerve, (2’) axon collaterals from neuron of the nucleus of the fifth nerve, ( 3 ) collaterals from spinothalamic tract, ( 4 ) collaterals of pyramidal tract fibers, ( 5 ) collaterals and/or terminals from medial longitudinal fasciculus. Right side: large reticular cell in the ventral reticular complex showing various dendrite systems; ( a ) medial longitudinal fasciculus, ( b ) vestibular complex, ( c ) descending fifth nerve complex, ( d ) spinothalamic collaterals, ( e ) pyramidal collaterals.
tions from descending vestibular and/ or spinal tigeminal systems while dorsomedial branches, if any, may receive synaptic contributions from collaterals of fibers running in the medial longitudinal fasciculus and occasionally from contralateral systems. There is often some degree of admixture and dilution by boutons en passage from the rostrocaudal z o n a l elements which characterize all parts of the reticular formation. However, it is not possible to predict the location of such terminals; they do not appear to develop appreciable density at any point along the shafts. For the purposes of our working model, it seems quite appropriate to conceive of each major dendrite shaft as under presynaptic control of one predominant system. This picture may well be complicated by the as-yet-unexplored effects of local field phenomena present in the various nuclei and tracts which these typically long dendrites may penetrate in the tightly packed core. Such mechanisms, if significant, would probably develop their effects upon the dendrite shaft by extrasynaptic (ephaptic) means.
OF PATTERN AND PLACE IN DENDRITES
15
2. Spinal Neurons in the Dorsal Horn Another interesting example of segregation of presynaptic terminals upon individual dendrite shafts of single neurons is found in the large lamina IV neurons deep to the gelatinosal complex in the dorsal horn. The substantia gelatinosa is largely made up of the terminal elaborations of axons innervating the cutaneous surface of the body. In the usual transverse preparations stained by the chrome-silver methods ( Cajal, 1909), these terminal plexuses or lobules (Szentagothai, 1964) present a series of domains shaped like tall thin Italian cypresses. Sagittal preparations reveal that this appearance is owing primarily to viewing the plexuses “edge-on,” since they actually consist of long neuropil plates of minimal thickness extending hundreds or thousands of microns in the rostrocaudal plane. Similarly, the small gelatinosal cells which are immersed in this presynaptic matrix actually possess extensive dendritic domains, again developed almost entirely along the longitudinal axis (Scheibel and Scheibel, 1968a). Just ventral to this highly organized synaptic area is a layer of large neurons (lamina IV of Rexed, 1952) whose dendrites appear to show three principal orientations; lateral, dorsal, and medial (Fig. 5). The dorsal dendrites ascend into the cutaneous terminal plexuses just described, in diverging conical array and apparently receive virtually their entire presynaptic load from this source. These dendrites bear long convo-
FIG.5. Slightly schematized drawing showing the relations between the dendrites of a spinal cord lamina IV neuron and the three major sets of afferents which it receives. Coarse cutaneous afferent fibers (1) synapse on dorsal dendrites, d; collaterals and/or terminals of the lateral corticospinal fibers ( 2 ) synapse on lateral dendrites (1); collaterals and/or terminals of fibers from ventral part of midline white matter (dorsal columns) synapse on medial dendrites, m. Based on Golgistained sections of spinal cord.
16
MADGE E. SCHEIBEL AND ARNOLD B. SCHELBEL
luted spines similar to those found on gelatinosal cells, in marked contrast to the smoother, horizontally oriented shafts. In combination with similar types of data from other areas, it is difficult to avoid concluding from this observation that the nature of the presynaptic input helps determine the morphology (and perhaps even the presence or absence) of dendritic spines. The lateral dendrites are largely recipient to collaterals and terminals of the lateral corticospinal tract ( Scheibel and Scheibel, 1966b) descending from the sensorimotor strip and adjacent areas of frontal, parietal, and temporal neocortex. The medial are mainly receptive to terminal fibers from the medioventral portion of the dorsal columns, an area of intraspinally derived projection elements. These three dendrite systems clearly sample inputs of highly contrasting significance. The dorsal system presumably extracts information from a series of parallel neuropil plates acting as a first level of representation for parallel cutaneous fields upon the surface of the skin. The integrative operations of this system are presumably capable of modulation by cortical ( suprasegmental) and spinal (segmental) mechanisms via synaptic arrays on lateral and medial dendrites, respectively. It has, in fact, been demonstrated that spinal afferent conduction in the dorsal horn is susceptible to cortical control (Hagbarth and Kerr, 1954) and to manipulation of spinal input at remote levels (Wall, 1967).
B. DENDRITES AS POLYRECEPTIVE ELEMENTS 1. The Purkinje Cell One of the classic neurohistological examples of precise synaptic placement can be found in the Purkinje ( P ) cell of the cerebellum. Inasmuch as this is the principal efferent element of cerebellar cortex, it is not surprising that both of the major corticipetal afferent systems impinge upon this neuron. The climbing fiber, distributed essentially one per P cell, ascends along the primary and secondary dendrite branches only. The individual axon components divide and fuse a number of times in their course, thereby forming a kind of anastomotic vine partly enveloping the subjacent dendrite system. These climbing fiber elements “ride” the primary-secondary dendrite system virtually to the pial surface, thereby ensuring a continuous and intensive type of contact with the nonspine-bearing portions of the dendrite domain. Electrophysiological analysis reveals that the climbing fiber is, in consequence, a powerful and reliable activator of the individual P cell (Eccles et al., 1966a). The second major input to the Purkinje neuron is the parallel fiber system, arising from the subjacent granule cell complex. These elements,
OF PATTERN AND PLACE IN DENDRITES
17
running in enormous numbers parallel to the surface of cerebellar cortex, traverse the bidimensional P cell dendrite domains at right angles, effecting synaptic contact exclusively with the spines of the tertiary dendrite system. Fox and his co-workers (1967) have estimated that there may be as many as 120,000 spines on a single P cell and allowing, on the average, two presynaptic contacts per spine, it is obvious that the number of discreet impingements by parallel fibers on the tertiary dendrite system of a P cell is very great. This system has also been found to develop excitatory synaptic pressure on the P cell, although the response train is rapidly quenched by combined feed forward and feedback inhibitory effects also mobilized by parallel fiber activation of adjacent elements ( Eccles et al., 1966b). A third system contributing significantly to the presynaptic input is the axon system of cerebellar basket cells. These neuronal elements, which exist in moderate concentrations in the lower third of the molecular layer, extend their dendrites in tridimensional array into the parallel fiber stream, their main synaptic source of excitation. Their axons extend for many hundreds of microns at right angles to the course of parallel fibers, generating dense axonal terminal baskets about the axon hillockinitial segment areas of several rows of Purkinje cells. In effect, they usually envelop the P cell soma, the normal locus of the axon hillock. However, in the 5 to 10%of cases where the P cell axon issues from a primary dendrite, the basket cell terminal is generated here, instead. In either case, the electron microscope reveals the exclusive presence of symmetric synaptic profiles with flattened vesicles, a pattern now generally believed associated with inhibition ( Uchizono, 1965). Physiological data suggest that the basket cell input is an essential link in the inhibitory system of the cerebellar cortex (Eccles et al., 1967). Its position about the soma1 trigger zone is optimal for engendering a rapidly developed phasic control over neuronal spiking behavior (Eccles, 1964) and serves as an effective foil to the powerful synaptic driving effects mediated by the climbing fiber and parallel fiber systems farther out along the dendrites.
2. The Hippocampal Pyramid Another classic example of the degree of precision with which presynaptic terminals may be organized along neurons in a laminated environment is that of the hippocampal pyramid cell. Like the cerebellum, the hippocampus provides an example of a relatively simple 3-layered cortex where the source and termination of afferent elements are known and the major intracortical circuitry adequately delineated (Cajal, 1911; Lorente de N6, 1934). The pyramids are organized in a
18
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
single layer with their basal dendrites extending toward the fimbrial surface of the hippocampus, the apical shafts toward the deep boundary of separation from the dentate gyrus. Thus the dendritic system of each hippocampal pyramid traverses the entire thickness of cortex, offering maximal opportunity for sampling the synaptic milieu. As in the case of cerebellar Purkinje cells, and as we shall see below in the case of cerebral cortex pyramids, the hippocampal pyramidal soma is enshrouded by a rather dense axonal basket, generated by axons of adjacent local circuit or “basket cells,” terminating in symmetric synaptic profiles with flattened vesicles. Once again, this critical perisomatic position should offer maximal phasic control over the spike-initiating zone of the axon hillock-initial segment. It is physiologically appropriate, and consonant with current theoretically derived models, that this input proves to be inhibitory in nature (Andersen and Eccles, 1965), as the experimental data, indeed, demonstrate. Since the parent basket cells are driven, in part, by synaptic terminals generated by the outflow axons of many of these hippocampal pyramids, this seems to offer a unique example in mammalian neurohistology where both the synapses and pathway of a recurrent inhibitory system can be traced (Andersen, 1965). Along the comparatively short course of the basal dendrites of each hippocampal pyramid are a group of synaptic terminals apparently generated by axon collaterals of adjacent pyramids and of other nonbasket-producing local circuit cells. The precise role of these synaptic endings remain to be determined, although it seems not unlikely that those which are closely adjacent to the soma may be inhibitory, and those located farther toward the dendrite tips, excitatory. The apical dendrite system provides a rich example of synaptic termini, hierarchically ordered from soma to dendrite tip. Figure 6A identifies them from soma outward as basket cell endings, mossy fibers (originating in dentate pyramids), association paths (probably from septum and contralateral hippocampus ) , and Schaeffer collaterals (from hippocampal pyramids of the C A, region), all interspersed with terminals of short axoned (local circuit) cells. The latter apparently continue out onto the terminal twigs of the apical arches where endings from extrahippocampal afferents may also be found. The studies of Andersen (1965) and of Andersen and Eccles (1965) emphasize the preponderance of inhibitory effects exerted by most of these terminal systems with the apparent exception of (1) those along the apical twigs and ( 2 ) the endings of the Schaeffer collaterals. The latter terminate densely about the apical shaft, some 400 to SOOp from the cell body, in a virtually continuous cuff of asymmetrical synaptic profiles rich in
OF PATTERN AND PLACE IN DENDRITES
19
FIG. 6. Arrangement of presynaptic terminals on the polyreceptive dendrite systems of a hippocampal pyramid ( A ) and a large fifth layer pyramid of cerebral cortex ( B ) . A: Synaptic terminals include ( a ) collaterals of afferent fibers of presumably extrahippocampal source; ( b ) Schaeffer collaterals; ( c ) septa1 afferents; ( d ) mossy fibers; ( e ) basket cell terminals; ( f ) collaterals from other pyramidal cells. B: Synaptic terminals include ( a ) nonspecific thalamic and brainstem reticular core; ( b ) specific afferent radiation (i.e., geniculocalcarine radiation); ( c ) contralateral (callosal) afferents; ( d ) basket cell axons of adjacent stellate cells; ( e ) recurrent collaterals of other pyramidal cells. Based on Golgi-stained material.
spherical vesicles ( Hamlyn, 1963). Activation of this system apparently generates a considerable conductance change across the dendritic membrane, coeval with a large extracellular wave as index of depolarization of the apical shaft. All other terminal systems along the shaft, with even a fair degree of proximity to the soma, appear inhibitory in nature, their effectiveness decreasing roughly as a function of their distance from the trigger zone (Andersen, 1965). With the exception of the already rather remotely situated cuff of Schaeffer collaterals, all excitatory endings must therefore be considered ineffectively placed to exert any action save a rather low level tonic one upon the soma1 trigger zone.
3. Pyramids of the Cerebral Cortex We have saved until last a consideration of specificity of the placement of synapses along cortical pyramids, for several reasons. For one, this multilaminate structure is more complex, by several orders of magni-
20
MADGE E. SCHEIBEL AND ARNOLD B. SCHEIBEL
tude, than any other system. For another, most of the relevant data have been developed in our own laboratory over the past few yearssome still unpublished-and are accordingly subject to modification with further work and to more experience with other species. Finally, despite the intriguing nature of the data, and the extensive literature on electrical studies of neocortex, functional correlations still must remain speculative in nature, attesting, once more, to the complexity of cortical organization. Our findings are based largely on the use of Golgi techniques following section of selected corticipetal afferent systems in newborn animals. Because of studies of Colonnier (1964) and Walberg (1963),it has been established that following loss of the relevant presynaptic afferent system, the spines along that section of dendrite receptive to the afferent system, degenerate. It follows that, upon a suitable interval (30 days), spine counts along dendrites of suspected terminal areas should show diminution relative to nondenervated control areas, a presumption borne out by experiment. Using this method, a rather specific arrangement of afferent terminals upon cortical pyramids has been demonstrated and we shall use, as a paradigm, the fifth layer pyramid which characteristically spans most of the thickness of cortex. 1. Specific afferent fiber systems as epitomized by the geniculocalcarine (visual) radiation terminate directly upon the central third of the apical shaft ( Globus and Scheibel, 1967a). It has been known since the time of Cajal (1909, 1911) that such fibers generate a dense plexus in cortical layer 4,the site of densest accumulation of stellate or granule (local circuit, Golgi type 11) cells. It was accordingly inferred that these local circuit elements were the primary receptors for specific corticipetal projections, and only secondarily transferred the excitation to cortical pyramids, the major outflow elements of cortex. The loss of spines along apical shafts of the pyramids strongly indicates the presence of direct projections without intercalated cortical elements, especially in the absence of any noticeable changes in the local circuit cells, which might suggest a transsynaptic degenerative process. This conclusion is supported by our correlative structure-function studies in cortices of newborn animals, where it is clear that, at the perinatal phase of cortical development in some species, primary afferent fibers and pyramids are present and at least rudimentarily active at a time when the stellate elements of layer 4 are not sufficiently developed to serve as relays (Scheibel and Scheibel, 1W).Our data do not rule out the possibility that these stellate cells may eventually receive synaptic termini from the specific sensory radiation. However, this synaptic arrangement can no longer be considered either primary or exclusive. 2. The projection of axial nonspecific systems from brainstem or thalamus upon cortex has received abundant physiological documenta-
OF PA"J3RN AND PLACE I N DENDRITES
21
tion (Moruzzi and Magoun, 1949; Magni and Willis, 1963; and others), but anatomical support has proven more elusive. The pluriareal afferent system described by Lorente de N6 (1943) has been suggested as part of the terminal cortical elaboration of this system and has received critical reappraisal by Nauta and Whitlock (1954). Recent studies by Skinner and Lindsley ( 1967) have identified, by electrophysiological means, the rostra1 path of the thalamic nonspecific system, via the inferior thalamic peduncle, onto the orbitofrontal cortex. At approximately the same time, we have had the opportunity to study orbitofrontal tissue following unilateral lesions to the inferior thalamic peduncle. Spine couhts suggest a low density synaptic innervation along the entire length of apical shafts of orbitofrontal cortex (Scheibel and Scheibel, unpublished). This agrees with direct Golgi observation of projection fibers from the anterior third of the thalamic nonspecific system (Scheibel and Scheibel, 1967). It is likely, though not yet proven, that the projections from the brainstem reticular core (posterior to thalamus) upon cerebral cortex, both direct and indirect, are similarly applied to the apical shafts of pyramids, 3. Axons from a specific locus on one cortical hemisphere project through the corpus callosum to a contralateral mirror image point. This commissural projection terminates upon the oblique branches of apical shafts and apparently upon no other site (Globus and Scheibel, 196%). 4. Recurrent collateral systems from the axons of pyramidal cells constitute a massive intracerebral system of local circuits. Terminal synaptic sites are found upon the basilar dendrite shafts and apical arches of surrounding pyramids up to 3 to 5 mm distant (Globus and Scheibel, unpublished). Since the function of this system appears to be largely inhibitory ( Kameda et al., 1969), it provides cortical elements with an inhibitory surround probably devoted, at least in part, to the enhancement of representational interfaces. 5. As in previously described cortical structures, a basket cell system whose terminals are applied closely about the pyramidal somata has also been described by a number of authors (Cajal, 1911; Colonnier, 1965; Marin-Padilla, 1969). In this case, the pericellular envelope of terminals appears built up of synaptic arrays from axons of a number of different layer 4 stellate cells. On the basis of considerations previously noted, the system may be considered inhibitory in function although this conclusion must still be considered tentative.
C. SOMETHOUGHTS ON THE SIGNIFICANCE OF SYNAPTIC POSITION IN COMPLEX CORTICAL SYSTEMS Several interesting conclusions can be drawn from this brief examination of synaptic loci along cortical pyramids. Afferents of extracortical
22
MADGE E. SCHEJBEL AND ARNOLD B. SCHEIBEL
origin (specific and nonspecific projections) are applied only to the vertical components (apical shafts) of the neurons, while afferents of intracortical origin terminate exclusively on horizontal components (basilar dendrites, oblique branches, and tips of apical arches ) . We have found that for a given cortical area, the maximal horizontal breadth of the dendrite domain (as expressed by the spread of the apical arches, basilar dendrites, and oblique branches) of any pyramid approximates a constant figure within 5 to 7% (Globus and Scheibel, 1967~).The length or height of the domain depends on the position of the pyramidal cell body which can vary from a location in the superficial part of lamina 2 to the depths of layer 6. Thus the height of the domain may vary from less than 200 p to more than 2000 p , If we assume a rough correspondence between the amount of dendritic surface and the number of synaptic terminals contained thereon, it becomes clear that for any cortical area, each pyramid bears approximately the same number of terminals of intracortical origin, while the number of extracortically derived terminals will vary as a function of the position (depth) of the soma. In this way, the relative precision with which synaptic place is maintained along cortical pyramids helps to maintain at a constant value the total influx of stored (intracerebral) information available to all cells of an area, Similarly, since the depth of each pyramid in cortex determines the length of the apical shaft and, pari passu, the total influx of extracortical information, we might speculate that each cell in a given cortical sector is thereby enabled to compute a set of correlation functions unique to itself, on the basis of its position. Another conclusion growing out of the consistent arrangement of synaptic terminals concerns the relative efficacy of the various afferent systems. Drawing largely on the mathematical predictions of Rall ( 1964), supported by physiological data where available, it would appear that in the cerebral cortex, as in other cortical structures we have examined, the most powerful type of phasic control is exerted directly on the somal trigger zone via basket endings by adjacent local circuit elements. It is probably not an exaggeration to suggest that the cortex thereby maintains absolute control over the output performance of its intrinsic elements. The most powerful synaptic driving influence that can be exerted upon cortical pyramids is undoubtedly that of the specific afferent fibers which densely cuff the central portion of the apical shafts of fifth layer pyramids in an almost continuous collar of asymmetric, round vesicle-containing synaptic profiles. Although this location is usually several hundred microns from the somal trigger zone, the powerful and well-localized zone of depolarizing postsynaptic potentials produced here is unquestionably strongly reflected at the spike trigger zone. In contrast, the low
OF PATTERN AND PLACE. IN DENDRITES
23
density, linear type of synaptic continuum, along most of the shaft and apical arches produced by nonspecific afferents, is more likely to exert a long-term, low-grade tonus upon the trigger zone. Such an input may function less as a drive mechanism than as a bias adjust, continuously readjusting the l e ~ ofl response sensitivity of cortical pyramids to the moment-to-moment fluctuations in the responsiveness or alertness of the organism. Modulation of still greater complexity may be conceived as resulting from the other systems already cited. IV. Conclusions
We have shown in several neuropil fields of increasing complexity that there is some degree of precision in the ordering of the synaptic scale of terminating afferents. In some cases, such as the large lamina IV cells of the spinal cord, specific dendrites appear allocated to specific inputs. In much more complex fields, such as those of neocortex, there appears to be a hierarchy of preferential sites, each afferent system represented in maximal density of terminals along one dendritic segment. Formerly we would have believed that, upon this hierarchy of place, there could be superimposed a hierarchy of values with a single slope, i.e., the closer to the soma, the more effective the postsynaptic potentials generated along that segment of dendrite in modulating the spikeinitiating mechanism of the soma1 trigger zone. Such ideas deserve reevaluation in the light of evidence that there may be more than one trigger zone on a neuron and that, in some cases at least, spikes may develop and travel along portions of dendrite toward soma and axon hillock (Green and Petsche, 1961; Spencer and Kandel, 1961; Purpura et aE., 1966; and others). Under these conditions, distance from the cell body may no longer be the sole criterion of importance. Instead, the position of the terminals in relation to dendritic trigger zones in various positions throughout the dendrite field become of increasing significance, and a new responsibility devolves upon the investigator to devise recording techniques of sufficient resolution to identify such subsidiary foci of spike-initiating activity. No short review is likely to do justice to the extensive literature on dendrites, their manifold patterns, the range of their physiological activity, and the increasingly venturesome models proposed in explanation of their roles in the processing of information. As in any rapidly progressing field, experimental data demand verification, and hypotheses must face the challenge of time. In limiting ourselves to an examination of the morphology of dendritic domains, and the arrangement of various presynaptic systems within them, we have sought to present data which can reasonably be expected to remain valid and of value to theories of
24
MADGE E. SCHEBEL AND ARNOLD B. SCHELBEL
dendrite function, whatever the ultimate models propose. Without making “form follows function” an article of blind faith, we are powerfully persuaded that this now-trivial phrase remains of far-from-trivial import. If we are to interpret successfully the functional displays culled from studies of dendrites in action, then field shape and orientation as well as synaptic distribution must provide the background for such assays. We have chosen examples where pattern and form are clearly etched. Other equally compelling examples might have been selected, or added to this roster. The interests and prejudices of the writers determine the specifics of selection and exclusion. However, we would like to believe that the lessons which they illustrate are sufficiently general and compelling to transcend the specific examples, whether we have chosen wisely or ill. REFERENCES Aitken, J. T., and Bridger, J. F. (1961). 3. Anat. 95, 38. Andersen, P. (1965). In “The Brain and Conscious Experience” (J. C. Eccles, ed.), p. 89. Springer Verlag, New York. Andersen, P., and Eccles, J. C. (1965). Symp. Biol. Hung. 5, 219. Bishop, G. H., and Clare, M. H. (1952). J. Neurophysiol. 15, 201. Bishop, G. H., and Clare, M. H. (1953). J. Neurophyviol. 16, 1. Bok, S. T. (1959). “Histonomy of the Cerebral Cortex.” Elsevier, Amsterdam. Burke, R. E. (1967). 1. Neurophysiol. 30, 1072. Cajal, S. R. (1894). “Die Retina der Wirbelthiere.” Bergmann, Wiesbaden. Cajal, S. R. (1909). “Histologie du Systhme Nerveux de 1’Homme et des Verthbrhs,” Vol. 1. Maloine, Paris. Cajal, S . R. (1911). “Histologie du Systhme Nerveux de l’Homme et des VerthbrBs,” Vol. 2. Maloine, Paris. Colonnier, M. (1964). J . Anat. 98, 47. Colonnier, M. (1965). In ‘The Brain and Conscious Experience” (J. C. Eccles, ed.), p. 1. Springer Verlag, New York. Colonnier, M. ( 1967). Personal communication. Dale, H. H. (1935). PTOC.Roy. Soc. Med. 28, 319. Eccles, J. C. (1964). “The Physiology of Synapses.” Springer, Berlin. Eccles, J. C., Llinb, R., andISasaki, K. ( 1966a). J. Physiol. (London) 182, 268. Eccles, J. C., Llinb, R., and Sasaki, K. (1966b). Exptl. Brain Res. 1, 82. Eccles, J. C., Ito, M., and Szentagothai, J. (1967). “The Cerebellum as a Neuronal Machine.” Springer Verlag, New York. Fox, C. A., and Barnard, J. W. (1957). 3. Anat. 91, 299. Fox, C. A., Hillman, D. E., Siegesmund, K. A., and Dutta, C. R. (1967). Progr. Brain Res. 25, 174. Gerlach, 0. (1871). Von dem Ruckenmark in Strickers Handbuch. Quoted in Cajal (1909), p. 54. Gesell, R., Brassfield, C. R., and Lillie, R. H. (1954). J. Comp. Neurol. 101, 331. Globus, A,, and Scheibel, A. B. (1967a). Erptl. Neurol. 18, 116. Globus, A.,and Scheibel, A. B. (1967b). Science 156, 1127. Globus, A., and Scheibel, A. B. ( 1 9 6 7 ~ )J.. Comp. Neurol. 131, 155.
OF PATlXRN AND PLACE IN DENDRITES
25
Goldberg, J. M., and Brown, P. B. (1969). j . Neurophysiol. 32, 613. Golgi, C. ( 1903). “Opera Omnia,” Vols. 1 and 2. Ulrico Hoepli, Milan. Gray, E. G. (1959). J. Anat. 93, 420. Gray, E. G. ( 1964). In “Electron Microscopic Anatomy” ( S . M. Kurtz, ed.), p. 369. Academic Press, New York. Green, J. D., and Petsche, H. (1961). EZectroencephalog. Clin. Neurophysiol. 13, 868. Grundfest, H. (1957). Physiol. Reu. 37, 337. Hagbarth, K. E., and Kerr, D. I. B. (1954). 3. Neurophysiol. 17, 295. Hamlyn, L. H. (1963). I. Anat. 97, 189. Hild, W., and Tasaki, 1. (1962). J. Neurophysiol. 25, 277. Hubel, D. H., and Wiesel, T. N. ( 1959). 3. Physiol. (London) 148, 574. Kameda, K., Nagel, R., and Brooks, V. B. (1969). J. Neurophysiol. 32, 540. Kandel, E. R., Frazier, W. T., and Coggeshall, R. E. (1967). Science 155, 346. Leontovitch, T. A., and Zhukova, G. P. (1963). J. Comp. Neurol. 121,347. Lettvin, J. Y., Maturana, H. R., Pitts, W. H., and McCulloch, W. S. ( 1961). In “Sensory Communications” ( W. Rosenblith, ed.), p. 757. MIT Press and Wiley, New York. Lorente de N6, R. (1934). I. Pyschol. NIWO~. 46, 113. Lorente de N6, R. ( 1939). 1. Neurophysiol. 2, 402. Lorente de N6, R. (1943). Cited in Fulton, J. F. (1943). “Physiology of the Nervous System,” p. 274. Oxford Med. Publ., Oxford. Lorente de N6, R. (1947). 3. Celluhr Comp. Physiol. 29, 207. Magni, F., and Willis, W. D. ( 1963). Arch. Itul. B i d . 101, 667. Mannen, H. ( 1966). In “Correlative Neurosciences. Part A: Fundamental Mechanisms’’ (T. Tokizane and J. P. Schadb, eds.), p. 131. Elsevier, Amsterdam. Marin-Padilla, M. (1969). Bruin Res. 14, 633. Moruzzi, G., and Magoun, H. W. ( 1949). Electroencephulog. Clin. Neurophysiol. 1, 297. Mountcastle, V. B. ( 1961). In “Sensory Communication” (W. A. Rosenblith, ed.), p. 403. MIT Press and Wiley, New York. Nauta, W. J. H., and Whitlock, D. G. (1954). In “Brain Mechanisms and Consciousness” (J. F. Delafresnaye, ed.), p. 81. Thomas, Springfield, Illinois. Nelson, P. G. (1966). J. Neurophysiol. 29, 275. Nelson, P. G., and Frank, K. (1964). 3. Neurophysiol. 27, 913. Olszewski, J. (1954). In “Brain Mechanisms and Consciousness” (J. F. Delafresnaye, ed.), p. 54. Thomas, Springfield, Illinois. Purpura, D. P., and Cohen, B. (1962). J. Neurophysiol. 25, 621. Purpura, D. P., McMurtry, J. G., Leonard, C. F., and Malliani, A. (1966). I. Neurophysiol. 29, 954. Rall, W. (1962). Ann. N.Y. Acad. Sci. 96, 1071. Rall, W. (1964). In “Neural Theory and Modeling” (R. F. Reiss, ed.), p. 73. Stanford Univ. Press, Stanford, California. Rall, W. (1967). J. Neurophysiol. 30, 1138. Rall, W., Burke, R. E., Smith, G. T., Nelson, P. G., and Frank, K. (1967). J. Neurophysiol. 30, 1169. Ram6n-Molinar, E., and Nauta, W. J. H. (1966). J. Comp. Neurol. 126, 311. Rexed, B. (1952). 1. Comp. Neurol. 96, 415. Scheibel, M. E., and Scheibel, A. B. (1955). J. Comp. Neurol. 10%77.
26
MADGE E. SCHEUBEL AND ARNOLD B. SCHEIBEL
Scheibel, M. E., and Scheibel, A. B. (1958a). Electroencephalog. Clin. Neurophysiol. Suppl. 10, 42. Scheibel, M. E., and Scheibel, A. B. (1958b). In “Reticular Formation of the Brain” (H. Jasper et al., eds.), p. 31. Little, Brown, Boston, Massachusetts. Scheibel, M. E., and Scheibel, A. B. (1962). In “Interhemispheric Relations and Cerebral Dominance” (V. B. Mountcastle, ed.), p. 26. Johns Hopkins Press, Baltimore, Maryland. Scheibel, M. E., and Scheibel, A. B. (1963). Ekctroencephalog. Clin. Neurophysiol. Suppl. 24, 235. Scheibel, M. E., and Scheibel, A. B. (1966a). In “The Thalamus” (D. P. Purpura and M. Yahr, eds.), p. 13. Columbia Univ. Press, New York. Scheibel, M. E., and Scheibel, A. B. (196613). Brain Res. 2, 333. Scheibel, M. E., and Scheibel, A. B. (1967). Brain Res. 6, 60. Scheibel, M. E., and Scheibel, A. B. (1968a). Brain Res. 9, 32. Scheibel, M. E., and Scheibel, A. B. (1968b). In “The Neurosciences” ( G . Quarton, T. Melnechuk, and F. Schmitt, eds.), p. 577. Rockefeller Univ. Press, New York. Scheibel, M. E., and Scheibel, A. B. (1969). Brain Res. 13, 417. Scheibel, M. E., Scheibel, A., Mollica, A., and Moruzzi, G. (1955). J. Neurophysiol. 18, 309. Scheibel, M. E., Uchiyama, K., Uchiyama, T., and Scheibel, A. B. (1961). Unpublished observations. Sholl, D. A. (1956). “The Organization of the Cerebral Cortex.” Methuen, London. Skinner, I. E., and Lindsley, D. B. (1967). Bruin Res. 6, 95. Smith, T. G., Wuerker, R. B., and Frank, K. (1967). 1. Neurophydol. 30, 1072. Spencer, W. A., and Kandel, E. R. ( 1961). J. Neurophysiol. 24, 272. Szentagothai, J. (1964). J. Comp. Neurol. 122, 219. Tauc, L., and Gerschenfeld, H. M. (1961). Nature 192, 366. Uchizono, K. ( 1965). Nature 207, 642. Walberg, F. ( 1963). Exptl. Neurol. 8, 112. Wall, P. D. (1967). J. Physiol. (London) 188, 403.
THE FINE STRUCTURAL LOCALIZATION OF BIOGENIC MONOAMINES IN NERVOUS TISSUE By Floyd E. Bloom laboratory of Neuropharmacology, Division of Special Mental Health Research, National Institute of Mental Health, Saint Elizobeths Hospital, Washingfon, D. C.
I. Introduction . . . . . . . . . . . . 11. Model Tissue Experiments and the “Ideal Localizing Paradigm” . A. Criteria for the Cytochemical Localization of Monoamines . . B. Reactivity of Biogenic Amines with Electron Microscope Fixatives . . . . . . . . . and Stains in Vitro . C. Model Experiments in Vivo . . . . . . . . D. Constraints on the Use of Autoradiography . . . . . 111. The Binding of Biogenic Monoamines to Cellular Organelles . . A. Background . . . . . . . . . . . . B. Monoamine Binding Reactions to Tissue Components . . . IV. Localization of Monoamines in Nervous Tissue . . . . . A. Peripheral Sympathetic Nerve Terminals . . . . . . B. Central Nerve Terminals . . . . . . . . . C. Monoamine Cell Bodies and Nonterminal Axons . . . . V. Conclusions . . . . . . . . . . . . References . . . . . . . . . . . .
27 28 28 29 35 38 39 39
40 41 41 53 59 61 62
I. Introduction
The recent history of biological electron microscopy (see Barrnett and Tice, 1963; Zobel and Beer, 1 9 6 ) indicates the increasing efforts which have been made to develop techniques imparting chemical as well as morphological information. Despite these efforts, electron cytochemical reactions are at best able to identify a select few nonenzymatic cellular components, most of which fall into the category of macromolecules such as DNA, glycogen, glycoproteins, lipids, and certain partially characterized charged proteins (Beer, 1965; Bloom and Barrnett, 1970). In neuropharmacological research, special attention has been devoted to the problem of high resolution cytochemical methods for the identification of synaptic transmitter substances in intact nervous tissue, as this essential criterion must be satisfied in order to identify a substrate as the likely transmitter for particular defined synaptic contacts (see McLennan, 1963; Paton, 1958; Bloom and Giarman, 1968a,b; Bloom, 1969). In t h i s review, the currently available electron cytochemical 27
28
FLOYD E. BLOOM
methods for the biogenic monoamines, norepinephrine ( NE ), dopamine (DA), and serotonin (5-HT) will be critically analyzed. The electron microscopic details of monoamine-storing nervous tissues has already been reviewed many times in the recent past (Grillo, 1966; Bloom and Aghajanian, 1968a; Bloom and Giarman, 1968a; Hokfelt, 1968a,b; Tranzer et al., 1969; Jaim-Etcheverry and Zieher, 1 9 6 9 ~ ) .Particular emphasis will now be placed on the state of knowledge of the cytochemical reactions involved in the localizations. Hopefully this will provide an interpretive base for the data at hand and stimulate further experimentation. II. Model Tissue Experiments and the "Ideal localizing Paradigm"
A. CRITERIAFOR THE CYTOCHEMICAL LOCALIZATION OF MONOAMINES In order to establish the identity and specificity of a cytochemical reaction designed to localize a substance as small as NE, DA, or 5-HT, the following criteria may be of value: 1. The precipitate or electron stain can be shown to selectively react with the desired substance in vitro. The relevant chemical reactions on this area are reviewed below (Section 11, B and C ) . 2. The distribution of the reactive tissue sites agrees with light microscopic histochemical and cellular biochemical analyses of the substance. Almost all quantitative ultrastructural evaluations of staining methods for monoamines are predicated upon the fluorescence histochemical data (see Van Orden et al., 1966; Bloom and Aghajanian, 1968a; Hokfelt, 1968a,b). The data on nerve ending particles, synaptic vesicle fraction analyses, and fluorescence histochemistry of monoamines are discussed separately (Section 111). 3. The amount of the reactive material should fluctuate in proportion to the amount of amine in the tissue when pharmacological depletion studies, loading studies, or catabolic inhibition cause fluctuations in the biochemically measurable levels. Such studies have formed the bulk of the data in which electron microscopic analyses of peripheral and central nervous tissues have been studied after pharmacological manipulations. This data will be discussed in detail (Section V ) . 4. The tissue elements reacting to the staining method should be confirmed by autoradiographic studies in which radioactive amine is physiologically introduced into the tissue pool of monoamine, and then serves as a separate marker for the sites binding the substance. This criterion has several subrequirements of its own, and is discussed separately ( Section 11, D ) . 5. Destruction of the nerve pathways which give rise to the mono-
LOCALIZATION O F MONOAMINES
29
amine-containing fibers should remove all the axons which gave a positive staining reaction. This criterion would appear to be relatively easily established for the peripheral nervous system, where the classical neuroanatomy is well established. However, in actual practice, it has been applied only irregularly there and quite rarely in the central nervous system (Section V ) . 6. The staining reaction should be confirmed by auxiliary cytochemical methods for the demonstration of synthetic or catabolic enzymes relevant to the monoamines. This last criterion is mere wishful thinking at the present time, since none of the synthetic enzymes, and only monoamine oxidase (Boadle and Bloom, 1969) of the catabolic enzymes, appear to be approachable from this standpoint, even by light microscopy. However, since enzymes are dynamic macromolecules, they may be localizable either by formation of an electron-opaque catabolite as is the standard approach for such enzymes as adenosine triphosphatases (see Barrnett and Tice, 1963) or cholinesterases (Koelle, 1969), or by electron microscope immunocytochemistry ( Sternberger, 1967).
B. REACTIVITY OF BIOGENIC AMINESWITH ELECTRON MICROSCOPE FIXATIVES AND STAINSin Vitro An extensive armamentarium of light microscopic reactions are available to identify the monoamines histochemically in adrenal medullary chromaffin cells, intestinal enterochromaffin cells, and mast cells. These reactions were developed empirically and have only become understood as the identification of the particular monoamines involved became clarified. However, inasmuch as the majority of these reactions depend upon the development of specific colored end-products, they did not appear directly applicable to the electron microscope. As applied to nervous tissues, prior to 1965, the only available cytochemical reactions on the nature of synaptic vesicle contents were based upon the peculiar variations in electron opacity of the vesicles after using OsO, as a combined fixative and electron stain (de Robertis and Pellegrino de Iraldi, 1961a,b; Grill0 and Palay, 1962; Richardson, 1958, 1962, 1963, 1964). The basis for accepting an osmiophilic subcellular precipitate as an indicator of monoamine content stemmed almost entirely from the untested assumption that the monoamines were “known to be potent reducing substances” (de Robertis and Pellegrino de Iraldi, 1961a,b). While this statement has indeed been borne out by subsequent independent experimentation, we shall see that interpretation of the reactions and their applicability to different types of amine-storing tissues is still quite an open field, eagerly awaiting new approaches. If tissue monoamine stores can be approximated by a solution of the
TABLE I REACTION OF MONOAMINES WITH STAININQ FIXATIVES ~~~
~~~~
~~~
~~
~
~~~~
~~
~~
~
~~
Test for reaction
Amine Norepinephrine Epinephrine Dopamine Serotonin 5-OH dopaminei 6-OH dopamine a-Methyl norepinephrine Metaraminol
0 ~ 0 4 "
+ + +
+ 0 0 0
Formaldehydeb
Glutaraldehydec
0 0 0 0
+ + +
+
KMn04d
++ ++ ++ ++ ++ ++ ++ ++
Glutal. K2Cr20p
Glutal. Agf
++++ ++
Van Orden et aZ. (1966). Hopsu and Makinnen (1966). Wood and Barrnett (1964), Conpland et al. (1964), Solcia et al. (1969). Hokfelt and Jonsson (1968). Wood and Barrnett (1964), Jaim-Etcheverry and Zieher (1968a, 1969~). f Tramezzani et al. (1964), Cannata et al. (1968). Solcia et al. (1969). * Coupland et al. (1964), Machado (1967), Tranzer and Thoenen (1967), Tranzer et al. (1969). a Tranzer and Thoenen (1967). a
++ + + +
+
+
Glutal. ninhydrino 0
0
+
Glutal. OsOah
+ + +
?
3
m
P0 0
z
LOCALIZATION OF MONOAMINES
31
amine, then test tube reactions may help us understand the reactivity of these substances with the commonly used fixatives (Table I ) , These tests indicate that a very large spectrum of naturally occurring and synthetic catecholamines and indolealkylamines will “reduce” Oso, and KMnO, to form grossly visible precipitates. However, from the reported data, it is uncertain whether such precipitates indicate insoluble polymers of the oxidized amines, or of the reduced metallic oxidants, or of some coordination complex between the two. Since it is the electron opacity of the precipitate which is most crucial, this information is obviously needed to interpret the qualitative chemical analyses.
1. Reactions of OsO, When Oso, is used as a fixative, it is ordinarily maintained in buffered solutions at pH 7-7.5, and as a 1-2%solution, for periods of 1 4 hr. Two questions essential to the problem at hand are retention of the monoamine in its tissue site during the fixation process with oso, and the subsequent oxidation-reduction reaction indicated by the test tube experiments. Because of its slow penetration, oso, is commonly used in immersion fixation at temperatures in the 3’5°C range, by which it is hoped to slow autolysis of cellular organelles. However, the cooler temperature is also likely to influence the reactivity of the 0 s and of the available reactive groups in the tissue, as well as the relative extraction of reactive tissue components. The reactions undergone by oso, were originally thought to be reduction of the 0 s to “osmium black,” a finely granular form of metallic osmium (Hanker et al., 1967). Despite the large number of investigations into the nature of the reaction of osmium in vitro and with tissue components (see Adams et al., 1967), it is still not certain which of the many reactions contribute to the electron opacity of the tissues and which to the reduction of osmium, The most recent data suggest that oso, is able to form several types of coordination compounds with reactive tissue components (Hanker et al., 1964,1966,1967; Seligman et al., 1966; Adams et al., 1967; Litman and Barmett, 1969), some of which may continue to form polymeric compounds leading to opaque precipitates within the tissue structure. In addition to double bonds, oso4 is reduced by mercaptyl and thiocarbamyl groups (Hanker et al., 1964, 1967), of which only the former occtws in animals. Proteins and polysaccharides are said to react poorly with Os, although proteins are broken up by it and “leeched” from the tissues during prolonged exposures ( Hake, 1965). This latter property is likely to be the cause of some of the high electron contrast of membranes of Os0,-fixed tissues (Pease, 1964).
32
FLOYD E. BLOOM
2. Other Oxidizing Substances
The only other metallo-oxidants of proven or suggested value as fine structural fixatives or electron strains are KMnO, (and other alkali metal salts of Mn0,- such as Na or Li) and K2Cr20,.Of the two, Mn0,has the somewhat greater redox potential (1.51, as compared to 1.33for Oso,). In both cases, the redox potential is increased by use of acidic unbuffered solutions (Cotton and Wilkinson, 1966), favoring the formation of the dioxide forms of each metal ( CrO, and MnOz). The tissue groups reacting with these substances are not well characterized aside from being “reducing substances” ( see Hake, 1965; Pearse, 1969) , although tissue proteins are thought to be particularly broken down by Mn0,- (Lenard and Singer, 1968). MnOz occurs in nature as a grayblack precipitate which would be expected to be somewhat more electron opaque than chromium oxide, although the latter has been found in tissue (Pearse, 1969) and filter residues (Arnold and Hager, 1968a,b), while the former has not. Since MnO, is readily attacked by reducing solutions, it should be possible to remove its contribution to electron opacity by this means and thus lead to an evaluation of the opacity of pigments it may have formed from the monoamines. As to the preservation of fine structure, Mn0,- salts in concentrations of 343% (Richardson, 1966; Hokfelt, 1967b,c, 1968a,b; Grillo, personal communication) can yield acceptable results on small blocks of tissue immersed for 2-4 hr at 0°C. The “fixation” with Crz072-is poor unless previously well fixed with aldehyde (Wood and Bannett, 1964; Tranzer and Snipes, 1968). 3. Metallic Oxidation after Primary Exposure to Aldehyde Fixatives a. Reactions with Formaldehyde in Solution. Although the standard choice for most optical microscopists, formalin was initially bypassed as a fixative for electron microscopy (see Pease, 1M4). Nevertheless, as demonstrated in freezeldry fluorescence histochemistry, the condensation of DA, NE (reactions 1 and 2), and 5-HT (reaction 3) with formaldehyde vapor rapidly produces an insoluble form of the amine (see Corrodi and Jonsson, 1968) which should be available for electron staining. On
33
LOCALIZATION OF MONOAMINES
the other hand, with respect to test tube precipitate formations, there is generally little to be seen between the NE, DAY5-HT, and formaldehyde in solution (Eranko, 1967; Hopsu and Makinnen, 1966; Laties et al., 1967). Provided a condensation of the Pictet-Spengler type did occur (see Corrodi and Jonsson, 1968), the resultant heterocyclic compounds ( quinolines and carbolines ) could effectively reduce metallic oxidants, although the exact nature and extent of the reaction remains to be studied. b. Reaction with Glutaraldehyde. The dialdehyde of glutaxic acid was first reported to be a superlative fixative for the fine structure by Sabatini et al. (1963). When solutions of this fixative are mixed with monoamines in the test tube, obvious yellowish precipitates can be seen to form with each of the 3 monoamines which are primary amines, but not with epinephrine, which is a secondary amine (Table I ) . The form of this reaction is believed to be (4)
A
B
1
As a dialdehyde, polymer formation by this reaction might also proceed (see Coupland and Hopwood, 1966) and would account for the majority of the yellow precipitate mentioned above. However, each NE molecule has only one reactive site, and each glutaraldehyde only two; therefore, if the ratio of 1:1 in the final precipitate is valid ( Coupland and Hopwood, lW),the exact structure of such a polymer is difficult to understand. The reaction of the monoamines with glutaraldehyde does not alter the reducing power of these substances (provided that excess aldehyde is removed) nor does it alter the reactivity of the pyrrolic indole of 5-HT ( Solcia et al., 1969), suggesting that the condensation must not close the terminal side chain into a ring form as occurs with formaldehyde, Hence, we would expect (no direct published data exist) that the monoamine-glutaraldehyde polymer should also be capable of reacting with the oxidants (reactions 4,B, C, D ) , although the relative amount of coordination compound formation which would occur must also be
34
FLOYD E. BLOOM
evaluated. Clearly the complex of aldehyde and monoamine can reduce alkaline silver salts to the metal (Tramezzani et al., 1964; Cannata et aZ., 1968; see Fig. 2).
4. Oxidation of the Monoamines to Insoluble Pigments A great body of rather precise organic chemical data and histochemical observations is available on the formation of pigments from catecholamines, because this is the main route for the formation of melanins (see Pearse, 1961) and aminochromes (see Heacock, 1965). In the case of the naturally occurring catecholamines, the reaction is believed to be ( 5 )
The aminochromes are of further interest in several regards. First, they represent the natural form of catechol-polymers such as melanin, which are known to be electron opaque in electron microscopic investigations of melanophores (Riley and Fortner, 1963). This indicates that equivalently electron-opaque products might be expected to occur from monoamines if the proper cytochemical production method were available. Second, the precise chemical changes during the oxidative cyclization reaction (see reactions 5, A-F) have recently been worked out (Harrison et al., 1968). These data indicate the reaction to be p H dependent, increasing in direct relation to H+ concentration, and that the hydrogens removed during the oxidation are most likely to have come from the two phenolic groups and the amino group. Furthermore, the reaction was noticeably catalyzed by Zn". Of pertinence to the interpretation of studies on the tissue retention of dl-73H-norepinephrine radioactivity with various fixatives (see below), no hydrogens were removed from the 7 ethylamine carbon during the oxidation. A naturally occurring plasma transhydrolase which would remove this side chain H+has been reported (reaction 5, G; Pichler et al., 1968). Similar information on the nature of the 5-HT oxidation would be very useful.
LOCALIZATION OF MONOAMINES
35
C. MODELEXPERIMENTS in Vivo 1. Catecholumine Test Tissues Regardless of the success of in vitro tests, only with application to tissues can the relative sensitivity of the method be evaluated. Thus, with the first attempts at specific localizations of catecholamines by electron microscopy, the tissue tested was the adrenal medullary cell, in which the high concentrations of catecholamines, the Iight microscopic success of the chromaffin reaction, and the rather extensive data on isolated chromaffin granules, made the chances for cytochemical localization of NE likely. Wood and Barrnett (1964) were, in fact, able to show that adrenal medulla fixed in glutaraldehyde and exposed to acidic solutions of K,Cr,O, resulted in selective opacification of the chromaffin granules of NE-containing cells, but not those of epinephrine cells. The latter remained unstained until the pH approached neutrality. Subsequently, Coupland et a2. (1964; Coupland and Hopwood, 1966) showed the same cytochemical separation between NE cells and epinephrine cells occurred if neutral Oso, (Fig. 1) were substituted for K,CrzO,. The latter reaction appears superficially to be less selective, since the Oso, also makes multiple organelles and membranes electron opaque, whereas the former method results in much greater opacification of chromaffin granules than other cytoplasmic structures. In both cases the reaction seems to be based upon the selective retention of the primary amine, NE, in the tissue by the glutaraldehyde, while epinephrine is lost either in the acidic rinses or during the exposure to osmium. In the reaction system proposed by Coupland, it should be noted that the “negative” reaction given by the epinephrine-containing granules is not completely negative, but that the granules exhibit a fibrillar, moderately electron-opaque, central matrix. The condensation of glutaraldehyde with NE in the granule also appears to account for the positive staining of the slightly opaque chromaffin granules exposed to ammoniacal silver after glutaraldehyde fixation (Tramezzani et al., 1964; Cannata et al., 1%8; Fig. 2). On the other hand, adrenal medullary tissue fixed in KMnO, shows no electron opacity within the chromaffin granules of either cell type (Duncan and Yates, 1967), although Hokfelt has obtained some precipitate in the NE cells of rat (personal communication).
2. lndolealkylamine Test Tissues While the adrenal medulla provides an effective test system for the localization of NE, there appeared to be no equivalent system for 5HT,
36
FLOYD E. BLOOM
FIG.1. Adrenal medulla of normal rat, after fixation with glutaraldehyde/OsOa.
LOCALIZATION OF MONOAMINES
37
FIG. 2. Norepinephrine-containing adrenal medullary cell from cat showing positive glutaraldehyde/silver reaction over chromaffin granules. All other cytoplasmic organelles, nucleus, and epinephrine-containing cells remain unreactive X 18,000. Contributed by Drs. S. R. Chiocchio and J. H. Tramezzani (see Tramezzani et al., 1964; Cannata et al., 1968).
until Tranzer et al. ( 1966) reported that rabbit platelets (which normally contain about 350 pg of 5-HT per 1O’O platelets) fixed in glutaraldehyde and exposed to OsO, exhibit unique electron-opaque organelles which can only be seen after this type of preparation. This organelle appears as a membrane-bounded vacuole in which the osmium exposure after glutaraldehyde produces an extremely electron-opaque deposit. The “osmiophilic” material in the vacuole is decreased if the platelets are exposed to reserpine to block 5-HT storage, and it can be restored if the platelets are incubated in rather high concentrations of 5-HT ( 1 mg/ml) . The same type of granule can be produced in guinea pig platelets incusequence (see Coupland et al., 1964). Very dense electron-opaque deposits are present in chromaffin granules of norepinephrine cell at top, while those of epinephrine-containing cell at bottom are much less electron opaque. The cells are separated by an intercellular space in which molls exhibiting large granular vesicles (arrows) may also be seen X 24,000. Insets show each type of chromaffin granule at higher power. Insets X 108,000 ( Bloom, unpublished).
38
FLOYD E. BLOOM
bated in 5-HT and can be seen in human platelets from patients having abnormally high platelet 5-HT levels (Boullin et al., 1969; Hattori, 1967). Platelets have also served as a model system for a triple fixation sequence method for the localization of 5-HT (Jaim-Etcheverry and Zieher, 1968a,c, 1969a). The reaction of Wood and Barmett (1964) for NE is blocked by initial fixation in liquid formaldehyde, after which glutaraldehyde exposure followed by K,Cr,O, results in selective opacification of the platelet granules (Tranzer et al., 1966), and of similarly appearing granular material in cells of the endocrine pancreas and thyroid (JaimEtcheverry and Zieher, 1968b,c). In each case, the exclusive independent criterion by which the reactive material is identified as 5-HT is based upon the in vitro reaction and upon the ability of reserpine to deplete the reactive material as it depletes the 5-HT. ON THE USEOF AUTORADIOGRAPHY D. CONSTRAINTS
Although electron microscopic autoradiography is often regarded as “high resolution,” with all commercially available emulsions of halide crystal sizes between 50 and 300 mp, the true resolution can be no greater than 80-150 mp, (Saltpeter et al., 1969). Therefore, autoradiography under the best of circumstances would only be able to distinguish certain types of axons and structures the size of chromaffin granules, while completely unable to distinguish among adjacent synaptic vesicles. Despite these disadvantages in resolution, autoradiography can still be a valuable adjunct to other cytochemical methods in localizing tissue chemical components, provided certain constraints are met. In the general circumstance in which the radioactive material is taken up by the cells and incorporated into a macromolecule, one needs only to ascertain that the amount of material injected as a tracer label did not alter the cellular activity of the cells, and that the radioactivity which remains in the tissue is not translocated from the sites labeled before fixation (see Stumpf and Roth, 1968). In the case of neurotransmitters, such as the monoamines in the case at hand, it must be ascertained that the amount of monoamine injected does not overload the relatively specific axonal processes for intra-axonal accumulation (see Iversen, 1967; Fuxe and Ungerstedt, l W ) , that radioactive metabolites of the injected substance are retained in the tissues to a substantially lower extent, and that the main, if not exclusive source of tissue radioactivity after fixation, is in fact due to the substance to be localized. Thus, Taxi and Droz (1969) have shown that only the catecholamine is retained by the peripheral sympathetic tissues after their preparative procedures. Similarly, Aghajanian and I showed that there was minimal retention of 3H-NE radioactivity after acute treatment of the central nervous system with
LOCALIZATION OF MONOAMINES
39
reserpine, suggesting that the unbound metabolites of the injected monoamine do not result in falsely positive autoradiographic localization ( 196713) I l l . The Binding of Biogenic Monoamines to Cellular Organelles
A. BACKGROUND By virtue of the tremendous amount of data collected by biochemical neuropharmacologists ( Glowinski et al., 1965, 1966; de Robertis, 1966; Whittaker, 1966; Pellegrino de Iraldi et al., 1968), cytochemists have a great deal of background with which to approach the problem of fine structural localization. The subcelhlar distribution of tissue norepinephrine was first studied on homogenates of the adrenal medulla (Blaschko and Welch, 1953) and splenic nerve (von Euler and Hillarp, 1956). In these tissues and in several sympathetic organs analyzed later (see Stjarne, 1966; Potter, 1967; Iversen, 1967), the monoamine content was richest in the microsomal fragments containing particulate structures on the order of 30-200 mp in size by electron microscopy. This binding of monoamines to particulate elements in honiogenates has thereafter been referred to trivially as the “storage granule” or granular amine fraction, in reference to the chromaffin granules. When subcellular fractionation studies were extended to the central nervous system (see de Robertis, 1966; Whittaker, 1966), the catecholamines could be found in those fractions of the homogenate which contained pinched-off nerve endings and in which synaptic vesicles could be seen. The greatest enhancement of specific concentration of acetylcholine (ACh) occurred when rather pure collections of the synaptic vesicles were obtained from ACh-rich nerve ending fractions. Highly purified vesicle fractions containing monoamines have not been prepared (see Maas and Colburn, 1965), due in part to lack of methods to retain the amines within the particles during the separation procedures ( Michaelson and Whittaker, 1963; Michaelson, 1967). Nevertheless, it is widely considered that the major portion of the particulate fraction monoamine is contained within synaptic vesicles, and that those portions of the axon in which vesicles are most heavily concentrated are also revealed by fluorescence histochemistry at the light microscopic level of resolution (see Dahlstrom and Fuxe, 1965; Fuxe, 1965a; Fuxe, 1965b). Recently, fluorescence histochemical data have been interpreted to indicate that this method may actually be most successful in demonstrating the monoamine which lies outside the presumptive storage vesicles but still within the axoplasm (Van Orden et al., 1969). While the above data and numerous indirect supportive observations relate monoamine storage to subcellular particles in either homogenates
40
FLOYD E. BLOOM
or tissue elements observed by light microscopy (see Iversen, 1967), electron microscopic resolution is required to relate the particulate storage fraction to specific nerve terminals and to specific organelles within the nerve terminals. REACTIONS TO TISSUE COMPONENTS B. MONOAMINEBINDING Before proceeding to the data contributing directly to this solution, let us examine the possible modes of binding of tissue monoamines to the subcellular organelles. Most of this type data have arisen from two sources: the study of adrenal chromaffin granules and of the similar but clearly not identical “granules” isolated from bovine splenic nerves. The chroma5n granules contain, in addition to the monoamines, large amounts of adenosine triphosphate ( ATP) as well as proteins, lipids, and possibly ribonucleic acids ( Schumann, 1966). During physiological release of the adrenal catecholamines, the ATP and at least two granule specific proteins are also released (Douglas, 1968; Kirschner, 1969). In both chromaffin granules and splenic nerve granules, the ratios of the monoamine to ATP are usually quite constant in a ratio of 1 ATP to 4 NE. This has lead to the speculation that the catecholamine may be stored in the granule by a form of coordination complex, in which an endogenous metal, such as Cu, may act to form a ternary complex (Maas and Colburn, 1965; Colburn and Maas, 1965). Such conclusions have been tested by simulation of the systems chemically in uitro and demonstrating monoamine binding. Present data are unclear regarding the amounts of protein that can be found in isolated brain synaptic vesicles thought to store norepinephrine (Colburn and Maas, 1965; Potter, 1967), and the contribution of protein to the formation or stabilization of the ternary complexes thus cannot yet be established. Furthermore, based on in vitro data, phospholipids such as phosphatidylinositol and phosphatidylserine can also be shown to exhibit binding affinity for catecholamines (Formby, 1968). Since these phospholipids also occur within the synaptic vesicles, they may provide some physiological binding as well. However, the main body of evidence on subcellular binding chemistry suggest that the catecholamine is held inside the vesicle by the formation of a complex between the metal (Ca++and/or Cu++) and the ring (phenolic) hydroxyls ( Maas and Colburn, 1965). This is of particular importance when we consider the variations between the effects of fixative on reactivity with monoamines in vitro and in oivo, and the differences between reactivity of different tissues to the same fixative. Clearly if it is the phenolic hydroxyls which must be oxidized to form the metallic or organometallic electron-opaque product, the availability
LOCALIZATION OF MONOAMINES
41
of these groups must be established by local tissue conditions and fixative-ligand interactions. IV. localization of Monoamines in Nervous Tissue
A. PERIPHERAL SYMPATHETIC NERVETERMINALS The possibility that sympathetic nerve terminals could be morphologically distinguished from other types of nerve terminals arose when multiple types of synaptic vesicles were observed in the nerves to the pineal (de Robertis and Pellegrino de Iraldi, 1961a,b) and to intestine (Grillo and Palay, 1962). The vesicles newly described were distinguishable from the routinely observed spherical electron-lucent synaptic vesicles on the basis of size and electron opacity of the contents after fixation with Os04. 1. Small Granular Vesicles (SGV)
These vesicles measure 40-60 mp and exhibit variable degrees of internal electron opacity, dependent upon the type of fixation and the tissue (Figs. 3-7). The SGV appear to be most easily demonstrated in the nerves of the pineal, and can be seen with approximately decreasing ease in this order: pineal (Milofsky, 1957; de Robertis and Pellegrino de Iraldi, 1961a,b; Wolfe et al., 1962; Fig. 7A; Pellegrino de Iraldi and de Robertis, 1963; Wolfe, 1965; Bondareff, 196-5, 1966; Bondareff and Gordon, 1966; Bloom and Giarman, 1967; Kelly, 1967; Machado, 1967; Machado et al., 1968; Wartenberg, 1968; Bloom and Giarman, 1970; Fig. 3A, B; Pellegrino de Iraldi and Gueudet, 1969; Fig. 5A, B) > vas deferens (Richardson, 1962; Clementi, 1965; Bloom and Barrnett, 1966; Hokfelt, 1966b; Van Orden et al., l966,1967a,b; Farrell, 1968; Tranzer and Thoenen, 1967a,b, 1968b; Tranzer et al., 1969; Fig. 4A, B) >iris ( Richardson, 1964, 1966; Duncan and Micheletti, 1966; Hokfelt, 1966a, 1968a,b; Fig. 6A, B, C ) > nictitating membrane (Van Orden et al., 1967c; Esterhuizen et al., 1968b) > intestine (Grillo and Palay, 1962; Gabella, 1967; Taxi, 1969) > blood vessels (Devine, 1967; Devine and Simpson, 1967, 1968; Ruskell, 1967; Graham et al., 1968; Fig. 7B; Lever et al., 1968; Siggins and Bloom, 1969; Bloom, unpublished observations ) > heart ( Wolfe and Potter, 1963; Thaemert, 1966; Potter, 1967) > endocrine pancreas (Legg, 1967; Esterhuizen et al., 1968a; Shorr and Bloom, 1970). These tissue differences can only be partially explained in terms of tissue content and relative extent of innervation, although these factors must obviously be of importance, However, the main known distinguishing feature of these tissues (aside from the relative turnover rates of norepinephrine and
FIG.3. Sympathetic axons after fixation with either glutaraldehyde/OsO, sequence (A, Bloom, unpublished) or KMnOa (B, Hokfelt, unpublished). Both methods show electron-opaque deposits in the LGV and SGV, but more granular material is seen with KMn04. A, X 108,000; B, X 115,000. 42
FIG.4. Rat vas deferens showing influence of fixation on the electron-opaque deposits of the SGV. A, fixation with triple fixation sequence (paraformaldehydeglutaraldehyde, KzCr20r,Os04) described by Tranzer and Snipes ( 1968). Empty vesicles at left are surface invaginations of smooth muscle fibers ( m ) ; B, fixation with OsO,; X 55,000. Contributed by Dr. J. P. Tranzer. 43
FIG.5. Rat pineal after treatment with p-Cl-phenylalanine; pineal divided and halves fixed either in glutaraldehyde/OsOd sequence ( B ) or with OsOI only ( A ) . Note the relative paucity of SGV in B (compare with Fig. 3 A ) with respect to A. A, X 60,000; B, X 45,000 (from Pellegrino de Iraldi and Gueudet, 1969; contributed by Dr. A. Pellegrino de Iraldi).
44
FIG. 6. A. Cat iris &ed with glutaraldehyde/Os04 sequence after four intraperitoneal injections of 5-hydroxydopamine (20 mg/kg) over 48 hr. Of the three nerve terminals in this field, the vesicles of two are completely filled with an electron-opaque material. The synaptic vesicles of the other axon (presumably 45
46
FLOYD E. BLOOM
neural activity under the condition prior to and during fixation) appears to be the method for fixation used in their study. In the same tissues, the ease of demonstrating the granular deposits in the peripheral autonomic nerve vesicles appears to occur in the following decreasing order: 3% KMnO, (Richardson, 1966; Hokfelt, 1967a, 1968a,b; Van Orden et al., 1969; Bloom and Giarman, 1970; Figs. 3B and 6A) > glutaraldehyde/dichromate/OsO, (Tranzer et al., 1969; Fig. 4A, B) > glutaraldehyde/ Oso, (Bloom and Barrnett, 1966; Van Orden et al., 1966, 1967a,b,c; Machado, 1967; Bloom and Giarman, 1970; Pellegrino de Iraldi and Gueudet, 1969; Figs. 3A, 4A, and 5A) > formaldehyde Oso, (Bondareff, 1965) > OsO, (d e Robertis and Pellegrino de Iraldi, 1961a,b; Grillo and Palay, 1962; Grillo, 1966; Figs. 4B, 7A). These differences cannot be explained on the extent to which the fixative retains the tissue monoamine (Hokfelt and Jonsson, 1968; Bloom and Giarman, 1970; Taxi and Droz, 1969) or on the relative preservation of tissue fine structure (Devine and Laverty, 1968). Does the presence of SGV (Figs. 3,5,6,7,8A) serve to indicate monoamines? We can start by answering a more general question, but one which is equally helpful, by stating that peripheral nerves which exhibit the SGV are almost certainly and exclusively the norepinephrine-containing axons. This conclusion is established by the observations that with the proper fixation, such nerves can be seen in all sympathetically innervated tissues (Richardson, 1966; also see reviews by Bloom and Giarman, 1968a,b; Jaim-Etcheverry and Zieher, 1969c; Tranzer et al., 1969). Such nerves disappear when the sympathetic axons are surgically severed (Pellegrino de Iraldi et al., 1965; Van Orden et al., 1 9 6 7 ~). These axons are not seen after immunosympathectomy (Richardson et al., cited by Sjoqvist et al., 1965) or when degeneration is due to 6-hydroxydopamine (Devine and Laverty, 1968; Tranzer and Thoenen, 196%; Devine, 1969; Siggins and Bloom, 1969). Such nerves can be localized independently of fixation by electron microscopic autoradiography after labeling with 3H-NE (Wolfe et al., 1962; Fig. 7A; Devine and Simpson, 1967; Taxi and Droz, 1966b; Esterhuizen et al., 1968a,b; Graham et al., 1968; Lever et al., 1968; Fig. 7B; Budd and Saltpeter, 1969) or 3H-dihydroxyphenylalanine (Taxi and Droz, 1966a,b). Not all of these latter cholinergic) remain completely electron-lucent. X 50,000 (from J. P. Tranzer and Thoenen, 1967; contributed by Dr. J. P. Tranzer). B and C. Rat iris dilator muscle after pretreatment with a norepinephrine synthesis inhibitor. Tissues of irides B and C were handled identically except that nerves to iris B were stimulated electrically (20 stimuli/sec for 90 min) before fixation in KMn04. B, X 36,000; C , X 31,000 (modified from Hokfelt, 196813; contributed by Dr. T. Hokfelt).
LOCALIZATION OF MONOAMINES
47
FIG. 7. A. Electron microscopic autoradiograph localizing radioactive norepinephrine over nerve terminals of die rat pineal. Tissue fixed with intravascular
48
FLOYD E. BLOOM
experiments satisfy the dosage and retention criteria cited previously (see Section 11, D ) but all are mutually supportive. Finally, the SGV seen with KMnO, fixation can be depleted with nerve stimulation (Richardson, 1963; Hokfelt, 1968a,b; Fig. 6B, C ) , as well as drugs. The next question that arises is whether the deposit which makes these vesicles morphologically unique from other synaptic vesicles of the same size range (such as those seen in neuromuscular junction and other nonadrenergic peripheral junctions) is in itself indicative of the relative monoamine content. The observations which favor equating the granular deposit with catecholamine storage are derived from the observation that the relative numbers of granular vesicles per nerve terminal tend to decrease with amine depletion by reserpine (Pellegrino de Iraldi and de Robertis, 1961, 1963; Richardson, 1963; Clementi, 1965; Hokfelt, 196610; Van Orden et al., 1966), metaraminol (Bondareff and Gordon, 1966), or a-methyl-rn-tyrosine (Bloom and Barmett, 1966; Van Orden et al., 1966) and can be enhanced or restored by monoamine oxidase inhibitors (Pellegrho de Iraldi and de Robertis, 1963; Van Orden et aZ., 1967a) with or without dihydroxyphenylalanine ( Pellegrino de Iraldi and de Robertis, 1964; Clementi, 1965) or by loading with NE (Van Orden et al., 1966), a-methyl-NE (Bondareff, 1966; Hokfelt, 1967a,c, 1968a,b), or &OH DA (Tranzer and Thoenen, 1967b). The data which tend to refute equating the granular deposits with catecholamine content in the peripheral vesicles stem first from the observations that success or failure in the demonstration of the vesicle granularity is not proportional to the amount of radioactive catecholamine retained in the tissue (Devine and Simpson, 1968; Hokfelt and Jonsson, 1968; Taxi, 1968; Taxi and Droz, 1969; Bloom and Giarman, 1969) or in homogenate fractions (Michaelson and Whittaker, 1963; Michaelson et al., 1968; Whittaker, 1W; Michaelson, 1967; Potter, 1967). Second, by autoradiography, heavy deposits of silver grains can frequently be seen over axons in which the granular vesicles exhibit minimal granularities (Lever et al., 1968; Devine and Simpson, 1968; Esterhuizen et al., 1968a,b; Budd and Saltpeter, 1969; Taxi, 1969) indicating, at the least, that catecholamines can occur within the vicinity of the vesicles without the vesicles osmium tetroxide 30 min following the injection of 12.5 pg of radioactive norepinephrine. The silver grains are concentrated over the nerve terminals in which small granular vesicles can be clearly seen. X 37,380 (contributed by Dr.David E. Wolfe). B. Autoradiographic localization of n~repinephrine-~H over sympathetic nerves to cat pancreatic arteriole. Nerves labeled in vivo by intra-arteriolar perfusion of approximately 100 pg norepinephrine over 25 min and fixed in glutaraldehyde/Os04 45 min later. Note, despite large number of silver grains over nerve, only the LGV have any electron opacity, A few grains overlay the cytoplasm of the fibroblast ( f ) . X 50,000.Contributed by Dr. J. D. Lever (see Lever et al., 1968).
FIG. 8. A. Sympathetic ganglion of rat fixed in KMn04, showing electron-opaque deposits in both LGV and SGV in one of the two nerve processes X 100,000. Contributed by Dr. T. Hokfelt (see Hokfelt, 1967b, 1968a,b). B. Normal rat hypothalamus fixed by perfusion with glutaraldehyde and exposed to OsO4 in solution at
50
FLOYD E. BLOOM
being granular. These arguments could be explained away most simply by proposing that the type of fixation was adequate to bind the catecholamine to the tissue, but that the correct conditions for producing the electron deposits with the metallic oxidant (see Section 11, B, 4) have not been found. However, after KMnO, fixation, the small granular vesicles seen exhibit fewer autoradiographic grains than do other portions from identical tissue prepared with glutaraldehyde/ OsO,. The latter exhibit multiple autoradiographic grains but fewer granular vesicles (Bloom and Giarman, 1970; Taxi and Droz, 1969); were it not for these observations, there would be no reason to doubt the conclusion that the presence of the intravesicular granularity is indicative of the catecholamine. However, these as yet unexplained observations indicate the need for caution before reaching such a conclusion, particularly when considered in the light of observations on NE in the central nervous system and in neuronal cell bodies (see Section IV, B and C). 2. Distinguishing N E and 5-HT in SGV An additional feature complicating the quantitative interpretation of the SGV precipitate arises from observations that certain “adrenergic” nerves may also store 5-HT (Bloom and Giarman, 1967, 1970; JaimEtcheverry and Zieher, 1968a,b,c; Pellegrino de Iraldi and Gueudet, 1969; Fig. 5A, B). On the basis of biochemical experiments, it can be estimated that more than half of the monoamine contained in the nerves to the rat pineal may be 5-HT rather than NE (Neff et al., 1969). This may be one explanation for the ease with which the SGV in the pineal nerves are demonstrated with various fixatives (see above, Section IV, A, 1). It is, therefore, of considerable interest that depletion of the 5-HT following synthesis inhibition with p-C1-phenylalanine ( Koe and Weissman, 1966; Lovenberg et al., 1968) produces loss of the SGV with glutaraldehyde/ OsO, fixation but not with primary fixation to either OsO, (Pellegrino de Iraldi and Gueudet, 1969; Fig. 5A, B ) or KMnO, (Bloom and Giarman, 1970). By the use of the triple staining sequence formaldehyde-glutara1dehyde-K2Cr,O7 ( Jaim-Etcheverry and Zieher, 1968a,b,c, 1969a,c), differential staining of 5-HT can also be achieved with only partial loss of sensitivity. With this technique, it is possible to demonstrate storage of 5-HT in the nerves to the rat vas deferens (Snipes et al., 1968) if there has first been depletion of the NE by 6OOC. In contrast to results with standard glutaraldehyde/OsO, sequence on brain, numerous electron-opaque deposits are seen in both the small and large synaptic vesicles in this terminal. X 50,000 (unpublished micrograph from Bloom and Aghajanian, 1 9 6 8 ~ ) .
LOCALIZATION OF MONOAMINES
51
synthesis inhibition ( Jaim-Etcheverry and Zieher, 1969a) . Such observations thus provide the possibility of untold complicating factors in the production of SGV precipitates in the brain (see below) where the knowledge of possible transmitters stored in vesicles is still primeval. 3. Large Granular Vesicles
In addition to the SGV (40-60 mp) which exhibit homogeneous opaque granular content after oso,, Grillo and Palay also described a larger vesicle, 80-120 mp in size, which exhibited a more fibrillar electron-opaque deposit, but of less opacity than that seen in the SGV. The LGV constitute about 1 5 % of the vesicles in various peripheral adrenergic nerve terminals (Bondareff, 1965; Van Orden et al., 1966, 1967a,b), but it is also seen in nerve terminals classically considered to be cholinergic, such as the preganglionic axons to a variety of sympathetic ganglia (Taxi, 1961;Grillo and Palay, 1962; Grillo, 1966; Clementi, 1965). The same type of large granular vesicle appears to be the main form of granular synaptic vesicle seen in the retina (Pellegrino de Iraldi and Jaim-Etcheverry, 1967b) and in the nervous systems of invertebrates (Best and Noel, 1969; Rude et al., 1969; Van Orden et al., 1969). The granular contents of the larger vesicle appear to be unrelated in relative electron opacity to the amount of monoamine in the tissue (Bondareff, 1965; Bloom and Barmett, 1!366), and statistical interpretation of autoradiographs of pineal nerves indicates no relatively increased number of grains over these vesicles with respect to the SGV (Budd and Saltpeter, 1969). Nevertheless, despite these negative correlations there is still some evidence, recently obtained, which suggests that the large granular vesicles may be participants in the monoamine storage process of peripheral nerves. These data come from the observations that loading tissue with 5-hydroxydopamine and examining it after glutaraldehydel OsO, fixation reveals increased electron opacity over the LGV in nerve terminals if they are terminal adrenergic axons, but not in preganglionic cholinergic axons ( Tranzer and Thoenen, 1968). Similar selective increases in the electron opacity of the LGV of adrenergic nerves have been seen after loading and KMnO, fixation (Hokfelt, 1968a,b) and after 5-HT loading using the triple sequence for 5-HT reactivity (JaimEtcheverry and Zieher, 1968a). These observations need not reflect differences among the LGV of chemically different nerve types, but may simply indicate the uptake specificities of the axonal membrane (Tranzer and Thoenen, 1967; Tranzer and Thoenen, 1968). In addition, when ligature constrictions of peripheral nerve trunks cause accumulation of biochemically and histochemically demonstrable norepinephrine (Dahlstrom, 1967), mainly LGV are found to be increased
52
FLOYD E. BLOOM
LOCALIZATION OF MONOAMINES
53
in number by electron microscopic observation (Kapeller and Mayor, 1969a,b). An interesting clue to the possible function of LGV is that they are found in “cholinergic” rat neuromuscular junction during its morphogenesis, but are rare thereafter (Kelly and Zacks, 1969). The LGV are also the first vesicles seen in nerves to developing pineal (Machado et al., 1968).
B. CENTRAL NERVETERMINALS Knowing of the positive correlation between small granular vesicles and catecholamine in the peripheral nervous system, and the near negative correlation with the LGV, the noncombatant reader may find it difficult to understand the cause of the confusion over the localization of central monoamines, and which has only recently been partially clarified. Because small granular vesicles could not be demonstrated in the central nervous system, prior to 1967, all attention was devoted to the central LGV (Figs. 8B-10). These vesicles were presumed to be potential indicators of central monoamines, owing to the positive reaction of some LGV with the Wood-Barrnett procedure (Wood, 1966). They also appear in synaptosome fractions obtained from NE-rich areas of the hypothalamus (de Robertis et al., 1965) and according to some authors they alter their frequency after depletion of central stores (Pellegrino de Iraldi et al., 1963; Bak, 1965, 1967; Ishii et al., 1965; Matsuoka et al., 1965; Shimizu and Ishii, 1965; Halaris et al., 1967; Ishii, 1967) and increase in frequency after monoamine oxidase inhibitors and monoamine precursors (Pellegrino de Iraldi et al., 1963; Hashimoto et al., 1965; Ishii, 1967; Pellegrino de Iraldi and Jaim-Etcheverry, 1967a; Pfeiffer et at., 1968; Zambrano, 1968).Others disagree (Fuxe et al., 1965; Bloom and Aghajanian, 1968a). Further evidence supporting the relationship between the central LGV and monoamine storage was their presence in the majority of nerve terminals identified by autoradiography as containing NE-sH ( Aghajanian and Bloom, 1966, 1967a; Lenn, 1967; Descarries and Droz, 1968a,b; Fig. QA, B) or 3H-5-HT ( Aghajanian and Bloom, 1967b; Fig. lo). Furthermore, LGV are seen in the nerve terminals which degenerate after lesions of monoamine pathways (Aghajanian et aZ., 1969; Raisman, 1969). Finally, LGV are observed in FIG. 9. Autoradiographic localization of norepinephrine-’H in rat brainstem neuropil. Rat pretreated with a monoamine oxidase inhibitor and given 500 pC (specific activity 8 C/mM) intraventricularly 3 hr before fixation with glutaraldehyde/OsO, sequence. A and B are adjacent thin sections, in both of which the same axon terminal can be seen to be heavily labeled; LGV, but no SGV can be seen. X 10,OOO. Contributed by Drs. L. Descarries and B. Droz ( s e e Descarries and Droz, 1968a,b).
54
FLOYD E. BLOOM
LOCALIZATION OF MONOAMINES
55
the majority of brainstem and hypothalamic nerve terminals which degenerate after intracisternal injection of 6-hydroxydopamine ( Bloom et al., 1969). However, with the successful application of Mn0,- fixation to the central nervous system ( Hokfelt, 1967a,c, 1968a,b; Hokfelt and Jonsson, 1968), large granular vesicles could no longer be considered to be the only potential storage organelle for central monoamines. By using Mn0,on thin slices of tissue, Hokfelt was able to observe small granular vesicles in nerve terminals in hypothalamus, locus coeruleus, and median eminence of untreated rats. After incubation of the slices in NE, 5-HT, or a-methyl-NE (1-10 pg/ml), SGV could be seen frequently in terminals from caudate nucleus, locus coeruleus, and suprachiasmatic nucleus; their appearance could be blocked if the animals or the incubating media offered exposure to drugs capable of blocking the uptake or storage processes. Furthermore, nerves capable of binding a-methylNE disappear from the caudate after lesions of the substantia nigra ( Hokfelt and Ungerstedt, 1969). While these data on the effects of Mn0,- fixation in the central nervous system were being collected, Aghajanian and I reported statistical evaluations on the significance of the central large granular vesicles (Bloom and Aghajanian, 1968a). We were able to show that the distribution of central nerve terminals containing several large granular vesicles vaned throughout the rat central nervous system in relatively good correlation with the total reported values for regional content of NE and 5-HT, although not for DA. However, we were unable to observe any profound alteration in the electron opacity (with glutaraldehyde/ OsO,) of the central large granular vesicles after manipulating the monoamine levels. By using electron-opaque stains for proteins which did not depend on an oxidation-reduction reaction (Bloom and Aghajanian, 1966, 1968b), we concluded that while the LGV were likely to occur in nerve endings containing monoamines, most of their electron opacity after glutaraldehyde/ OsO, was due to a proteinaceous component in their internal matrix. This conclusion was also directly applicable to the peripheral LGV (also see Jaim-Etcheverry and Zieher, 1969b), although as we have already seen, such vesicles in the periphery do not appear to be exclusive possessions of adrenergic nerves. Furthermore, FIG. 10. Autoradiographic localization of 5-HT-’H in pontine raphe nucleus of normal rat, Tissue prepared with standard glutaraldehyde/Os04 sequence 2 hr after intracisternal injection of 50 pC (specific activity 5.5 C/mM) generally labeled 5-HT. Several grains are clustered over one terminal in which electron-lucent elliptical synaptic vesicles and 2 LGV are seen. X 108,000 (Unpublished micrograph from Bloom and Couch).
56
FLOYD E. BLOOM
LOCALIZATION OF MONOAMINES
57
terminals with KMn04 SGV (Hokfelt, 1968a) can be seen in less than half the number of terminals showing LGV with glutaraldehyde/Os04 (Bloom and Aghajanian, 1 W a ) when the same brain regions are quantitated. We might conclude at this point that the localization problem has now been finally solved with respect to both central and peripheral granular vesicles. The frustrating truth is that we must still attend to some annoying complications. As in the peripheral nervous system, there was a disconcerting discrepancy in the brain between the retention of the amine and the appearance of the SGV (see above, Section V, A, 1). Here, there is the additional problem that two types of central small granular vesicles appear not to correlate with monoamine content: such vesicles can be seen in the rabbit brain, despite reserpine treatment (Tranzer et al., 1969) and can be produced in glutaraldehyde-fixed brain by exposure to Oso, at elevated temperatures (Bloom and Aghajanian, 1968c; Fig. 8B), although this procedure appears to “leech” out the radioactivity. Furthermore, the “hot osmium” SGV persist despite prolonged and repeated administrations of reserpine, and do not increase in frequency after inhibition of monoamine oxidase. The success of the “hot osmium” technique may depend upon the fact that osmium vapors are more effective sources of electron-opaque “osmium black” precipitates (Hanker et al., lW),but their persistence despite depletion of amines suggest they react with some vesicle component having reducing or coordinating potency, but which is distinct from the monoamine. Furthermore, since the latter substance resists reserpine, this alleged reducing component would not be likely to fluctuate in proportion to the monoamine, as do the MnO, deposits described by Hokfelt (1968a,b). Nevertheless, the appearance of SGV alone cannot be any more conclusive evidence for the occurrence of monoamines than can the mere observation of LGV. Both types of granular vesicles should be subjected to tests for the satisfaction of the criteria proposed above (Section 11, A) . Hopefully, these fixations can eventually be tested in turn against other cytochemical methods which will not depend solely upon the unknown
FIG.11. Effects of hation on the electron opacity of vesicles in rat sympathetic ganglioneurons. A, Axodendritic synapse in which LGV are seen in the nerve terminal and small vesicles with electron-opaque deposits are clustered in the cytoplasm of the dendrite (arrows). Fixation with OsO,; X 62,000, inset X 110,000. B, Portions of two adjacent ganglioneurons after fixation with NaMnOa. Numerous SGV are seen clustered throughout the cytoplasm of both cells (arrows), X 16,000, inset X 55,000. Unpublished micrographs contributed by Dr. M. Grillo (see Grillo, 1966)
.
58
FLOYD E. BLOOM
FIG.12. ( top ) Autoradiographic localization of n~repinephrine-~H over perikaryon
LOCALIZATION OF MONOAMINES
59
chemical reactance of undefined “polymers” of monoamines and metallic oxidants.
C. MONOAMINE CELLBODIESAND NONTERMINAL AXONS Since there appears to be a rather reasonable association between SGV and stores of monoamines in the nerve terminals, one might expect that the same type of vesicle would account for the amine present in the cell body and along the axons. From fluorescence histochemical observations (Dahlstrom and Fuxe, 1965), the cell bodies normally fluoresce after gaseous formaldehyde, but this fluorescence is greatly augmented by pretreating the animals with monoamine oxidase inhibitors. This experiment has been performed by two separate groups using electron microscopy to search for cellular organelles which increased following such treatment; in both cases no such organelle could be found (Lenn, 1965; Fuxe et al., 1966). When sympathetic ganglioneurons are subjected to subcellular fractionation, little or no particulate storage form of NE is found (Fischer and Snyder, 1965). Furthermore, no matter which of the fixative procedures are successful in revealing the SGV of the terminals, it is rarely found possible to see such vesicles within the cytoplasm of the cell body unless MnO, salts are used (cf. Grillo, 1966 and Fig. 11; Hokfelt, 1968a,b; Tranzer et al., 1969; Van Orden et al., 1969). On the other hand, the cell bodies of both central and peripheral NE neurons do exhibit autoradiographic labeling with 3H-NE ( Descarries and Droz, 1968a,b; Fig. 12; Taxi, 1969), particularly when monoamine oxidase has been inhibited. However, in the latter cases, the labeling appears to be somewhat random with respect to perikaryal organelles, although the activity within the cells is clearly greater than the surrounding tissues. Descarries has suggested (personal communication) that some type of macromolecular material may be present within such cells to bind the NE once it has entered the cell. Such a macromolecule could represent an “extra vesicular” type of binding, such as that seen in longer sympathetic axons. Similar suggestions were also put forward to account for in locus coeruleus of untreated rat, fixed 30 min after intraventricular injection (500 pC, 7.3 C/mM). Generalized labeling of all cytoplasmic and nuclear volume is observed with no specific association of label with any organelles. X 8,000. Unpublished micrograph contributed by Drs. L. Descarries and B. Droz (see Descarries and Droz, 1968a,b). FIG. 13. ( bottom) Autoradiographic localization of n~repinephrine-~H after in uivo labeling of bovine splenic nerve, routinely fixed with glutaraldehyde/Os04 sequence. Grains are seen over several axons, but less than half of these exhibit LGV in the same plane of the section. X 20,000 (modified from Stjarne et al., 1969).
60
FLOYD E. BLOOM
the autoradiographic localization of NE-3H over bovine splenic nerve axons in which no vesicles (neither LGV or SGV) could be seen (Stjarne et al., 1969; Fig. 13). No loading of cell body organelles with 5-hydroxydopamine has been seen ( Tranzer, personal communication) . Thus, for the present, we must conclude that the monoamine cell bodies are even more diEEicult sites in which to localize these substances. Despite both SGV and LGV occurring in and around the Golgi apparatus of the cell bodies, as well as in isolated areas of both the perikaryon and dendrites, in no case do they seem to be present in sufficient numbers to account for the content measurable by biochemical or fluorescence histochemical approaches. While special techniques are required to selectively identify 5-HTstoring organelles in some mammalian tissues ( see Jaim-Etcheverry and Zieher, 1969c), it is interesting that the spectrofluorometrically identified 5-HT in the colossal cell of the leech ganglion can be seen with routine
FIG.14. The electron-opaque deposits in the vesicles associated with the Golgi apparatus of the Collossal cell of the Leech ganglion. These deposits are correlated with microspectrofluorometric histochemically identified 5-HT. Fixation with glutaraldehyde/OsO, sequence. X 60,000 (modified from Rude et al., 1969; contributed by Dr. R. Coggeshall).
LOCALIZATION OF MONOAMINES
61
methods of fixation (Rude et al., 1969; Fig. 14). Again, this indicates the wide tissue and species variability encountered in such localizations. Since the enzymes for the synthesis of the monoamines are carried to the terminals after synthesis by the rough endoplasmic reticulum (see Dahlstrom, 1967; Barondes, 1968), some of the perikaryonal monoamine content could be accounted for on the basis of the activity of these enzymes after they are synthesized and while enroute to the nerve terminals. Pulse labeling autoradiographic experiments during the recovery from synthesis inhibition would be most interesting in this regard, particularly with p-C1-phenylalanine inhibition of tryptophan hydroxylase (Koe and Weissman, 1966; Lovenberg et al., 1968), because new enzyme must be synthesized for recovery to occur after this treatment.
V.
Conclusions
On the basis of a large number of experimental approaches which combine various neurocytological and histochemical observations, the association of NE-storing nerve terminals in the peripheral sympathetic nervous system is well correlated with intra-axonal SGV. The LGV occurring in these nerves seem to play only a minor role in the storage; although they do participate, the LGV are also found in other types of nerve fibers and thus their basic cellular function remains unclear. The same conclusions relating SGV to central monoamine stores could well be valid. However, there seems to be as wide a variation between the requirements for demonstrating these vesicles in the brain as there is among various peripheral axon systems. These differences in staining do not seem to be solely explicable on the basis of promptness or adequacy of fixation and may reflect some underlying differences among the manner or lability of the binding within storage vesicles. A nonvesicular binding material may be ubiquitously present throughout the monoamine perikaryon and portions of the axons of these cells. Finally, the exact composition of the SGV granule and its qualitative and quantitative relation to the monoamine believed to be present in the vesicle remains to be established. ACKNOWLEDGMENTS While the lnal responsibility for the views and interpretations presented here are properly borne by the author, I was privileged to have a most cooperative correspondence with many of my colleagues. In addition to the very kind contributions of numerous unpublished electron micrographs from Drs. Chiocchio, Coggeshall, Descarries, Droz, Grillo, Hokfelt, Lever, Pellegrino de Iraldi, Trammezzani, and Tranzer, prepublications and personal communications were also received from Professors Taxi and Wood. MIS. E. Batenberg and Miss J. Kuprys were of immense assistance in the tissue
62
FLOYD E. BLOOM
preparation and literature searches. Prof. V. Horack, Department of Chemistry, Georgetown University, graciously advised me on the possible reactions described. REFERENCES Adams, C. W. M., Abdulla, Y. H., and Bayliss, 0. B. (1967). Histochemie 9, 68. Aghajanian, G. K., and Bloom, F. E. (1966). Science 153, 308. Aghajanian, G. K., and Bloom, F. E. (1967a). J. Phurmcol. Exptl. Therap. 156, 23. Aghajanian, G. K., and Bloom, F. E. (1967b). J. Pharmacol. Exptl. Therap. 156, 407. Aghajanian, G. K., Bloom, F. E., and Sheard, M. H. (1969). Brain Res. 13, 266. Arnold, M., and Hager, G. (1968a). Histochemie 14, 72. Arnold, M., and Hager, G. (196813). Histochemie 14, 297. Bak, I. J. (1965). Experientia 21, 568. Bak, I. J. (1967). Exptl. Brain Res. 3, 40. Barondes, S. H. (1968). J. Neurochem. 15, 343. Barrnett, R. J., and Tice, L. W. (1963). Proc. 1 s t Intern. Congr. Histochem. Cytochem., 1963, New York. p. 139. Macmillan (Pergamon), New York. Beer, M. (1965). Lab. Invest. 14, 1020. Best, J. B., and Noel, J. (1969). Science 164, 1070. Blaschko, H., and Welch, A. D. (1953). Arch. Exptl. Pathol. Pharmakol. NaunynSchmiedebergs 219, 17. Bloom, F. E. (1969). Ann. Rept. Med. Chem. p. 270. Bloom, F. E., and Aghajanian, G. K. (1966). Science 154, 1575. Bloom, F. E., and Aghajanian, G. K. (1968a). J. Pharmacol. Exptl. Therap. 159, 261. Bloom, F. E., and Aghajanian, G. K. (1968b). J. Ultrastrud. Res. 22, 361. . 24, 1225. Bloom, F. E., and Aghajanian, G. K. ( 1 9 6 8 ~ )Experientia Bloom, F. E., and Barmett, R. J. (1966). Nature 210, 599. Bloom, F. E., and Barmett, R. J. (1970). In “The Ultrastructure of Animal Tissues” (R. J. Barmett, ed.). North-Holland Publ., Amsterdam. In press. Bloom, F. E., and Giarman, N. J. (1967). Anat. Record 157,351. Bloom, F. E., and Giarman, N. J. (1968a). Ann. Rev. Pharmacol. 8, 229. Bloom, F. E., and Giarman, N. J. (1968b). Ann. Rept. Med. Chem. p. 264. Bloom, F. E., and Giarman, N. J. (1970). Biochem. Pharmucol. 18. Bloom, F. E., Algeri, S., Gropetti, A., Revuelta, A., and Costa, E. (1969). Science 166, 1284. Boadle, M. C., and Bloom, F. E. (1969). J . Histochem. Cytochem. 17, 331. Bondareff, W. (1965). Z. Zellforsch. Mikroskop. Anat. 67, 211. Bondareff, W. (1966). Exptl. Neurol. 16, 131. Bondareff, W., and Gordon, B. (1966). J . Pharmacol. Exptl. Therap. 153, 42. Boullin, D. J,, Bloom, F. E., Costa, E., and O’Brien, R. A. (1969). Proc. 4th Intern. Pharmacol. Meeting, Basel,, 1969, p. 246. Budd, G. C., and Saltpeter, M. M. (1969). J. Cell Biol. 41, 21. Cannata, M. A., Chiocchio, S. R., and Tramezzani, J. H. (1968). Histochemie 12, 253. Clementi, F. (1965). Experientia 21, 171. Colbum, R. I N . , and Maas, J. W. (1965). Nature 208, 97. Corrodi, H., and Jonsson, G. (1968). J . Histochem. Cytochem. 15, 65. Cotton, F. A., and Wilkinson, G. (1966). “Advanced Inorganic Chemistry” 2nd Ed., p. 796. Wiley (Interscience), New York. Coupland, R. E., and Hopwood, D. (1966). Nature 209, 590. Coupland, R. E., Pyper, A. S., and Hopwood, D. ( 1964). Nature 201, 1240.
LOCALIZATION OF MONOAMINES
63
Dahlstrom, A. (1967). Arch. Pharmakol. Exptl. Pathol. 251, 93. Dahlstrom, A,, and Fuxe, K. (1965). Acta Physiol. Scand. Suppl. 232, 1. de Robertis, E. (1966). Pharmucol. Reu. 18, 413. de Robertis, E., and Pellegrino de Iraldi, A. (1961a). Anat. Record 139, 299. de Robertis, E., and Pellegrino de Iraldi, A. (1961b). 1. Biophys. Biochem. Cytol. 10, 361. de Robertis, E., Pellegrino de Iraldi, A., Rodriguez de Lores Amaiz, G., and Zieher, L. M. (1965). Life Sci. 4, 193. Descarries, L., and Droz, B. (1968a). Electron Microscopy, Proc. 4th European Regional Conf., Rome, 1969 p. 527. Descarries, L., and Droz, B. (1968b). Compt. Rend. 266, 2480. Devine, C. E. (1967). Proc. Uniu. Otago Med. School 45, 7. Devine, C. E. (1969). Proc. Univ. Otago Med. School 47, 4. Devine, C. E., and Laverty, R. (1968). Experientia 24, 1156. Devine, C. E., and Simpson, F. 0. (1967). Am. J. Anat. 121, 153. Devine, C. E., and Simpson, F. 0. (1968). J. Cell Biol. 38, 184. Douglas, W. W. (1968). Brit. J. Pharmucol. 34, 451. Duncan, D., and Micheletti, G. (1966). Texas Rept. Biol. Med. 24, 576. Duncan, D., and Yates, R. (1967). Anat. Record. 157, 667. Eranko, 0. (1967). Ann. Reu. Phurmucol. 7 , 203. Esterhuizen, A. C., Spriggs, T. L. B., and Lever, J. D. (1968a). Diabetes 17, 33. Esterhuizen, A. C., Graham, J. D. P., Lever, J. D., and Spriggs, T. L. B. (1968b). Brit. J. Phurmucol. 32, 46. Farrell, K. E. (1968). Nature 217, 279. Fischer, J. E., and Snyder, S. (1965). J. Phamnacol. Exptl. Therap. 150, 190. Formby, F. (1968). Mol. Pharmucol. 4, 288. Fuxe, K. (1965a). Acta Physiol. Scand. Suppl. 247, 39. Fuxe, K. (1965b). 2. Zellforsch. Mikroskop. Anat. 65, 573. Fuxe, K., and Ungerstedt, U. (1966). Life Sci. 5, 1817. Fuxe, K., Hokfelt, T., Nilsson, O., and Reinius, S. (1966). Anat. Record 155, 33. Fuxe, K., Hokfelt, T., and Nilsson, 0. (1965). Am. J. Anat. 117, 33. Gabella, G. ( 1967). J. Microscopie 6, 863. Glowinski, J,, Kopin, I. J., and Axelrod, J. (1965). J. Neurochem. 12, 25. Glowinski, J., Snyder, S. H., and Axelrod, J. (1966). J. P h a m c o l . Exptl. Therap. 152, 282. Graham, J. D. P., Lever, J. D., and Spriggs, T. L. B. (1968). Brit. J . Phumacol. 33, 15. Grillo, M. A. (1966). P h m c o l . Reu. 18, 387. Grillo, M. A., and Palay, S. L. ( 1962). In “Electron Microscopy” ( S . S. Breese, ed.), Vol. 2, p. U-1. Academic Press, New York. Hake, T. (1965). Lab. Invest. 14, 1208. Halaris, A., Ruther, E., and Matussek, N. (1967). 2. Zellforsch. Mikroskop. Anat. 76, 100. Hanker, J. S., Seaman, H. R., Weiss, L. P., Veno, H., Bergman, R. A,, and Seligman, A. M. ( 1964). Science 146, 1039. Hanker, J. S., Deb, C., Wasserkrug, H. L., and Seligman, A. M. (1966). Science 152, 1631. Hanker, J. S., Kasler, F., Bloom, M. G., Copeland, J. S., and Seligman, R. M. (1967). Science 156, 1737. Harrison, W. H., Whisler, W. W., and Hill, B. J. (1968). Biochemistry 7, 3089.
64
FLOYD E. BLOOM
Hashimoto, Y., Ishii, S., Ohi, Y., and Imaizumi, R. (1965). Japan. J. Phurmacol. 15, 395. Hattori, A. (1967). Electromicroscopy (Tokyo) 16, 239. Heacock, R. A. ( 1965).Aduan. Heterocyclic Chem. 5, 205. Hokfelt, T. (1966a). Acta Physiol. Scand. 67, 255. Hokfelt, T. ( 19Mb). Experientia 22, !%. Hokfelt, T. ( 1967a). Acta Physiol. Scand. 69, 125. Hokfelt, T. (1967b). Brain Res. 5, 121. Hokfelt, T. ( 1 9 6 7 ~ )2. . Zellforsch. Mikroskop. Anat. 79, 110. Hokfelt, T. (1968a). W.D. Thesis, p. 4. Tryckeribolaget lvar Haeggstrom AB, Stockholm. Hokfelt, T. (1968b). Z . Zellforsch. Mikroskop. Anat. 91, 1. Hokfelt, T., and Jonsson, G. (1968). Hktochemie 16,45. Hokfelt, T., and Ungerstedt, U. (1969). Acta Physiol. Scand. 76, 415. Hopsu, V. K., and Makinnen, E. 0. (1966). J. Histochem. Cytochem. 14, 434. Ishii, S. (1967). Arch. Histol. Japm. 28, 355. Ishii, S., Shimizu, N., Matsuoka, M., and Emaizumi, R. (1965). Biochem. Pharmacol. 14, 183. Iversen, L. L. ( 1967). “The Uptake and Storage of Noradrenaline in Sympathetic Nerves.” Cambridge Univ. Press, London and New York. Jaim-Etcheverry, G., and Zieher, L. M. (1968a). Anat. Record 160, 476. Jaim-Etcheverry, G., and Zieher, L. M. (1968b). 2. ZeUforsch. Mikroskop. Anat. 86, 393. Jaim-Etcheverry, G., and Zieher, L. M. (1968~). Experientia 24, 593. Jaim-Etcheveny, G., and Zieher, L. M. (1969a). J. Phurmacol. Exptl. Therap. 166, 264. Jaim-Etchevemy, G., and Zieher, L. M. (1969b). 3. Cell Biol. 42, 855. Jaim-Etcheverry, G., and Zieher, L. M. ( 1 9 6 9 ~ ) PTOC. . 1 s t Intern. Symp. Cell Biol. Cytophamcol., Venice, 1969. Raven Press, New York. (in press). Kapeller, K., and Mayor, D. (1969a). Proc. Roy. SOC. (London) B172, 39. Kapeller, K., and Mayor, D. (196913). Proc. Roy. SOC. (London) B172, 53. Kelly, A. M., and Zacks, S. I. (1969). J. Cell Biol. 42, 154. Kelly, D. E. (1967). Anesthesiology 28, 6. Kirschner, N. (1969). Advan. Biochem. Psychopharmucot. 1, 71. Koe, B. K., and Weissman, A. (1966). J. Phamnacol. Exptl. Therap. 154, 499. Koelle, G. B. ( 1969). Federation Proc. 28, 95. Laties, A. M., Lund, R., and Jacobowitz, D. (1967). 1. Histochem. Cytochem. 15, 541. Legg, P. G. (1967). 2.Zellforsch. Mikroskop. Anat. 80, 307. Lenard, J., and Singer, S. S. (1968). J. Cell B i d . 37, 117. Lenn, N. J. (1965). Anat. Record 153, 399. Lenn, N. J. (1967). Am. J. Anat. 120, 377. Lever, J. D., Spriggs, T. L. B., and Graham, J. D. P. (1968). J. Anat. 101, 15. Litman, R. B., and Barrnett, R. J. (1969). Anat. Record 163,313. Lovenberg, W., Jequier, E., and Sjoerdsma, A. (1968). Aduan. Pharmacol. 6A, 21. Maas, J. W., and Colbum, R. W. (1965). Nature 208, 41. Machado, A. B. M. (1967). Stain Technol. 42, 293. Machado, A. B. M., Machado, C. R. S., and Wragg, L. E. (1968). Experientia 24, 464.
LOCALIZATION OF MONOAMINES
65
McLennan, H. ( 1963). “Synaptic Transmission,” p. 134. Saunders, Philadelphia, Pennsylvania. Matsuoka, M., Ishii, S., Shimizu, N., and Imaizumi, R. (1965). Experientia 21, 1. Michaelson, I. A. (1967). Ann. N.Y. Acud. Sci. 144, 387. Michaelson, I. A., and Whittaker, V. P. (1963). Biochem. Pharmacol. 12, 203. Michaelson, I. A., Taylor, P. W., Richardson, K. C., and Titus, E. (1968). J, Pharmacol. Exptl. Therap. 160, 277. Milofsky, A. (1957). Anat. Record 3, 435. Neff, N. H., Barrett, R. E., and Costa, E. (1969). European 1. Pharmcol. 5, 348. Paton, W. D. M. (1958). Ann. Reu. Physiol. 20,431. Pearse, A. G. E. (1961). “Histochemistry, Theoretical and Applied,” 2nd Ed., p. 631. Little, Brown, Boston, Massachusetts. Pearse, A. G. E. (1969). “Histochemistry, Theoretical and Applied,” 3rd Ed., Vol. 1, p. 759. Little, Brown, Boston, Massachusetts. Pease, D. C. (1964). “Histological Techniques for Electron Microscopy,” p. 60. Academic Press, New York. Pellegrino de Iraldi, A,, and de Robertis, E. (1961). Experientia 17, 122. Pellegrino de Iraldi, A., and de Robertis, E. (1963). Intern. J. Neurophumacol. 2, 231. Pellegrino de Iraldi, A., and de Robertis, E. (1964). Proc. 2nd Intern. Congr. Endocrinol. London, 1964 No. 83, 355. Pellegrino de Iraldi, A,, and Gueudet, R. (1969). Intern. J. Neuropharmacol. 8, 9. Pellegrino de Iraldi, A,, and Jaim-Etcheverry, G. (1967a). Brain. Res. 6, 614. Pellegrina de Iraldi, A., and Jaim-Etcheverry, G. ( 1967b). Z. Zellforsch. Mikroskop. Anat. 81. 283. Pellegrino de Iraldi, A., Duggan, F., and de Robertis, E. (1963). Anat. Record 145, 521. Pellegrino de Iraldi, A., Zieher, L. M., and de Robertis, E. (1965). Progr. Brain Res. 10, 389. Pellegrino de Iraldi, A., Zieher, L. M., and Jaim-Etcheverry, G. (1968). Aduan. Phrmucol. 6A, 252. Pfeiffer, A. K., Szato, D., Polkouits, M., and Okros, I. (1968). Exptl. Brain Res. 5, 79. Pichler, H., Suko, J., and Hertting, G. (1968). Biochem. Pharmucol. 17, 1329. Potter, L. T. (1967). Circulation Res. 20, Suppl. 3, 13. Raisman, G. (1969). ExptE. Brain Res. 7, 317. Richardson, K. C. (1958). Am. J. Anat. 103, 99. Richardson, K. C. (1962). J. Anat. 96, 427. Richardson, K. C. ( 1963). Biochem. Phrmucol. 12, 10. Richardson, K. C. (1964). Am. I . Anat. 114, 173. Richardson, K. C. ( 1966). Nature 210, 756. Riley, V., and Fortner, J. G. (1963). Ann. N.Y. Acad. Sci. 100, 1. Rude, J., Coggeshall, R. E., and Van Orden, L. S. (1969). J. Cell Biol. 41, 832. Ruskell, G. L. (1967). 2.Zellforsch. Mikroskop. A n d . 83, 321. Sabatini, D. C., Bensch, K. G., and Barrnett, R. J. (1963). J. Cell Biol. 17, 19. Saltpeter, M. M., Bachmann, L., and Saltpeter, E. E. (1969). J. Cell Biol. 41, 1. Schumann, H. J. (1966). Pharmacol. Reu. 18, 433. Seligman, A. M., Wasserkrug, H. L., and Hanker, J. (1966). J. Cell Biol. 30, 424. Shimizu, U., and Ichii, S. (1965). Arch. Histol. Japon. 24, 489.
66
FLOYD E. BLOOM
Shorr, S. S., and Bloom, F. E. (1970). Z. Zellforsch. Mikroskop. Anat. 103, 13. Siggins, G. R., and Bloom, F. E. (1969). Pharmacologist 11, 263. Sjoqvist, F., Titus, E., Michaelson, I. A., Taylor, P., and Richardson, K. C. (1965). Life Sci. 4, 11%. Snipes, R. L., Thoenen, H., and Tranzer, J. P. (1968). Erpedentia 24, 1026. Solcia, E., Sampietro, R., and Capella, C. (1969). Histochemie 17, 273. Sternberger, L. A. (1967). J. Histochem. Cytochem. 15, 139. Stjame, L. (1966). P h a m c o l . Reu. 18, 425. Stjame, L., Roth, R. H., Bloom, F. E., and Giarman, N. J. (1969). J . Phurmucol. Exptl. Therup. Stumpf, W. E., and Roth, L. J. (1968). Aduan. Tracer Methodol. 4, 113. Taxi, J. (1961). Bull. Assoc. Anat. 47, 794. Taxi, J. (1968). Compt. Rend. Acad. Bulgure Sci. 21, 1229. Taxi, J. (1969). Progr. Brain Res. 31, 5. Taxi, J., and Droz, B. (1966a). Compt. Rend. 263, 1326. Taxi, J., and Droz, B. (196613). Compt. Rend. 263, 1237. Taxi, J., and Droz, B. (1969). In “Cellular Dynamics of the Neurons” ( S . H. Barondes, ed. ) . Academic Press, New York. Thaemert, J. C. (1966). J. Cell Biol. 28, 37. Tramezzani, J. H., Chiocchio, S . R., and Wasserman, J. H. (1964). J. Histochem. Cytochem. 12, 890. Tranzer, J. P., and Snipes, R. L. (1968). Electron Microscopy, Proc. 4th European Regional Conf. Rome, 1988 p. 519. Tranzer, J. P., DaPrada, M., and Pletscher, A. (191%). Nature 212, 1574. Tranzer, J. P., and Thoenen, H. (1967a). Erperientia 23, 123. Tranzer, J. P., and Thoenen, H. (1967b). Experientiu 23, 743. Tranzer, J. P., and Thoenen, H. (1968a). Experientia 24, 155. Tranzer, J. P., and Thoenen, H. (196813). Erperientia 24, 484. Tranzer, J. P., Thoenen, H., Snipes, R. L., and Richards, J. G. (1969). Progr. Brain Res. 31, 33. Van Orden, L. S., Bloom, F. E., Barrnett, R. J., and Giarman, N. J. (1966). J. Pharmucol. Exptl. Therap. 154, 185. Van Orden, L. S., Bensch, K. G., and Giarman, N. J. (1967a). J. Pharmacol. Exptl. Therap. 155, 428. Van Orden, L. S., Bensch, K. G., Langer, S. Z., and Trendelenburg, U. (1967b). J. P h a m c o l . Exptl. Therap. 157, 274. Van Orden, L. S., Vugman, I., Bensch, K. G., and Giarman, N. J. ( 1 9 6 7 ~ ) .J. Pharmucol. Exptl. Therup. 158, 195. Van Orden, L. S., Schaefer, J. M., and Burke, J. P. (1969). Phamcologist 11, 178. von Euler, U. S., and Hillarp, N. A. (1956). Nature 177, 44. Wartenberg, H. (1968).Z. Zellforsch. Mikroskop. Anat. 86, 74. Whittaker, V. P. (1966). Pharmucol. Reu. 18, 401. Wolfe, D. E. (1965). Progr. Bruin Res. LO, 332. Wolfe, D. E., and Potter, L. T. (1963). Anat. Record 145, 301. Wolfe, D. E., Potter, L. T., Richardson, K. C., and Axelrod, J. (1962). Science 138,
440. Wood, J. G. (1966). Nature 209, 1131. Wood, J. G., and Barrnett, R. J. (1964). 1. Histochem. Cytochm. 12, 197. Zmbrano, D. (1968). Neuroendocrinobgy 3, 99. Zobel, C. R., and Beer, M. (1965). Intern. Reu. Cytol. 18, 363.
BRAIN LESIONS AND AMlNE METABOLISM By Robert Y. Moore Department of Pediatrics and Medicine (Neurology) and fhe Joseph P. Kennedy, Jr. Mental Retardation Research Center, The University of Chicago, Chicago, Illinois
I. Introduction . . . . . . . . 11. Subcortical Lesions and Brain Amine Levels . A. The Medial Forebrain Bundle . . . . B. The Midbrain Tegmentum . . . . 111. Interpretation of Lesion Effects on Brain Amines A. The Peripheral Model B. The Central Nervous System . . . . IV. Conclusions . . . . . . . . References . . . . . . . .
. . . . .
.
. . . . . .
.
.
.
.
.
.
. . . . . .
. . . . . .
. . . . . .
. . . . . .
.
.
.
.
.
.
.
.
67 69 69 71 72 72 73 88 89
I. Introduction Finally I should like to speak a word of warning against the present tendency to ascribe very complex functions to the thalamus and brainstem. (Lashley, 1951, p. 36)
The studies to be described here have utilized the techniques of localized tissue destruction in the central nervous system to define the specific neuronal elements with which the biogenic monoamines, serotonin, norepinephrine, and dopamine, are associated in the brain. When the studies were begun, nearly ten years ago, few data were available on the biogenic amines in brain beyond designation of their gross tissue localization and some effects of pharmacological manipulation of amine levels. But over the intervening years a number of experimental programs using the lesion technique, electrical or chemical stimulation, pharmacological manipulation, and combinations of these have demonstrated a role for the biogenic amines in such activities as central autonomic control, neuroendocrine regulation, maintenance of sleep patterns, control of extrapyramidal motor function, elaboration of affective behavior, and learning. Most commonly these programs have analyzed the organization of the central nervous system in the context of the concept of localization of function which holds that specific functions are controlled by specific components of the nervous system. Our own studies were also conceived in this framework, as they arose from attempts to explain the behavioral effects of some subcortical lesions. Following the important theoretical papers of Herrick (1933) and 67
68
ROBERT Y. MOORE
Papez (1937) and the pioneering experimental work of Kluver and Bucy (1937), there has been a steady growth of interest in the subcortical telencephalic nuclei and related areas of the diencephalon and brainstem. Among the subsequent contributions were many that focused upon alterations of behavior resulting from stimulation or ablation of subcortical areas. One example of these was the “rage” syndrome observed by Brady and Nauta (1953) with ablation of the septal nuclei in the rat. Bilateral destruction of the nuclei causes a transient state of irritability in the animals characterized by an exaggerated startle response, ready assumption of a fighting posture upon stimulation, and excessive struggling, vocalization, and biting in response to handling. From the anatomical studies of Nauta (1956, 1958) it was evident that the septal nuclei comprised part of a system which included the hippocampus, the lateral hypothalamus, and a region of the dorsal and medial midbrain tegmentum designated by Nauta (1958) the “limbic midbrain.” In a series of experiments based upon these observations we found that lesions in the hippocampus and lateral hypothalamus also produced a transient irritability similar to but less marked than that observed in septal rats. Rats with lesions in the dorsomedial midbrain tegmentum, in contrast, were easily handled and exhibited none of the irritability of the septal animals but did show severe attack behavior (Heller et al., 1962; Harvey et al., 1964). This behavior occurred only when the animals were housed together. Animals with this lesion appeared normal when alone but attacked each other so persistently when together that both animals sustained numerous bites, and one often died unless they were separated (Heller et al., 19s2). From these observations it was evident that two lesions within the same system might have quite different behavioral sequelae and that these were not explicable in terms of the anatomical variables alone. At the same time that these experiments were being done, attempts to modify the behavioral effects of the lesions provided a new direction. Both septal animals and animals with lesions in the dorsomedial midbrain tegmentum showed a marked sensitivity to certain drugs, particularly barbiturates (Heller et al., 1%0; Harvey et al., 1964). Each of these lesions produced a fourfold increase in barbiturate sleeping time, whereas lateral hypothalamic, hippocampal, and other lesions had no significant effects upon the response to barbiturates (Harvey et al., 1964). This sensitivity to barbiturates could not be explained on the basis of lesion effects on brain or body weight, temperature regulation, drug metabolism, adrenal function, or brain levels of the drug (Heller et al., 1960; Harvey et al., 1964). The changes in behavior noted with the two effective lesions, septal and dorsomedial tegmental, combined with the
69
BRAIN LESIONS AND AMINE METABOLISM
alteration in sleeping time suggested another possibility, that the effects of the lesions might be related to a change in cerebral metabolism of the amine serotonin. The sedative effect of reserpine had been related to decreases in brain serotonin, and it was proposed that this amine represented a central neurotransmitter, possibly mediating parasympathetic activities such as sleep (Brodie et at., 1956; Brodie and Shore, 1957). In addition, there was considerable speculation regarding the role of derangements in serotonin metabolism in the pathogenesis of severe behavioral abnormalities such as the functional psychoses ( Woolley, 1962). Because of this we elected to investigate the effects of subcortical lesions on brain serotonin levels in an attempt to provide a correlation for the behavioral effects and the responses to drugs noted above. II. Subcortical lesions and Brain Amine levels
A.
THEMEDIALFOREBRAIN BUNDLE
As in the behavioral and pharmacological studies outlined above, a series of bilateral electrolytic lesions were placed in telencephalic, diencephalic, and midbrain areas of adult male rats. Whole brain serotonin levels were determined 35 days postoperatively. The results of our first study are presented in Table I. Four of the lesions used produced significant decreases in brain serotonin. Lesions in the septa1 area, in the ventral midbrain tegmentum (adjacent to the interpeduncular nucleus), TABLE I EFFECT OF BILATERAL LESIONSON WHOLEBRMNSEROTONIN LEVELSIN THE RAT"
Lesion group
Percent change in serotonin level from normal controls
Sham operated Caudate nucleus Hippocampus Septa1 area Medial hypothalamus Medial forebrain bundle (lateral hypothalamus) Habenula Ventromedial midbrain tegmentum Dorsomedial midbrain tegmentum Pontine tegmentum
+3 0 -5 -1 2 -7 -36b -7 - 15b - 14b f 7
From Heller et al. (1962). Differences from control statistically significant, p were not significant, p > .05. Q
< .01.
All other differences
70
ROBERT Y. MOORE
and in the dorsomedial midbrain tegmentum reduced brain serotonin levels by 12-151 in comparison to normal, unoperated controls. Lesions in the lateral hypothalamus had a more marked effect, reducing serotonin levels by 36%.The changes in brain serotonin content observed with sham operation or other electrolytic lesions were not significantly different from control values. The observed changes in amine levels did not correlate well with the behavioral effects of the lesions or with sensitivity to barbiturates, but the lesions which affected brain serotonin levels did share one feature. Consideration of the morphological relations of the areas which, when destroyed, led to decreases in brain serotonin levels prompted the conclusion that the integrity of one neural system was necessary for the maintenance of normal serotonin levels in the rat brain. The most marked lesion effect upon brain serotonin (-36%) was caused by lesions in the lateral hypothalamus. This area of the hypothalamus contains a few, scattered cells and a complex tract, the medial forebrain bundle, which interconnects the basal telencephalon, the hypothalamus, and the midbrain reticular formation ( Guillery, 1957; Nauta, 1958, 1963). The septal, ventral midbrain tegmentum and dorsomedial midbrain tegmentum lesions also reduced brain serotonin levels, and each of these lesions destroyed areas receiving fibers from and contributing significant numbers of fibers to the medial forebrain bundle in the lateral hypothalamus. In contrast, the five lesions which did not alter brain serotonin did not destroy numbers of medial forebrain bundle projections. The medial hypothalamic lesions were confined to the medial nuclear region and spared the medial forebrain bundle. The caudate nucleus and pontine tegmentum lesions each transected a number of long fiber systems and ablated a nuclear area but none related to the medial forebrain bundle. The habenular and hippocampal lesions were of particular interest because each of these nuclei is closely related to the medial forebrain bundle system although neither contributes fibers into it at the level of the lateral hypothalamus. Thus, each lesion which significantly reduced brain serotonin levels in contrast to those which did not, either transected the medial forebrain bundle or destroyed areas contributing fibers to that tract in the lateral hypothalamus. On this basis it was suggested that the loss of brain serotonin produced by the lesions was the result of degeneration of serotonin-producing fibers within the medial forebrain bundle ( Heller et al., 1962). Subsequent experiments provided confirmatory data. The medial forebrain bundle is predominantly an uncrossed pathway, originating and terminating on the same side of the brain ( Guillery, 1957). Unilateral destruction of the medial forebrain bundle produced a fall in brain serotonin half that observed with bilateral lesions. But, when the effect was studied in brain halves, it was found to occur only on the side containing the lesion and to an extent
71
BRAIN LESIONS AND AMINE METABOLISM
equivalent to the bilateral lesion effect (Harvey et al., 1963). Further experiments provided similar information regarding the control of brain norepinephrine levels ( Heller and Harvey, 1963), indicating that the integrity of the medial forebrain bundle was essential to the maintenance of normal levels of both amines in brain. And, although as noted before, there was considerable information available on the regional distribution or serotonin and norepinephrine in brain (Bogdanski et al., 1957; Kuntzman et al., 196l), the experiments outlined here first demonstrated the association of these amines with a specific group of central neurons.
B. THE MIDBRAINTEGMENTUM In the previous experiments it was evident that the exact localization of the lesion was critical to the effect on amine levels. Lateral hypothalamic lesions which failed to transect the fibers of the medial forebrain bundle, for example, had much less effect upon brain amine levels than ones which did interrupt the tract (Heller and Moore, 1965). Similarly, anatomical analysis of the tegmentum lesions indicated that there were critical areas for production of neurochemical effects. The most effective lesions were pIaced at the level of the isthmus, and, at this level, lateral lesions appeared to have more effect upon norepinephrine whereas medial lesions affected both amines. To test this further another experiment was carried out in which a number of different bilateral lesions were made, and the brains assayed for content of both serotonin and norepinephrine (Heller and Moore, 1985). In this experiment the location of each lesion was verified anatomically. The results of the experiment are presented in Table 11. Medial forebrain bundle and dorso-
SELIKTIVE
TABLE 11 EFFECTS OF BIL~TERAL LESIOXS ON BRAIN SER OT ONIN A N D NOREPINSPHRINE I N THE RAT^ ~~~
~~
Percent difference from sham opersted group
Lesion group
Serotonin
Caudate nucleus Medial hypothalamus hledial forebrain bundle Dorsomedial midbrain tegrnentum Ventrolateral midbrain tegmentum Central gray
$2 -2 -33D - 28b -3
Eroni Heller and Moore (19G5). Differences statistically significant, p cant, p > 3 5 .
- 18b
Norepinephrine -9
-7 -26b -24b -32* -7
a
< .01. All other
differences were not signifi-
72
ROBERT Y . MOORE
medial tegmental lesions caused significant decreases in both serotonin and norepinephrine. The two other tegmental lesions, however, demonstrated selective effects upon brain amine content. Ablation of a part of the ventrolateral tegmentum [in the paralemniscal field of the tegmentum (Berman, 1968)] resulted in a decrease in norepinephrine without altering serotonin. Central gray lesions, on the other hand, affected only serotonin. As in previous studies, the other lesions did not significantly alter brain levels. From the morphological analysis of the lesions it was evident that the dorsomedial tegmental lesions, which produced falls in both amines, involved both tegmental areas. We concluded from this that the paralemniscal tegmental field and its associated fiber bundles was essential for the maintenance of brain norepinephrine and the central gray for brain serotonin. Since both of these areas project into the medial forebrain bundle in the lateral hypothalamus, this conclusion was in accord with the view that the medial forebrain contained monoaminecontaining fibers, perhaps originating in the midbrain. Ill. Interpretation of Lesion Effects on Brain Amines
A. THEPERIPHERALMODEL The basis for the interpretation of the central lesion effects described above was a series of studies on the peripheral nervous system in which denervation was used as a tool to demonstrate the neural origin of transmitter substances. For example, destruction of preganglionic sympathetic fibers causes a marked reduction in acetylcholine content of the superior cervical ganglion (Brown and Feldberg, 1936; MacIntosh, 1938), and tissue catecholamines show a similar decrease following postganglionic sympathetic denervation (Cannon and Lissak, 1989; von Euler and Purkhold, 1951; Sidman et al., 1962; Sedvall, 1963).The loss of the amine in these instances is restricted to the denemated tissue and takes place rapidly, within 1 to 4 days (Kirkepar et al., 1%2; Trendelenberg, 1963; Malmfors, 19%). The time course over which amine is lost is in accord with electron microscopic observations on the rate at which the postganglionic axon terminals degenerate following axon section ( Roth and Richardson, 1969). These data on peripheral lesions conclusively demonstrate that section and subsequent degeneration of a peripheral axon is accompanied by loss of the appropriate neurotransmitter from the denervated tissue. In view of the obvious similarity in experimental design and results, we concluded that this model probably represented the mechanism by which central lesions affected brain monoamine levels. It should be noted, however, that the peripheral effects of lesions are not always as simple as outlined above. Preganglionic sympathetic denerva-
BRAIN LESIONS AND AMINE METABOLISM
73
tion, for example, does not alter norepinephrine levels in some tissues (Rehn, 1958; Fischer and Snyder, 1965); whereas in others, such as the pineal, amine levels are substantially decreased following such a lesion (Zieher and Pellegrino de Iraldi, 1966; Wurtman et al., 1967). The alteration of a tissue norepinephrine level by preganglionic denervation represents an effect of a lesion on amine metabolism mediated across a synapse in a cell which is presumably morphologically intact. The relevance and importance of this will be discussed in subsequent sections, B. THECENTRAL NERVOUSSYSTEM
1. Time Course of Amine Changes after Central Lesions From the many studies demonstrating denervation effects in the peripheral nervous system two major points were clear. First, section of a peripheral nerve causes a loss of neurotransmitter from innervated structures and, second, the time course of this loss correlates well with that for degeneration of the transected axons. To support the view that decreases in brain amine content produced by central lesions were owing to a direct denervation effect, we examined the time course over which the decreases in amine occurred and their distribution in the brain. A summary of one time course experiment is shown in Fig. 1. With unilateral medial forebrain bundle lesions there is a loss in brain serotonin and norepinephrine which first becomes evident on the second postoperative
POSTOPERATIVE DAY
FIG. 1. Time course of amine changes in the rat brains following unilateral medial forebrain bundle lesions. The serotonin and norepinephrine content of the brain half containing the lesion is expressed as a percent of the control side amine content, The original data from which the figure was prepared was presented by Moore and Heller (1967).
74
ROBERT Y. MOORE
day and the effect gradually increases until the twelfth day, when the amine levels stabilize at approximately 60%of control values. This time course differs from that following peripheral denervations in two ways: It is much more prolonged and there are no points of abrupt, large changes as are usually observed in the periphery. Attempts to correlate this time course with degeneration of the transected axons was only partially successful (Moore and Heller, 1967). In accord with the early part of the time course, degenerating axons were first noted following a medial forebrain bundle lesion on the second postoperative day. These increased in number until the fifth day but beyond that point no further changes were appreciated. Such changes might have occurred, however, and not have been demonstrated by the technique employed, the Nauta silver impregnation method for degenerating axons. The medial forebrain bundle contains many unmyelinated axons of which a substantial bundle proportion are less than 0.5 p in diameter (Moore, unpublished observations) and beyond the resolution of the light microscope. Unlike the situation in the periphery, there have not been as yet any studies reported on electron microscopy of the medial forebrain bundle following lesions transecting it. These would allow a direct comparison to be made between the time of onset of degenerative changes in the medial forebrain bundle and decreases in brain amine content. The data now available suggest that the time course for the amine changes differs from what one would expect with a direct denervation effect. 2. Regional Distribution Studies
The direct denervation interpretation also requires that the decreases in amine content occur from regions of the brain innervated by the transected axons. The connections of the medial forebrain bundle were well known (cf. Moore et al., 1965; Moore and Heller, 1967, for reviews), and experiments were designed to compare the areas of amine loss with the information on these connections. Initially, in order to carry out the regional distribution studies it was necessary to use an animal with a larger brain, the cat. Subsequently, refinements in analytical procedures permitted similar experiments on the rat. The data obtained from the two species are nearly identical (Moore and Heller, lW, 1967; Heller et al., 1964, 1966a,b; Moore et al., 1965, 19%) and, in themselves, indicate the generality of the findings. After transection of the medial forebrain bundle in the lateral hypothalamus there is a decrease in both serotonin and norepinephrine content throughout the telencephalon, whereas amine levels in the diencephalon and brainstem are unchanged. An example of the changes in regional brain serotonin content in the rat brain is shown in Table 111. In the telencephalic areas the fall in amine
BRAIN LESIONS AND AMINE METABOLISM
75
TABLE I11 REGIONAL EFFECTSOF MEDIALFOREBRAIN BUNDLELESIONSO N SEROTONIN LEVELSI N RAT BRAIN^ Percent difference from control
Region assayed
-66'
Cortex Septum Striatum Amygdala Hippocampus Brainstem From Moore and Heller (1967). Differences statistically significant, p
-49b -51b -54b -6gb $4
< .002.
content is from 49%to 68%below control values. The cerebral cortex was assayed as a single sample in this study, but in other experiments on the cat (Moore et al., 1965; Heller and Moore, 1968) the effect was found to occur in all areas of the cortex. A summary 'of another representative experiment on the cat is shown in Table IV. Large decreases in norepinephrine were observed in all areas of the cerebral cortex as well as in all subcortical, telencephalic areas. These vaned from 51%in the parietal cortex to 71%in a sample made up of the amygdaloid complex and hippocampal formation together. In this series of regional studies it was found that the magnitude of the lesion effect on amine levels was largely dependent upon the size and location of the lesion. The larger TABLE I V REGION i L EFFECTS O F ,\IEDI.4L F O R E B R ~ BUNDLE IN LESIONSO N NOREPINEPHRINE LEVELSI N THE CAT BRAIN" Region assayed
Percent difference from control
Frontal cortex Parietal cortex Occipital cortex Septum and caudate Amygdala and hippocampus Diencephalon Nidbrain Pons and medulla
-63' -51b -67b -63b -71b - 10 -6 +3
~
From Heller et at. (1966a). Differences statisticoally significant, p cant, p > .05. a
< .01. All other differences were not signifi-
76
ROBERT Y. MOORE
TABLE V REGIONAL EFFECTSOF VENTROLATERAL TEGMENTAL LESIONSON SEROTONIN AND NOREPINEPHRINE I N THE R.ATBRAINn ~
~~
Percent difference from control Region assayed Neocartex Septum Striatum Amygdala Hippocampus Diencephalon a
Ir
From Heller and Moore (1968). Differences statistically significant, p
Serotonin -2 -5
+4 -3 -12 +5
Norepinephrine -43b -53h -31b - 44b - 43b -47b
< .05.
the proportion of lateral hypothalamus destroyed by the lesion the greater the fall in amine content, to approximately a 70%level. The widespread effects of the medial forebrain bundle lesions on telencephalic amine levels were not explicable on the basis of our knowledge of projections of the axons destroyed. Similar observations were also made with tegmental lesions (Table V ) , Following ventrolateral tegmental lesions there is a decrease in norepinephrine content both in the diencephalon and the telencephalon. Brainstem norepinephrine was unaffected by the lesions. This effect of tegmental lesions on norepinephrine, like that of medial forebrain bundle lesions on serotonin and norepinephrine, occurred in all areas of the brain rostral to the lesion and was nearly equal in each area. As with the medial forebrain bundle effects, this provided problems of interpretation which may be emphasized by a review of the relevant anatomy. 3. Anatomical Considerations Two possible interpretations were immediately apparent. First, the amine loss following lesions could be viewed as a result of neuronal degeneration and, second, it could be interpreted as a form of “trophic” effect occurring in morphologically intact neurons. A review of the connections of the areas whose destruction produced decreases in amines brought forth several problems for the first interpretation. These areas lay in a core of tissue extending from the septa1 area rostrally through the lateral preoptic and hypothalamic areas and into the basal and medial midbrain caudally. In our experience no lesion rostral to the septum or caudal to the isthmus has altered brain amine levels, And, as noted above (Section II,A), the pathway crucial to these effects is the medial fore-
BRAIN LESIONS AND AMINE METABOLISM
77
brain bundle. This phylogenetically old tract provides the primary source of afferent and efferent connections of the hypothalamus (Bleier et al., 1966; Nauta, 1963) and contains large numbers of reciprocal interconnections between the basal telencephalon and a part of the basal and medial midbrain tegmentum ( Nauta, 1958, 1963; Guillery, 1957). Although considerable data were available on the connections of the medial forebrain bundle ( 6 .Nauta, 1958, 1963; Guillery, 1957; Wolf and Sutin, 1966), we elected to trace the exact distribution of the axons transected by our medial forebrain bundle lesions. Studies were carried out on both rats and cats in which lesions were made in the medial forebrain bundle or in the tegmentum in the same manner as in the amine experiments. Animals were killed at varying postoperative survival periods (rats, 2-12 days; cats, 5-14 days), and a series of sections from each brain was prepared by the Nauta-Gygax method (Nauta, 1957) for the selective impregnation of degenerating axons. Subsequently, a few brains have been studied using the Fink-Heimer technique (Fink and Heimer, 1967) which demonstrates degenerating axon terminals. The descending projections of the medial forebrain bundle are not immediately relevant to interpretation of the amine loss, and therefore will not be discussed. Ascending axons from a medial forebrain bundle lesion form a compact group in that tract. A few fibers enter the adjacent medial hypothalamus, but the majority are confined to the lateral hypothalamus where a number of terminal and preterminal axons are scattered among the cells of the lateral hypothalamic nucleus. At the level of the anterior hypothalamus some fibers leave the medial forebrain bundle to terminate in the anterior amygdaloid area. The main group of degenerating axons traverses the lateral preoptic area to enter the ascending arm of the diagonal band of Broca and, then, the septal nuclei. Numerous terminals are present along the course of the pathway in the lateral preoptic area, the nucleus of the diagonal band, and the medial and lateral septal nuclei. A few fibers run beyond the septal nuclei, over the rostrum of the corpus callosum, to enter the hippocampal rudiment. None of these could be traced for any distance caudally, and we did not observe projections from the medial forebrain bundle to either the neocortex or to telencephalic areas other than the septum, amygdaloid complex, and hippocampal rudiment. This holds true for both the Nauta and Fink-Heimer material, but final conclusions must be reserved because we have not as yet sampled a full series of postoperative survival times with the latter method. The hypothalamic and telencephalic projections observed with tegmental lesions were similar, particularly in that no fibers could be traced to neocortex. The discrepancy between the distribution of amine falls and the distribution of degenerating axons following the lesions raised an obvious diffi-
78
ROBERT Y. MOORE
culty in the interpretation of the results. Three alternatives were available. First, we could dismiss the neurochemical effects of the lesions on the grounds that they were the result of some nonspecific alteration of neuronal metabolism. This seemed unlikely because of the restricted distribution of the effects and their dependence upon exact localization of the lesions. Second, we could maintain the hypothesis that all of the effects were due to section and degeneration of amine-producing neurons. Third, we could propose an effect mediated, at least in some areas, across one or more intermediate neurons which may or may not be similarly affected. Such changes we have termed “transsynaptic” neurochemical effects of central lesions. Before discussion this further, it should be pointed out that the second alternative has been accepted by another group of workers on the basis of experiments using a recently developed histochemical method for the demonstration of monoamines in brain.
4. Fluorescent Histochemical Studies Coincident with our initial studies of lesion effects on brain serotonin and norepinephrine, Falck and Hillarp and their associates in Sweden developed a powerful histochemical method for the demonstration of monoamines in brain and other tissues (Falck et al., 1962; Carlsson et al., 1962; Falck, 1962). This method, now known as the Falck-Hillarp method, utilizes the condensation of monoamines with formaldehyde vapor in frozen-dried or dried tissue to form an intense fluorophor which can be visualized under appropriate conditions in the light microscope. Details of the development of the technique and its chemical basis have been reviewed recently by Corrodi and Jonsson (1967). In brain, serotonin, norepinephrine, and dopamine appear to be the principal monoamines demonstrated. On the basis of the early studies employing the method, the generalization was made that serotonin exhibited a yellow fluorescence and the catecholamines a greenish-yellow fluorescence (Falck et al., 1W2; Carlsson et al., 1962). Under certain conditions, however, the catecholamines may exhibit a yellow or, even, orangeyellow color and be indistinguishable from serotonin by visual inspection (Corrodi and Jonsson, 1967). The more recent development of microspectrophotofluorometry, which permits the determination of excitation and emission spectra from the histochemical preparations, makes possible an objective differentiation of the catecholamine and tryptamine fluorophors (Van Orden et aZ., 1965; Caspersson et al., 1966; Ritzen, 1966, 1967; Bjorklund et al., 1968). Combining fluorescence microscopy, microspectrophotofluorometry, the use of lesions, and pharmacological manipulation, then, allows the differential localization of the primary catecholamines and serotonin to specific neuronal elements in brain. With certain
BRAIN LESIONS AND AMINE METABOLISM
79
reservations the Falck-Hillarp can be viewed as the most useful technique available for studying the tissue localization of monoamines. The reservations arise primarily over two problems, resolution and sensitivity. The technique utilizes light micoscopy so that the limits of resolution are set at about 0 . 5 p For higher resolution, other techniques such as electron microscopic autoradiography are required. The sensitivity of the Falck-Hillarp method is great, but the lower limits of its application in tissue have not been well established. For this reason negative resuIts are difficult to interpret conclusively. In this regard Fuxe (1965) has noted, “It must consequently be kept in mind that areas which . . . are said to contain no CA [catecholamine] or 5-HT [serotonin] terminals may contain such terminals not visible in the fluorescence microscope.” Obviously absence of fluorescence could indicate an amine concentration below the sensitivity of the method, improper application of the method, or some peculiarity of the tissue which prevented proper application of the method. With these reservations in mind, we can now review the information obtained from the use of the Falck-Hillarp method in studying the central nervous system. In material from the brain and spinal cord, cell bodies are identified as neuronal on the basis of their size and configuration. “Terminals” are identified on the basis of their similarity in appearance to known axon-terminals in the peripheral sympathetic system ( autonomic ground plexus ) and probably correspond to bouton terminaux or bouton en passage. In general, dendrites and preterminal axons are not demonstrated unless some specific experimental manipulation has been performed. The first application of the Falck-Hillarp method to the central nervous system was made by Carlsson et al. (1962) who observed catecholamine-containing terminals in some nuclei of the medial hypothalamus. Carlsson et al. (1964) and Dahlstrom and Fuxe (1965) found both serotonin- and norepinephrine-containing terminals in the spinal cord and demonstrated that these belong largely to a group of bulbospinal neurons with cell bodies in the medullary reticular formation and axons traversing the reticulospinal tracts to terminate in the spinal cord gray matter. Subsequent studies on the histochemical localization of monoamines in brain has been based on two important papers. In the first of these, Dahlstrom and Fuxe (1964) examined the distribution of monoamine-containing cell bodies. Catecholamine neurons were present primarily in the ventral and lateral reticular formation of the medulla, pons, and midbrain. For the most part these appeared to be norepinephrine containing, but dopamine-containing cells were identified in the substantia nigra and adjacent ventral tegmental area (groups A9 and A10 of Dahlstrom and Fuxe, 1964) and in the arcuate nucleus of the hypothala-
80
ROBERT Y. MOORE
mus. Serotonin-containing cells were found almost exclusively in the medial reticular formation, particularly in the raphe nuclei, from medulla through the midbrain. With the exception of the arcuate nucleus, no monoamine cells were demonstrated in the diencephalon, telencephalon, or spinal cord. In contrast to this restricted distribution of monoaminecontaining perikarya, 1.arge numbers of terminals were found in nearly all areas of the central nervous system from the neocortex (Fuxe, 1965; Fuxe et al., 1968a) and subcortical telencephalic nuclei through the diencephalon, midbrain, pons, and medulla (Fuxe, 1965), and the spinal cord (Dahlstrom and Fuxe, 19%). The conclusions that could be drawn from this data were suggested by the work of Dahlstrom and Fuxe (1965) on the bulbospinal monoamine neurons. Transection of the spinal cord resulted in loss of histochemically demonstrable terminals distal to the lesion. Proximally, fluorescent material accumulated in the axon stumps, and this finally came to outline the entire neuron above the section. The application of this to the remaining cell bodies and terminals would then suggest that the terminals in the brainstem, diencephalon, and telencephalon are all derived from the cell bodies located in the brainstem. The first experimental test of this was provided by A n d h et al. (1964, 1965a, 1966) on a system of dopamine-containing neurons which appeared to be identical to the nigrostriatal pathway of the older neuroanatomical literature. Interest in this pathway had developed rapidly following the demonstration that dopamine was present in the neostriatum in high concentration (Bertler and Rosengren, 1959) and that the brains of individuals suffering from Parkinson’s disease had markedly reduced dopamine levels in the neostriatal nuclei and substantia nigra ( Ehringer and Hornykiewicz, 1960; Hornykiewicz, 1962). Since the primary pathology of Parkinson’s disease is present in the substantia nigra, these observations suggested that the pathophysiology of the disease involved disturbance of a dopaminergic nigrostriatal pathway ( Hornykiewicz, 1966). Experimental destruction of the substantia nigra results in a loss of dopamine from the neostriatum (Poirier and Sourkes, 1965; Poirier et al., 1967; Anden et al., lW),but attempts to demonstrate a nigrostriatal pathway by conventional anatomical methods have not been successful (Carpenter and McMasters, 1964; Cole et al., 1964). Using the Falck-Hillarp method, however, AndCn et al. (1964, 1965a, 1966) have provided substantial evidence for a nigrostriatal pathway in the rat brain. Lesions in the substantia nigra cause a substantial loss in catecholamine fluorescence from the caudate-putamen complex ( AndCn et al., 1964). Ablation of the neostriatum results in an accumulation of fluorescent material in axons of the internal capsule and cells of the pars compacta of the substantia nigra (AndBn et al., 1965a). The course of
BRAIN LESIONS AND AMINE METABOLISM
81
the projection appears to be through the subthalamic region and the retrolenticular part of the internal capsule (AndCn et al., 1965a, 1966). Our own observations in the cat are in accord with these and provide conclusive anatomical and chemical evidence for a nigrostriatal, dopaminergic pathway. As an extension of our studies on the medial forebrain bundle, we performed one experiment in which caudate nucleus dopamine content was determined following lesions in the region of the lateral hypothalamus in the cat (Moore and Heller, 1969; Table VI). After destruction of the medial forebrain bundle and the adjacent medial internal capsule, there is nearly total depletion of dopamine in the ipsilateral caudate nucleus. Associated with this there is severe retrograde degeneration in the pars compacta of the substantia nigra and the adjacent ventral tegmental area, If the lesion is restricted to the medial internal capsule, however, the decrease in dopamine is less, and retrograde degeneration is observed only in the substantia nigra, pars compacts. Subsequent studies have demonstrated also that there is a loss of the enzymes tyrosine hydroxylase and dopa decarboxylase in the caudate nucleus which is directly proportional to the loss of dopamine (Moore et al., 1969). This situation, then, is nearly identical to that seen with peripheral denervations and provides presumptive evidence that there is a nigrostriatal pathway arising from the ventral tegmental area and the pars compacta of the substantia nigra and traversing the medial internal capsule and adjacent medial forebrain bundle on its path to the caudate nucleus. Anatomical evidence for this was obtained in another study using the Fink-Heimer method ( Moore, 1969). Following restricted lesions in the substantia nigra and ventral tegmentum, degenerating axons were traced through the ventral tegmentum into the ventral portion of the field H or Forel. At rostra1 tuberal levels of the hypothalamus, the fibers came to run in the medial internal capsule and adjacent medial TABLE VI CAUDATE NUCLEUS DOPAMINE CONTENT FOLLOWING UNILATERAL DESTROYING COMPONENTS O F THE NIGROGTRIATAL PATHWAY" Percent difference in dopamine content from control caudate nucleus
Area destroyed Medial hypothalamus Medial internal capsule Medial internal capsule and medial forebrain bundle a
From Moore and Heller (1967). significant, p
* Differences statistically
< .01.
-5.1 -62.4* -92.3'
82
ROBERT Y. MOORE
FIG. 2. Terminal degeneration in the cat caudate nucleus following unilateral destruction of the nigrostriatal pathway is shown in A. B is taken from the control caudate nucleus, The large black area is an impregnated blood vessel. Fink-EIeimer stain, X960.
BRAIN LXSIONS AND AMINE METABOLISM
83
forebrain bundle before distributing ventrolaterally through the entopeduncular nucleus and globus pallidus into the putamen or dorsomedially into the caudate nucleus. Using this impregnation method with a 5-day survival period, large numbers of degenerating terminals were demonstrated in the neostriatum (Fig. 2 ) . The combination of the anatomical findings (from both anterograde and retrograde degeneration) and the neurochemical data, thus, gives full confirmation for the observations using the histochemical method. The demonstration of the pathway by anterograde degeneration is also of importance because it illustrates that a monoaminergic pathway may be shown by conventional neuroanatomic techniques. Following their observations on the nigrostriatal pathway the Swedish workers undertook an extensive series of experiments examining the effects of lesions on brain monoamines ( A n d h et al., 196513, 1966, 1967; Fuxe et al., 1968b; Hillarp et al., 1966). In each case these were taken to demonstrate that the serotonin and norepinephrine present in the forebrain occurred in terminals projecting to these areas from cell bodies in the brainstem. The proposed pathway for these neurons has been schematized (Andkn et al., 1966; Fig. 10). From the lateral brainstem cell bodies norepinephrine-containingaxons ascend in the medial forebrain bundle to distribute to the hypothalamus, thalamus, striatum, limbic forebrain, and neocortex. An identical pathway is proposed for serotonin except that the cell bodies are placed more medially. The evidence for the pathways is the same. Following a lesion in the tegmenturn or in the medial forebrain bundle, there is a loss of terminals distal to the lesion (i.e., in the forebrain) and an appearance of accumulation of fluorescent material in proximal cell bodies. Because these events are similar to those occurring with lesions in the nigrostriatal tract and the reticulospinal system, it was inferred that the mechanism of amine loss following tegmental and medial forebrain bundle lesions also represented degeneration of amine-containing neurons.
5. Direct Denewation vs. Transsynaptic Efects From our studies, and those of the Swedish group, it was evident that restricted subcortical lesions could produce widespread losses of monoamines from the forebrain. Yet, despite the amount of study devoted to this problem, the mechanism by which the amine loss takes place is not entirely understood. In our earlier studies we proposed the view that this represented degeneration of amine-containing neurons, but a failure to find anatomical correlates for the distribution of the amine loss led us to suggest that the effects were, at least in part, transsynaptic. The basis for this was, of course, the negative evidence regarding direct neural pro-
84
ROBERT Y. MOORE
jections from the areas destroyed by the lesion, particularly to the neocortex. But, as Bloom (1968) has noted, both groups have had to depend on negative evidence. The conclusions of the Swedish group have largely been based on their failure to demonstrate monoaminecontaining cell bodies above the brainstem, save for those innervating the median eminence. The absence of diencephalic and telencephalic monoamine cell bodies has been taken to indicate that none exists and, hence, that the terminals shown by the Falck-Hillarp method in the forebrain arise from brainstem neurons. This raises again the question of the sensitivity of the technique; that is, whether all monoamine-containing perikarya are demonstable in the brain even with pharmacological manipulation. There is no definitive answer to this question at present, but it is well to bear in mind Fuxe’s (1965) point that failure to demonstrate monoamine-containing neurons does not mean that they do not exist. Another question which can be raised concerns the exploitation of the technique. Several years ago catecholamine-containing cell bodies were observed in the olfactory bulb (Bertler et al., 1%6), and more recently Fuxe and Hokfelt (1969) have reported cell bodies in the subthalamic region. Those in the olfactory bulb are of particular interest in that they are the only ones thus far described in the telencephalon, and removal of the olfactory bulb produces changes in brain monoamines which have been interpreted to be transsynaptic (Pohorecky et al., 1969). It was evident from our initial experiments that the most compelling model for the central lesion effects has been the peripheral denervation studies. In the central nervous system the nigrostriatal pathway has conformed best to this model. The major points of similarity are as follows. Destruction of the pathway either at its origin in the substantia nigra or along its course causes a loss in neostriatal dopamine which is proportional to the number of nigrostriatal fibers transected. Complete transection of the pathway results in nearly complete loss of dopamine from the neostriatum (Moore and Heller, 1969). The loss of amine is accompanied by a loss of synthetic enzymes (tyrosine hydroxylase, dopa decarboxylase) which is also proportional to the extent of the lesion as well as to the amine loss (Moore et al., 1969). The time course of the amine loss in this system is not known, but it can be presumed to be in accord with that for degeneration of the fiber (about 5 days; Moore, 1!368). Finally, the origin, course, and distribution of the pathway can be demonstrated by conventional anatomical methods ( Moore, 1969). These observations can be compared with the situation which holds for the effects of medial forebrain bundle or tegmental lesions. After such lesions the loss of serotonin or norepinephrine never significantly exceeds 75%in any area of the forebrain regardless of the size or location of the
BRtlIN LESIONS AND AMINE METABOLISM
85
lesion. Of itself, this observation would imply that approximately 25%of the total monoamine pool is present in neurons with both cell bodies and terminals in the forebrain. Other evidence supporting this view has come from the studies of Parent et al. (1969) who observed only partial depletion of hypothalamic norepinephrine with extensive, bilateral lesions in the midbrain tegmentum. From their observations these authors concluded that the synthesis of hypothalamic norepinephrine takes place independently of central pathways to the hypothalamus. Further evidence that hypothalamic catecholamine- and tryptamine-containing terminals do not all arise from the midbrain tegmentum of the periventricular and arcuate nuclei has been presented by Bjorklund et al. (1970) in an elegant analysis of the monoaminergic innervation of the median eminence. In the analysis of the nigrostriatal pathway, the use of neostriatal lesions facilitated a description of the pathway by producing an accumulation of fluorescent material in the proximal axon (And& et aZ.,1965b, 1966). The application of this technique to the purported projections from medial forebrain bundle to the neocortex appears to present some problems. In our studies (Moore and Heller, 1967) as well as those of others (Wolf and Sutin, 1966), axons have been traced from the medial forebrain bundle through the septum into the hippocampal rudiment above the corpus callosum. Anden et al. (1967) have proposed that this pathway constitutes the route by which monoamine-containing neurons project terminals onto the neocortex. There is, as yet, no direct anatomical evidence for a pathway beyond the hippocampal rudiment, but the proposal is open to experimental test. To do this, we produced large, bilateral lesions in the septa1 area (cf. Harvey et al., 1964; Heller et al., 1962; for full descriptions) which completely transected all ascending fibers from the medial forebrain bundle into the septum. The effects of these lesions on telencephalic monoamines are shown in Table VII. The decreases in neocortical amines are quite modest and less than those observed with medial forebrain bundle lesions, and the only marked change was in hippocampal serotonin content, Two conclusions might be drawn from this data: first, that the pathway proposed by AndCn et a2. (1967) was incorrect or, second, that the decreases in amine content produced by these and other lesions are the result of mechanisms other than direct degeneration of amine-containing neurons. The time course of the amine falls produced by medial forebrain bundle lesions is also of interest in this context (cf. Section 111,B; Fig. 1).Unlike the time course for the loss of tissue catecholamines following peripheral denervation, central amines are lost slowly and, indeed, the process takes longer than would be expected for the axons destroyed to
86
ROBERT Y. MOORE
TABLE VJI REGIONAL EFFECTSOF SEPTALAREA LESIONSON SEROTONIN AND NOREPINEPHRINE I N THE RAT BRAIN. ~
~-
Percent difference from control Region assayed
Serotonin
Norepinephrine
Neocortex Amygdala Hippocampns Diencephalon Brainstem
-15b $2 -40b
- 26b
- -
a
From Heller and Moore (1968). Differences statistically significant, p
+14 +9
-10 -9 +10 +2
< .05.
undergo terminal degeneration. In general, central terminal degeneration takes place rapidly (Heimer, 1967) and in the cerebral cortex, for example, Colonnier ( 1964) has observed complete degeneration and phagocytosis of terminals within 9 days after all afferents were transected by undercutting. This can be compared with the 12 days required for complete amine fall following medial forebrain bundle lesions. The medial forebrain bundle does contain many very small axons, but the evidence now available indicates that these would degenerate more rapidly than larger fibers (Bloom, 1968). A further difference between the nigrostriatal lesion effects and the tegmental or medial forebrain bundle effects is apparent in contrasting amine and enzyme data from the two types of lesion. With nigrostriatal lesions, the loss of amines and synthetic enzymes occurs equally and proportional to the amount of pathway destroyed. A similar analysis on the other lesions is shown in Table VIII. With the medial forebrain bundle lesions the loss of dopa decarboxylase is much less than that of either amine. After lateral tegmental lesions, dopa decarboxylase is unaffected. This could be explained if the enzyme was present primarily in serotonin-producing neurons, but the general picture in this study was one of a diversity of effects. It should be noted, however, that the telencephalon is a very heterogeneous tissue in comparison with the neostriatum and the diversity of effects may reflect this. All of the information just outlined has contributed to the problem of interpreting the effects of medial forebrain bundle and tegmental lesions on brain amines. Nevertheless, the major discrepancy has arisen from anatomical considerations, and these should be reviewed carefully. The direct denervation hypothesis requires that there be direct projections from the lateral hypothalamus or tegmentum to diffusely and homogene-
87
BRAIN LESIONS AND AMINE METABOLISM
TABLE VIII DIFFERENTIAL EFFECTS OF M E ~ I AFOREBRAIN L BUNDLE AND VENTROLATERAL MIDBRAIN TEGMENTUM LESIONSO N TELENCEPHALIC MONOAMINES AND ENZYMES IN THE RAT^ Percent difference in telencephalic level from sham operated control
Lesion group Medial forebrain bundle Ventrolateral midbrain tegmen turn
Serotonin
Dopa Tyrosine Norepinephrine decarboxylase hydroxylase
-66b - 12
-51b -7Bb
-2Sb -5
-44b -30b ~
From Heller and Moore (1968). I , Differences statistically significant, p .05.
< .01. All other values not
significant, p
>
ously innervate the entire forebrain. Attempts to demonstrate these projections using conventional anatomical techniques have failed thus far (Moore and Heller, 1967; Heller and Moore, 1968). The use of a newer technique, the Fink-Heimer method (Fink and Heimer, 1967), has allowed demonstration of the nigrostriatal pathway and a wider distribution of medial forebrain bundle axons in the amygdala and septum than was previously known. We have not been able, however, to show axons to the neocortex, but this negative data must be taken skeptically until more extensive studies are carried out. It seems likely that some conventional anatomical technique would allow demonstration of at least the terminals of a medial forebrain bundle-neocortical pathway if such existed, as the terminals should be well within the resolving power of the light microscope (Guillery and Ralston, 1964; Alksne et al., 1966; Heimer, 1967; Heimer and Peters, 1968).In view of the recent demonstration of the nigrostriatal pathway, it cannot be stated that monoamine-producing neurons are refractory to conventional anatomical techniques. Electron microscopy is not a useful tool in surveying an area for axon terminals ( Alksne et aZ,, 1966), but it may be quite important if a localized area can be analyzed ( Aghajanian et al., 1969) and the electron microscopic criteria for axonal degeneration are carefully reviewed (Cohen and Pappas, 1969) , Although a reasonable doubt must be maintained, we have taken the bulk of available evidence to support the view that the loss of monoamines from the forebrain after medial forebrain bundle or tegmental lesions occur, in part, in neurons not directly damaged by the lesion. This, then, is an effect which is mediated across at least one synapse and
88
ROBERT Y. MOORE DIRECT DENERVATION EFFECT AREA OF AMINE LOSS LESION
TRANS-SYNAPTIC EFFECT 0
I -El
AREA OF AMINE LOSS
LESION
FIG.3. Diagrammatic representation of two possible mechanisms for amine loss following a brain lesion. In direct denervation the lesion results in degeneration of the destroyed elements. A transsynaptic mechanism proposes an alteration in amine metabolism in neurons whose innervation has been altered by a distant lesion.
which we have termed transsynaptic. The alternative views are represented diagrammatically in Fig. 3. It should be emphasized that this mechanism would account for only part of the amine loss; there is ample histochemical, chemical, and anatomical evidence to interpret the loss of amines from septum, for example, as a result of direct denervation. If the transsynaptic effect is accepted for part of the amine loss, two interesting questions arise. First, what is the state of the affected neurons? Transneuronal degeneration is not unknown in the central nervous system, but it occurs principally in sensory systems and there is no histological evidence to suggest it here. The most attractive hypothesis is that, as in the decentralized sympathetic neuron with a decreased norepinephrine content, the functional state of the central monoaminergic neuron is altered, but it is morphologically intact. The nature of the functional alteration would remain, then, open to investigation. The second question would relate to the possibility of returning the altered metabolic status of the affected neurons to normal. If this were possible, it would add another facet to the understanding and treatment of functional deficit resulting from central lesions. IV. Conclusions
Regardless of the interpretation of lesion effects on brain amine metabolism, the effects themselves are striking and should have marked functional consequences. The diffuse distribution of the effects of these subcortical lesions is of particular interest, for it returns us to Lashley’s
BRAIN LESIONS AND AMINE METABOLISM
89
warning noted at the beginning of this review. Lashley was concerned that very complex functions were being ascribed to primitive subcortical structures, and he felt that such functions would be mediated through participation of both subcortical and cortical systems. The importance of the subcortical regions focused upon by this review is without question. They are critical, for example, to the maintenance of food and water intake (Teitlebaum and Epstein, 1962; Morgane, 1969), the mediation of reinforcement mechanisms (Olds, 1962), and the control of sleep patterns (Jouvet, 1969). In all likelihood amine metabolism plays only a part in these functions, but the studies on subcortical control of forebrain amine metabolism reviewed here provide a firm foundation for understanding the interdependent participation of cortical and subcortical structures in the mediation of complex functions, ACKNOWLEDGMENTS The work reported here was supported by research grants MH-04954, NS05002, and HD-04581 from the National Institutes of Health, USPHS, and was carried out in collaboration with Dr. Alfred Heller, Department of Pharmacology, The University of Chicago. The author has been supported by a Research Career Development Award (K3-NB-7, 389) from the National Institute of Neurological Diseases and Blindness and is a John and Mary R. Markle Scholar in Medical Science. REFERENCES Aghajanian, G. K., Bloom, F. E., and Sheard, M. D. (1969). Brain Res. 13, 266. Alksne, J. F., Blackstad, T. W., Walberg, F., and White, L. E., Jr. (1966). Ergeb. Anut. Entwicklungsgeschichte 39, 1. AndBn, N. E., Carlsson, A., DahIstrom, A., Fuxe, K., Hillarp, N. A., and Larsson, K. ( 1964). Life Sci. 3, 523. AndBn, N. E., Dahlstrom, A., Fuxe, K., and Larsson, K. (1965a). Am. J . Anat. 116, 329. AndBn, N. E., Dahlstrom, A., Fuxe, K., and Larsson, K. (1965b). Life Sci. 4, 1275. AndBn, N. E., Dahlstrom, A., Fuxe, K., Larsson, K., Olson, L., and Ungerstedt, U. (1966). Actu Physiol. Scund. 67, 313. And&, N. E., Fuxe, K., and Ungerstedt, U. (1967). Experientia 23, 838. Berman, A. L. (1968). “The Brain Stem of the Cat: A Cytoarchitectonic Atlas with Stereotaxic Coordinates.” Univ. of Wisconsin, Madison, Wisconsin. Bertler, A., and Rosengren, E. (1959). Erperientiu 15, 10. Bertler, A., Falck, B., Owman, C., and Rosengren, E. (1966). Phurmcol. Rev. 18, 369. Bjorklund, A,, Ehinger, B., and Falck, B. (1968). J. Hktochem. Cytochem. 16, 263. Bjorklund, A,, Falck, B., Hromek, F., Owman, C., and West, K. A. (1970). Bruin Res. 17, 1. Bleier, R., Bard, P., and Woods, J. W. (1966). J . Comp. Neurol. 128, 255. Bloom, F. E. (1968). Adoun. Pharmcol. 6A, 207. Bogdanski, D. F., Weissbach, H., and Udenfriend, S . (1957). J . Neurochem. 1, 272. Brady, J . V., and Nauta, W. J. H. (1953). J. Comp. Physiol. Psychol. 46, 339.
90
ROBERT Y. MOORE
Brodie, B. B., and Shore, P. A. (1957). Ann. N . Y. Acad. Sci. 66, 631. Brodie, B. B., Shore, P. A., and Pletscher, A. (1956). Science 123, 992. Brown, G. L., and Feldberg, W. ( 1936). J. Physiol. (London) 86, 290. Cannon, W. B., and Lissak, K. (1939). J. Physiol. (London) 125, 765. Carlsson, A., Falck, B., and Hillarp, N. A. (1962). Acta Physiol. Scand. 56, Suppl. 196. Carlsson, A., Falck, B., Fuxe, K., and Hillarp, N. A. (1964). Acta Physiol. Scand. 60, 112. Carpenter, M., and McMasters, R. E. (1984). Am. J. Anat. 114, 293. Caspersson, T., Hillarp, N. A., and Ritzen, M. (1966). Exptl. Cell Res. 42, 415. Cohen, E. B., and Pappas, G. D. (1969). J . Comp. Neurol. 136, 375. Cole, M., Nauta, W. J. H., and Mehler, W. R. (1964). Trans. Am. Neurol. Assoc. 89, 74. Colonnier, M. (1964). J . Anat. 98, 47. Corrodi, H., and Jonsson, G. (1967). J . Histochem. Cytochem. 15, 65. Dahlstrom, A,, and Fuxe, K. (1964). Acta Physiol. Scund. 62, Suppl. 232. Dahlstrom, A., and Fuxe, K. (1965). Actu Physiol. Scand. 64, Suppl. 247. Ehringer, H., and Hornykiewicz, 0. ( 1960). Klin. Wochschr. 38, 1236. Falck, B. (1962). Acta Physiol. Scund. 56, SuppI. 197. Falck, B., Hillarp, N. A., Thieme, G., and Torp, A. (1962). J. Histochem. Cytochem. 7, 348. Fink, R. P., and Heimer, L. (1967). Bruin Res. 4, 369. Fischer, J, E., and Snyder, S. (1965). J . Pharmacol, Exptl. Therap. 150, 190. Fuxe, K. (1965). Acta Physiol. Scand. 64, Suppl. 64, 37. Fuxe, K., and HQkfelt, T. (1969). In “Frontiers in Neuroendocrinology” (W. F. Ganong and L. Martini, eds.), p. 47. Oxford Univ. Press, London and New York. Fuxe, K., Hamberger, B., and Hokfelt, T. (1968a). Brain Res. 8, 125. Fuxe, K., Hokfelt, T., and Ungerstedt, U. (1968b). Aduan. Pharmucol. 6A, 207. Guillery, R. W. (1957). J . Anat. 91, 91. Guillery, R. W., and Ralston, H. J. (1964). Science 143, 1331. Harvey, J. A,, Heller, A,, and Moore, R. Y. (1963). J . Pharmacol. Exptl. Therap. 140, 103. Harvey, J. A,, Heller, A., Moore, R. Y., Hunt, H. F., and Roth, L. J. (1964). J . Pharmcol. Exptl. Therap. 144, 24. Heimer, L. (1967). Brain Res. 5, 86. Heimer, L., and Peters, A. (1968). Brain Res. 8, 337. Heller, A., and Harvey, J. A. (1963). Pharmacobght 5, 264. Heller, A,, and Moore, R. Y. (1965). J . Pharmucol. Exptl. Therap. 150, 1. Heller, A., and Moore, R. Y. (1968). Advan. P h a m c o l . 6A, 191. Heller, A,, Harvey, J. A,, Hunt, H. F., and Roth, L. J. (1960). Science 131, 662. HelIer, A., Harvey, J. A., and Moore, R. Y. (1962). Biochem. Pharmcol. 11, 859. Heller, A,, Seiden, L. S., and Moore, R. Y. (1964). Phamulcologist 6, 196. Heller, A., Seiden, L. S., and Moore, R. Y. (1966a). Intern. J . Neurophamacol. 5, 91. Heller, A,, Seiden, L. S., Porcher, W., and Moore, R. Y. (1966b). J. Neurochem. 13, 967. Herrick, C. J. (1933). Proc. Natl. Acad. Sci. U.S . 19, 7. Hillarp, N. A,, Fuxe, K., and Dahlstrom, A. (1966). Pharmucol. Rev. 18, 727. Hornykiewicz, 0. (1962). Deut. Med. Wochschr. 87, 1807. Hornykiewicz, 0. (1966). Pharmucol. Rev. 18, 925.
BRAIN LESIONS AND AMINE METABOLISM
91
Jouvet, M. (1969). Science 163, 32. Kirkepar, S. M., Cervoni, P., and Furchgott, F. (1962). J. Phrmacol. Exptl. Therap. 135, 180. Kluver, H., and Bucy, P. C. (1937). Am. J. Physiol. 119, 352. Kuntman, R., Shore, P. A., Bogdanski, D., and Brodie, B. B. (1961). J. Neurochem. 6, 226. Lashley, K. S. (1951). Trans. Am. Neural. Assoc. 76, 34. MacIntosh, F. C. (1938). Arch. Intern. Physiol. 47, 321. Malmfors, T. (1965). Acta Physiol. Scand. 64, Suppl. 248, 56. Moore, R. Y. (1969). Paper presented at the Laurentian Conference on L-DOPA, Val David, Canada, November 11. Moore, R. Y., and Heller, A. ( 1964). Trans. Am. Neurol. Assoc. 89, 143. Moore, R. Y., and Heller, A. (1967). J. Pharmacol. Exptl. Therap. 156, 12. Moore, R. Y., and Heller, A. (1969). In “Progress in Neurogenetics” ( A . Barbeau and J. R. Brunette, eds.), p. 276. Excerpta Med. Found., Amsterdam. Moore, R. Y., Wong, S. L. R., and Heller, A. (1965). Arch. Neurol. 13, 346. Moore, R. Y., Bhatnagar, R. K., and Heller, A. (1966). Intern. J. Neuropharmacol. 5, 287. Moore, R. Y., Bhatnagar, R. K., and Heller, A. (1969). Unpublished observations. Morgane, P. J. (1969). Ann. N . Y. Acad. Sci. 157, 806. Nauta, W. J. H. (1956). J. Comp. Neurol. 104, 247. Nauta, W. J. H. (1957). In “New Research Techniques of Neuroanatomy” (W. F. Windle, ed. ), p. 17. Thomas, Springfield. Nauta, W. J. H. (1958). Brain 81, 319. Nauta, W. J. H. (1963). Advan. Neuroendocrinol., Proc. Symp., Miami, Flu., 1961, p. 5. Olds, J. (1962). Physiol. Rev. 42, 5%. Papez, J. W. (1937). A.M.A. Arch. Neurol. Psychiat. 38, 725. Parent, A,, Saint-Jacques, C., and Poirier, L. J. (19G9). Ex&. Neurol. 23, 67. Pohorecky, L. A., Zigmond, M. J., Heimer, L., and Wurtman, R. J. (1969). Federation Proc. 28, 795. Poirier, L. J., and Sourkes, T. L. (1965). Brain 88, 181. Poirier, L. J., Singh, P., Boucher, R., Bouvier, G., Olivier, A,, and Larocelle, P. ( 1967). Arch. Neurol. 17, 601. Rehn, N. 0. (1958). Acta Physiol. Scand. 42, 309. Ritzen, M. (1966). Exptl. Cell Res. 44, 505. Ritzen, M. (1967). Exptl. Cell Res. 45, 178. Roth, C. D., and Richardson, K. C. (1969). Am. J. Anat. 124, 341. Sedvall, G. (1963). Acta Physiol. S c a d . 59, Suppl. 213. Sidman, R. L., Perkins, M., and Weiner, N. (1962). Nature 193, 36. Teitlebaum, P., and Epstein, A. (1962). Psychol. Rev. 69, 74. Trendelenberg, U. ( 1963). 1. Phamnacol. Exptl. Therap. 142, 335. Van Orden, L. S., Vugman, I., and Giarman, N. J. (1965). Science 148, 642. von Euler, U. S., and Purkhold, A. (1951). Acta Physiol. Scand. 24, 212. Wolf, G., and Sutin, J. (1966). J. Comp. Neurol. 127, 137. Woolley, D. W. (1962). “The Biochemical Bases of Psychoses.” Wiley, New York. Wurtman, R. J., Axelrod, J., Sedvall, G., and Moore, R. Y. (1967). J. Pharmacol. Exptl. Therap. 157, 487. Zieher, L. M., and Pellegrino de Iraldi, A. (1966). Life Sci. 5, 155.
This Page Intentionally Left Blank
MORPHOLOGICAL AND FUNCTIONAL ASPECTS OF CENTRAL MONOAMINE NEURONS By Kjell Fuxe, Tomas Hokfelt, and Urban Ungerstedt Department of Histology, Karolinska Inrtitutet, Stockholm, Sweden
I. Morphology of Central Monoamine Neurons . . . . A. Methods to Map Out Monoamine Pathways . . . B. DA Pathways . . . . . . . C. NA Pathways . . . . . . . D. 5-HT Pathways . . . . . . E. Electron Microscope Studies on Central Monoamine Neurons 11. Function of Central Monoamine Neurons . . . A. DA Pathways . . . . . . . . . B. NA Pathways . . . . . . C. 5-HT Pathways . . . . 111. Some Conclusions . . . . . . . . A. Nigro-Neostriatal DA Neurons . . . . B. The Tubero-Infundibular DA Neurons . . . . C. The Central NA Neurons . . . D. The Central 5-HT Neurons . . . . References . . . .
.
. . . . . . . . . . . . . . . . . . . . . . .
. .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . , . . . . . . . . . . . . . . . . . .
93 94 96 98 101 102 104 104 110 115 119 119 119 119 120 121
In recent years several review articles have been published on the central monoamine neurons (see articles by Fuxe et aZ., 1968b, 1969a, 1970a, 1970c; A n d h et aZ., 1969a,b; Fuxe and Hokfelt, 1969). The present article will deal with work carried out in 1968 and 1969, especially in our laboratory, which has not been summarized in previous review articles. A major part of the work has been done in cooperation with the department of Pharmacology, Goteborg, Sweden (Head: Prof. A. Carlsson). I. Morphology of Central Monoamine Neurons
The detailed distribution of CA' and 5-HT nerve cell bodies and nerve terminals in the mammalian central nervous system has been given in previous articles (Dahlstrom and Fuxe, 1964b; Fuxe, 1965; Fuxe et aZ., 1968b, 1969a) using the histochemical fluorescence technique ( Falck et al., 1962; Falck, 1962; Hillarp et al., 1966; Corrodi and Jonsson, 1967). The cell bodies have a low amine concentration, whereas the terminals Abbreviations: CA = catecholamine( s ) , DA = dopamine, 5-HT = 5-hydroxytryptamine, &OH-DA = 6-hydroxy-dopamine, NA = noradrendine. 93
94
KJEU
FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
have high concentrations of monoamines. The axons, on the other hand, have very low amine concentrations so that they are barely visible in the normal animal. The vast majority of the NA cell bodies are localized in the pons and the medulla oblongata mainly in the lateral part of the reticular formation, whereas the DA cell bodies are exclusively localized in the mesencephalon with the exception of some DA cell body groups in the hypothalamus (see Fuxe and Hokfelt, 1969). The 5-HT cell bodies are localized mainly in the raphe complex of the reticular formation. The localization of the monoamine cell bodies has been confirmed for the cat by Jouvet’s group (Pin et al., 1968). The NA and 5 H T nerve terminals have a widespread distribution in the brain and spinal cord. The NA nerve terminals are found in high densities in many areas of the hypothalamus, the preoptic area, the limbic system, and the lower brainstem (see Fuxe, 1965; Fuxe et al., 1969a). The 5-HT nerve terminals have a similar distribution but are more difficult to detect than the NA nerve terminals, especially in the di- and telencephalon mainly because of the low sensitivity of the histochemical fluorescence method for 5-HT compared to that for CA (see Jonsson, 1967; Fuxe and Jonsson, 1967). Thanks to the discovery that 6-hydroxytryptamine (Jonsson et al., 1969), which gives a stronger fluorescence reaction than 5-HT (Jonsson and Sandler, 1%9), has a high affinity for 5-HT nerve terminals and can be made to accumulate only in the 5-HT and not in the CA neurons with the help of pharmacological tools, it has now become possible to perform detailed mapping of the distribution of 5-HT nerve terminals also (see e.g., Jonsson et al., 1969; Hokfelt and Fuxe, 1969).
A. METHODSTO MAP OUTMONOAMINE PATHWAYS Before describing these pathways in some detail the principal methods used to map out monoamine neurons will be mentioned. 1. A common method is to damage the axons with the help of precise stereotaxic lesions and to study the subsequent anterograde and retrograde degeneration of the neurons (see A n d h et al., 1966a). The anterograde degeneration involves the destruction of the amine-storage mechanism in the granules after 2-4 days, somewhat preceded by the breakdown of the membrane pump mechanism in the nerve cell membrane (see And& et al., 1966a; Hokfelt and Ungerstedt, 1969; Fuxe et al., unpublished data). Similar results have been observed in studies on the anterograde degeneration of peripheral adrenergic neurons ( Malmfors and Sachs, 1965). 2. Of great help in tracing the pathways has also been the fact that
ASPECTS OF CENTRAL MONOAMINE NEURONS
95
monoamines accumulate in the proximal part of the axons (cell body side) after an electrothermic lesion, owing to the rapid transport of amine storage granules from the cell bodies to the terminals via the axons (Dahlstrom and Fuxe, 1964a,b; Dahlstrom, 1965; Kapeller and Mayor, 1967). An accumulation of aniines in the axons can also be obtained by injecting colchicine over the monoamine axons and cell bodies in the peripheral nervous system ( Dahlstrom, 1968). Thus, stereotaxic injections of colchicine into various pathways can also be used to map out various monoamine neuron systems ( Ungerstedt, unpublished data). 3. A new tool of importance for mapping out monoamine neurons is 6-OH-DA. This drug was discovered by Tranzer and Thoenen (1968) to cause a degeneration of peripheral adrenergic neurons. Later on, Ungerstedt (1968) and Uretsky and Iversen (1969) found that 6-OH-DA could cause degeneration of central NA neurons. Thus, Ungerstedt (1968) also found a complete degeneration of the nigro-neostriatal DA neurons after intracerebral injections of 6-OH-DA into the substantia nigra. The nigral DA cell bodies markedly accumulate 6-OH-DA by way of the membrane pump, after which they .rapidly degenerate, possibly owing to the fact that 6-OH-DA is a strong reducing agent. Similar injections close to NA pathways cause anterograde degenerations of the NA neurons also. Furthermore, at the site of injection a damming up of fluorescent material can be seen in the NA axons on the cell body side offering possibilities of tracing the pathways (see above). The 5-HT neurons do not seem to be seriously affected by 6-OH-DA. 4. During the early postnatal period (Maeda and Dresse, 1968; Olson and Fuxe, to be published) there is an increased fluorescence intensity in the CA axons, which makes it easier to trace them also in the untreated animal, i.e., without performing studies of the types described in the previous three points. 5. Of great help in mapping out the axonal pathways have also been in uitro studies on brain slices with monoamines in the incubation bath. Owing to the reserpine-resistant uptake-concentration mechanism at the nerve cell membrane (Hillarp and Malmfors, 1964; Fuxe and Hillarp, 1964; Carlsson and Waldeck, 1965; Hamberger and Masuoka, 1965), the axons will become strongly fluorescent and easy to trace (Hamberger, 1967; Hokfelt and Fuxe, 1969, and unpublished data) provided that the intraneuronal monoamine oxidase (MAO) has been inhibited, or a-methylated amines have been used. 6. A new approach which recently has been used in our laboratory is to stimulate electrically the various monoamine pathways and cell body groups on one side of the brain and to study the increased amine depletion obtained in the terminals belonging to the stimulated mono-
96
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
amine neurons after inhibition of amine synthesis (Arbuthnott et al., unpublished data). 7. A pure pharmacological approach can also be helpful to evaluate the localization of the pathways. Thus, nialamide or other M A 0 inhibitors will cause a marked accumulation of amine in the central 5-HT neurons. Similarly, after nialamide-dopa treatment the CA nonterminal axons become clearly fluorescent owing to accumulation of CA formed from dopa (Dahlstrom and Fuxe, 196413, 1965; Fuxe, 1965).
B. DA PATHWAYS 1. Nigro-neostriatal DA neurons (And& et al., 1964a, 1965a, 1966a,b; Poirier and Sourkes, 1965; Ungerstedt, 1968; Hokfelt and Ungerstedt, 1969). 2. Mesolimbic DA neurons (And& et al., 1966a; Dresse, 1966). 3. Tubero-infundibuhr DA neurons (Fuxe, 1963, 1964; Fuxe and Hokfelt, 1966, 1967, 1969; Lichtensteiger and Langemann, 1966; Bjorklund, 1970). 1. The main nucleus of the nigro-neostriatal DA neurons is the zona compacta of the substantia nigra. Most of the cell bodies in this zone are DA nerve cell bodies (group A9; Dahlstrom and Fuxe, 196410). Some DA cell bodies are also found in the zona reticulata and the pars lateralis of the substantia nigra, which also belong to the nigroneostriatal DA neurons. Recently, studies after removal of n. caudatus putamen (NCP) also suggest that the CA cell bodies in the ventrolateral part of the midbrain tegmentum (group A8; Dahlstrom and Fuxe, 1964b) belong to this large uncrossed neurons system, inasmuch as they show marked reductions in fluorescence intensity and signs of atrophy after such operations ( Ungerstedt, unpublished data). These CA cell bodies may therefore also contain DA. In agreement with this view these CA cell bodies, together with most of the DA cell bodies of the substantia nigra, are the ones that show the most marked increases in fluorescence intensity following treatment with dopa (Butcher et al., 1970). Furthermore, after removal of the neostriatum there are no longer any marked increases in the fluorescence intensity of the DA cell bodies in groups A 9 and A 8 after dopa treatment but only in those surrounding the n. interpeduncularis (group A10) (Dahlstrom and Fuxe, 1964b) giving evidence for the view that both these CA cell body groups give rise to the nigro-neostriatal DA pathway. Evidence has been obtained by Poirier’s group ( Poirier, personal communication) that there may exist a medial and lateral nigro-neostriatal DA pathway innervating the cranial medial and caudal lateral part of the neostriatum respectively. In support of this view are the facts that the DA cell bodies in the
ASPECTS OF CENTRAL MONOAMINE NEURONS
97
medial part of the zona compacta and the DA terminals of the medial part of the neostriatum do not show as marked an increase in fluorescence intensity after dopa as do the DA-containing cell bodies and terminals in the lateral part of the zona compacta and the neostriatum respectively (Butcher et al., 1WO). A rough quantitative study of the nigro-neostriatal DA neurons (And& et al., 1966b) has revealed that the total number of DA cell bodies on one side was about 3500. The average amount of DA in each cell body was 2.5 pg with a concentration around 200 pglgm. Each of the DA varicosities of the terminals contained 2.5 x lo-' pg with a concentration of 8000 pg/gm wet weight. These figures are of the same order as those calculated for the peripheral adrenergic neurons (Dahlstrom, 1966). The calculations furthermore suggested that the total terminal system of each neuron was about 65 cm in length and contained on the average 500,000 varicosities, illustrating the high degree of divergence in the innervation pattern. This must be of high functional importance, since it allows nerve impulse activity in one DA neuron to influence a large number of nerve cells. The DA fibers to the neostriatum are caudally aggregated first medial to the crus cerebri. Then they diverge into the rostra1 crus cerebri and the retrolenticular part of the capsula interna and spread into the NCP by way of the fibrae capsulae internae. The DA nerve terminals are densely packed and very fine (Fuxe et al., 1964). Electron microscopically about 15%of all boutons in this nucleus have been found to belong to monoamine neurons (Hokfelt, 1968a). The varicosities are mainly 0.5-1 p in diameter . 2. The mesolimbic DA neurons have their cell bodies in the area surrounding the n. interpeduncularis (Anden et al., 1966a). After destruction of this CA cell body group (group A10; Dahlstrom and Fuxe, 1964b), the DA nerve terminals in the tuberculum olfactorium, n. accumbens, the dorsolateral part of the n. interstitialis striae terminalis and in the n. amygdaloideus centralis degenerate. Furthermore, several months after destruction of these parts of the limbic system, the DA cell bodies of group A10 have disappeared or appeared shrunk and atrophied with a very low fluorescence intensity. Caudally the DA fibers of this system run medially to the nigro-neostriatal DA fibers, whereas cranially they mainly lie ventral to the nigro-neostriatal DA fibers. In the tuberculum olfactorium the DA nerve terminals are found in somewhat higher density in the area surrounding the outer cell body layer. With the exception of the part of the n. accumbens close to the medial side of the anterior limb of the commissura anterior, the DA nerve terminals in the tuberculum olfactorium and n. accumbens have a somewhat lower
98
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
intensity than those present in the neostriatum. Because the number of the DA cell bodies in group A10 are of about the same order as that found in group A9 and 80% of the brain DA is found in the neostriatum, the mesolimbic DA neurons probably contain less amounts of DA than the nigro-neostriatal DA neurons. This is probably due to the fact that the terminal network of each mesolimbic DA neuron is much smaller than that of the nigro-neostriatal DA neurons. 3. The tubero-infundibular DA neurons have their cell bodies mainly localized to the anterior part of the n. arcuatus. The axons run ventrally toward the lateral border of the median eminence. Some of them enter directly the external layer caudally. In the external layer the axons give rise to a densely packed plexus of DA nerve terminals, which probably exert an axo-axonic influence in this layer (Hokfelt, 196713, 1968b). The DA terminal plexus is present also in the external layer of the infundibular stem. Some may be found also in the posterior lobe and in the pars intermedia (Bjorklund, 1968; Fuxe and Hokfelt, 1969).
C. NA PATHWAYS 1. Ascending NA Neurons a. Dorsal NA pathway ( Fuxe, 1965; Ungerstedt, unpublished data). In the first publications it was discovered that there existed a distinct fascicle of bundles of NA axons with varicose-like enlargements in the dorsolateral tegmentum lateral and slightly ventral to the fasciculus longitudinalis medialis, which abruptly turned ventrally at the border between di- and telencephalon to pass laterally of the fasciculus retroflexus into the subthalamus (mainly zona incerta and Forel’s field H I ) and into the lateral hypothalamic area. By consecutive unilateral sections of the brain at various levels this pathway has now been mapped out in detail ( Ungerstedt, unpublished data), and evidence was obtained that this bundle mainly originated from the NA cell bodies of the locus coeruleus. Part of the bundle could be traced to the most cranial part of the medial forebrain bundle. Further evidence for this view has been obtained in studies on rats in the postnatal period (Olson and Fuxe, unpublished data) and on brain slices after incubation with CA (Hokfelt and Fuxe, unpublished data). Also in these experiments it was possible to trace some axons of the dorsal bundle into the most cranial part of the medial forebrain bundle. Furthermore, most of the axons of the dorsal bundle could be directly traced back to the NA cell bodies of the locus coeruleus. It should be pointed out that these NA cell bodies probably have some large axon branches which participate in the innervation of the lower brainstem. Recently, unilateral lesions of the
ASPECTS OF CENTRAL MONOAMINE NEURONS DORSAL PATHWAY
99
---- ---
FIG.1. Schematic drawing of the principal construction of the central NA pathways. The huge collateral system of these NA pathways is illustrated. The dorsal ascending NA pathway mainly innervates the cortex cerebri and the hippocampal formation, and the ventral NA pathway mainly innervates the hypothalamus and the ventral parts of the limbic system. dorsal bundle has been made in the tegmentum (Ungerstedt, unpublished data). The results indicate mainly degeneration of the NA nerve terminals in the cortex cerebri and the hippocampal formation. In agreement with this, it has been found that electrical stimulation of the dorsal bundle will cause preferential release of amine from the NA nerve terminals in the cortex cerebri and the hippocampal formation (Arbuthnott et al., unpublished data). b. Ventral N A pathway (Anddn et al., 1966a,b; Fuxe, 1965; Ungerstedt, unpublished data). This pathway probably arises mainly from the NA cell bodies in the n. reticularis lateralis ( A l ; Dahlstrom and Fuxe, 1964b), in tr. rubrospinalis at the level of the superior olive (A5; Dahlstrom and Fuxe, 1964b), and in the reticular formation ventral to the peduncularis cerebelleris superior at the level of the n. motorius dorsalis n. vagi (A7; Dahlstrom and Fuxe, 1964b). Recently, this pathway has been described in detail by Ungerstedt (unpublished data). By use of 6-OH-DA injections it was possible to trace the bundles of axons from their site of origin (groups Al, A5, and A7) all the way into the medial forebrain bundle. The fibers came together in the pons where they aggregate medial to the outgoing fibers of the facial nerve. On their ascent they pass medial to motor nucleus V lying in the lateral part of the reticular tegmentum and turn medially along the dorsal surface of
100
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
the lemniscus medialis at the level of the caudal third of the substantia nigra. Before reaching the n. interpeduncularis they again turn rostrally and reach the medial forebrain bundle via the area ventralis tegmenti ( Ungerstedt, unpublished data). From lesion experiments ( Ungerstedt, unpublished data) there is strong support for the view that these axons mainly innervate the hypothalamus, the preoptic area, and many parts of the limbic system (n. interstitialis striae terminalis, ventral part; septa1 area). In agreement with this, it has been found that electrical stimulation of the ventral NA bundle at the level of n. interpeduncularis in the lateral part of the reticular formation causes mainly release of amines from NA nerve terminals in the hypothalamus, preoptic area, and the ventral parts of the limbic forebrain ( Arbuthnott et aZ., unpublished data ) .
2. Descending NA Neurons (Carlsson et al., 1964; Dahlstrom and Fuxe, 1965) The NA axons, which arise mainly from NA cell bodies in the n. reticularis lateralis ( A l ) , descend in the lateral and anterior funiculi. During their descent down the spinal cord they give off a large number of collaterals innervating the gray matter at various levels of the spinal cord. Inasmuch as many of the NA cell bodies also give rise to ascending axons (see above), it is probable that at least some of the NA cell bodies of group A1 have two main axons, one ascending and one descending axon.
3. NA Neurons Innervating the Lower Brainstem Since most of the NA cell bodies in the brain show retrograde cell body changes following lesions of the ascending NA pathways, it is likely that most of NA nerve terminals in the lower brainstem derive from collaterals of NA pathways ascending in the lower brainstem. It is, of course, possible that there exists a number of NA neurons which exclusively or mainly innervate the lower brainstem. The innervation of cortex cerebelli (Hokfelt and Fuxe, 1969) is, in many aspects, similar to that of cortex cerebri (Fuxe et d.,1968a) and hippocampal formation (Blackstad et aK, 1967). Thus, it is characterized by its diffuseness of innervation reaching almost all parts of the cortex cerebelli and lack of stratification in its innervation patterns. The morphological characteristics of the NA neurons are very similar to the reticular nerve cells described by Scheibel and Scheibel (1958) in Golgi preparations. These cells also have descending and/or ascending axons giving off a large number of collaterals to various nuclei of the lower brainstem. The functional significance of such nerve cells must be
ASPECTS OF CENTRAL MONOAMINE NEURONS
101
that these nerve cells can immediately influence neurotransmission in a large number of areas situated far apart at various levels of the brain and the spinal cord. In this way it would be possible to trigger off complicated behavioral or autonomic responses by increasing impulse traffic in the central NA neurons. Thus, the NA cell bodies of group A1 could immediately influence the transmission in the sympathetic lateral column, the dorsal motor nucleus V and the hypothalamus areas which all belong to the central autonomic system.
D. 5 H T PATHWAYS 1. Ascending 5-HT Neurons (Dahlstrom and Fuxe, 1964b; Fuxe, 1965; Heller and Moore, 1965; And& et al., 1966a) After treatment with nialamide, the 5-HT cell bodies in the raphe nuclei of the mesencephalon (n. raphe dorsalis, n. raphe rnedianus) and in the ventromedial reticular tegmentum can be seen to give rise to large numbers of ascending 5-HT axons, which run in the middle third of the tegmentum. First the axons run ventrally and then turn rostrally when approaching the n. interpeduncularis. The majority of the axons seem to lie close to the midline and become aggregated in a bundle lying medial to the fascicuIus retroflexus on the border between the mes- and diencephalon. These fibers enter the medial forebrain bundle by passing laterally close to the ventral outline of the fasciculus retroflexus, and most of them become aggregated close to the lateral surface of the fornix. In the lateral hypothalamic area there are also observed two other 5-HT bundles lying laterally which may originate from the lateral 5-HT bundles in the mesencephalon. One lies just beneath (ventral to) the most ventral part of the crus cerebri, the other one just dorsal to the lateral part of the optic tract. With the help of lesions of the lateral hypothalamic area and of the raphe nuclei, it has been possible to show that this pathway innervates large parts of the tel- and diencephalon, e.g., limbic forebrain structures and hypothalamus (And& et al., 196513, 1966a; Heller and Moore, 1965; Poirier et aZ., 1969). Also, after lesions of the raphe nuclei, electron microscopic signs of degeneration ( Aghajanian et aZ., 1969) have been observed in the suprachiasmatic nucleus, which is densely innervated by 5-HT nerve terminals (Fuxe, 1965). In agreement with this, it has been possible to show that electrical stimulation of the raphe nuclei results in increased formation of 5-hydroxyindoleacetic acid (5-HIAA) in the telencephalon ( Sheard and Aghajanian, 1968; Kostowski et al., 1969). Furthermore, indications of an increased release of 5-HT from the suprachiasmatic nerve terminals can be demonstrated histochemically after electrical stimulation provided that the amine synthesis is inhibited ( Arbuthnott et al., unpublished data).
102
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTFDT
2. Descending Bulbospinal5-HT Neurons (Carlsson et al., 1964; Dahlstrom and Fuxe, 1965) This pathway ascends in the most superficial part of the lateral and anterior funiculus probably arising mainly from 5-HT cell bodies in the raphe nuclei of the medulla oblongata (n. raphe obscurus, B1 according to Dahlstrom and Fuxe, 1964b; n. raphe pallidus; B2) and the 5-HT cell bodies surrounding the pyramidal tract at the cranial level of the medulla oblongata. The 5-HT fibers, just like the NA fibers, give rise to large numbers of collaterals innervating the gray matter of the spinal cord. A particularly large projection of 5-HT axons exists to the lumbal and sacral part of the spinal cord. It should be mentioned that many of the 5-HT cell bodies of the medulla oblongata are innervated by NA nerve terminals as are also, but to a lesser extent, the NA cell bodies of group A l . These aminergic links should be remembered when discussing brain circuitary and interactions between NA and 5-HT neurons.
3. 5-HT Neurons Innervating the Lower Brainstem As discussed in the section on NA neurons, two possibilities exist. The 5-HT nerve terminals could derive from axons belonging to short 5-HT neurons or derive from collaterals of long 5-HT neurons. Probably both types of 5-HT neurons exist. The number of short 5-HT neurons compared to long 5-HT neurons is not known.
MICROSCOPE STUDIESON CENTRAL E. ELECTRON MONOAMINENEURONS Early electron microscopic studies on peripheral nervous tissues revealed the presence of so-called granular or dense core vesicles in probable noradrenergic neurons ( Lever and Esterhuizen, 1961; De Robertis and Pellegrino de Iraldi, 1961a,b; Taxi, 1961a,b; Richardson, 1962). At least two groups could be distinguished according to Grillo and Palay (1962)-small (diameter about 5008, type 2 and 3) and large (diameter about 1000 A, type 1) granular vesicles. Autoradiographic (Wolfe et al., 1962) and pharmacological (Pellegrino de Iraldi and DeRobertis, 1W; Richardson, 1963; Bloom and Barrnett, 1966; Bondareff and Gordon, 1966; Hokfelt, 1966) studies indicated that the small granular vesicles were the main intraneuronal storage sites for NA and also that they seemed to be specific for NA neurons. The role of the large granular vesicles remained obscure since they seemed to be present also in non-noradrenaline neurons (Coupland, 1965; Fuxe et aZ., 1965, 1966; Clementi et al., 1966; Grillo, 1966). In subsequent studies with routine fixation techniques ( glutaraldehyde and/or osmium tetroxide) on central nervous tissue only large
ASPECTS OF CENTRAL MONOAMINE NEURONS
103
granular vesicles could be demonstrated in addition to large numbers of the classic so-called synaptic vesicles, which have a clear interior (see e.g., Sjostrand, 1953; DeRobertis and Bennett, 1954; Palade and Palay, 1954). The large granular vesicles were then suggested to represent the central NA storage sites (Pellegrino de Iraldi et al., 1963). Although autoradiographic studies ( Aghajanian and Bloom, 1966a,b, 1967; Lenn, 1967; Descarries and Droz, 1968) disclosed that the large granular vesicles indeed often were present in boutons belonging to monoamine neurons, pharmacological and regional distribution studies have added new information on the significance of the large granular vesicles as revealed after glutaraldeli yde-osmium tetroxide fixation ( Fuxe et al., 1965, 1966; Bloom and Aghajanian, 1968) : 1. Large granular vesicles are not exclusively present in monoamine neurons and thus cannot be used as a criterion for identification of these neurons. 2. The dense core of the large granular vesicles does not mainly reflect the intraneuronal amine levels, and thus the effect of drugs cannot be properly investigated on the basis of the large granular vesicles. 3. Although the large granular vesicles in monoamine neurons probably contain amines, the main intraneuronal storage site for monoamines is made up of small vesicles which with glutaraldehyde and/or osmium tetroxide fixation appear as agranulas vesicles. The introduction of potassium permanganate (KMnO,) as a fixative for the demonstration of monoamine storage sites by Richardson (1966) opened up new possibilities for investigating monoamine neurons at the ultrastructural level. With this fixative, m a l l granular vesicles could be visualized both in the peripheral and central nervous system (Hokfelt, 1967a,b, 1968a,b, 1969, 1970; Hokfelt and Jonsson, 1968; Hokfelt and Ungerstedt, 1969). These studies have revealed that DA, NA, and 5 H T neurons contain both small and large granular vesicles, which seem to be present in all parts of the neuron. The highest numbers of vesicles are found in the boutons, and most of the vesicles are of the small type-in certain peripheral adrenergic neurons the large ones constitute only a few percent of all vesicles ( Hokfelt, 1969). The presence of small granular vesicles in central monoamine boutons has also been shown in glutaraldehyde-dichromate-osmium tetroxide tissue after intraventricular injections of 5-hydroxydopamine (Tranzer et al., 1969). This dopamine analog, which is taken up into catecholamine neurons and accumulated in the storage vesicles, seems to facilitate and enhance the demonstration of the dense core in the granular vesicles (Tranzer and Thoenen, 1967). The fact that monoamine boutons can be identified at the ultra-
104
KJELL FUXE, TOMAS HOKFELT,
AND URBAN UNGERSTEDT
structural level has made it possible to estimate the monoaminergic input to various brain regions quantitatively (Hokfelt, 1968a). Thus, in the caudate nucleus about 15%,in the hypothalamic periventricular region about 4%, and in the hypothalamic suprachiasmatic nucleus about 5%of all boutons belong to monoamine neurons. It has also been possible to identify dopamine nerve endings in the median eminence (Hokfelt, 1967b). These nerve endings belong to the tubero-infundibular dopamine neurons and are probably involved in the regulation of gonadotropin secretion from the anterior pituitary (Fuxe and Hokfelt, 1969), probably via an axo-axonic influence in the median eminence ( Hokfelt, 1968b). The synaptic relations between monoamine boutons and other nervous structures are so far incompletely known (see Hokfelt, 1968a,b). In the hypothalamic areas probable NA and 5-HT boutons are associated, to a certain extent, with synapses of type 1 (Gray, 1961). Such synapses seem, however, to be comparatively rare in connection with probable DA boutons in the caudate nucleus. Test tube studies (Hokfelt and Jonsson, 1968) and pharmacological studies performed on brain slices in vitro (Hokfelt, 1968a,b) have given strong evidence for the view that the dense core in both the small and the large granular vesicles as revealed after KMnO, fixation is formed by a reaction between the amines and the fixative. Thus, the dense core directly reflects the presence of an amine at the moment of fixation. This opens up the possibility of studying the action of psychoactive drugs at the ultrastructural level.
II. Function of Central Monoamine Neurons
A. DA PATHWAYS 1. Nigro-Neostriatal D A Neurons
a. Motor Functions. This system is of great importance for normal movements and postures. Thus, the cause of the symptoms rigidity, hypokinesia, and tremor found in parkinsonism is probably due mainly to the degeneration of the nigro-neostriatal DA system (see Hornykiewicg 1966). In agreement with this it has been found possible to restore a relatively normal motor function in Parkinsonian patients by way of treatment with high doses of L-dopa (Cotzias et al., 1967, 1969; Duvoisin et al., 1969; Weiner et al., 1969; Anden et al., 1970). From studies on rats (Bartholini et al., 1967; Bartholini and Pletscher, 1968; Butcher and Engel, 1969; Butcher et al., 1970), we know that after treatment with dopa following peripheral dopa decarboxylase inhibition
ASPEmS OF CENTRAL MONOAMINE NEURONS
105
only the intraneuronal DA levels are increased, whereas there is a slight decrease in the NA stores (Butcher and Engel, 1969; Butcher et al., 1970) and a marked decrease in the 5-HT stores (Bartholini et al., 1968; Butcher and Engel, 1969; Butcher et al., 1970), probably due to displacement by DA formed from dopa in the NA and 5-HT neurons. Since locomotion is markedly increased following dopa treatment (200 mglkg) in combination with a peripheraI dopa decarboxylase inhibitor, there is good evidence that the increased DA levels in the DA neurons result in increased DA neurotransmission (Bartholini et al., 1969; Butcher et al., 1970). The locomotion is mainly composed of stereotyped movements (Butcher et al., 1970). Studies on rats with the neostriatum removed on one side have also given evidence that neostriatal DA neurotransmission is increased following dopa treatment (Anden et al., 1966a; Ungerstedt, unpublished data). We know, for example, from previous studies using this model in rats and from intraneostriatal injections of apomorphine and DA (Ungerstedt et al., 1969) that the nigro-neostriatal DA neurons on one side aim to turn the animal toward the opposite side, but that this effect of the DA neurons is counteracted by other afferent pathways to the same neostriatum. However, after dopa administration in combination with the Peripheral dopa decarboxylase inhibitor the rats turn toward the operated side, probably because of the increased DA receptor activity induced by the increased amounts of DA formed in the terminals from dopa and which leak out onto the receptor sites. The increased turning can be quantitatively measured by counting the turns per minute (Ungerstedt and Arbuthnott, unpublished data) in a specially built rotometer. In this way a quantitative estimation of the efferent output from the NCP can be obtained. From the above it is obvious that dopa treatment should increase DA transmission in normal human beings. However, it still remains to be explained why dopa is so effective in treatment of parkinsonism, inasmuch as a considerable degree of degeneration of the nigro-neostriatal DA neurons exists with decreased dopa decarboxylation. The following factors could be of importance when trying to explain the beneficial effects of dopa. 1. The remaining DA neurons have enough dopa decarboxylase activity left to convert dopa into DA. Some formation of DA (10-20%) may also occur in the pericytes of the capillary walls. However, the functional significance of the DA formed extraneuronally is probably not large, since it seems as if the symptoms of patients with complete degeneration of the nigro-neostriatal DA neurons are not alleviated by the dopa treatment. Dopa itself is probably not active, since after central
106
KJEU
FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
dopa decarboxylase inhibition it is no longer active, at least not in the rat. Furthermore, improvement after dopa is correlated with increased homovanillic acid ( HVA) levels in the CSF ( Weiner et al., 1969). 2. Because of a decreased DA neurotransmission in the neostriatum the receptor sites have developed a denervation supersensitivity, and therefore even minute amounts of DA formed can have functional significance. This view is strongly supported by studies in rats on nigroneostriatal DA neurons undergoing degeneration following SOH-DA injection into the substantia nigra (Ungerstedt, unpublished data) or following blockade of transmission by reserpine ( Fuxe and Ungerstedt, 1969; Ungerstedt, unpublished data). Thus, in these rats the effect of apomorphine, which stimulates DA receptors (Ernst, 1967; A n d h et al., 1967b), dopa, and amphetamine are markedly potentiated ( Ungerstedt, unpublished data; Fuxe and Ungerstedt, 1969). In many cases of parkinsonism, treatment with dopa has resulted in side effects such as nausea and vomiting. An interesting side effect has been the appearance of choreo-athetoid movements, which usually are parallelled by marked increases of HVA in the cerebrospinal fluid (Weiner et al., 1969). One explanation of these hyperkinetic side effects may therefore be that too much DA is being formed in the remaining DA nerve terminals, so that DA receptors in certain parts of the neostriatum are being overstimulated. This may be of particular significance in cases when mainly the medial or lateral nigroneostriatal DA pathway has degenerated. In these cases dopa will cause an overstimulation of the remaining pathway, which could lead to development of hyperkinesias. This possibility is now being tested with lesions in the substantia nigra and local injection of apomorphine into various parts of the NCP. Recently, certain antiparkinsonian drugs ( Fuxe et aZ., unpublished data) such as certain antihistamine agents ( diphenylpyraline and dexbrompheniramin) and adamantine have been found to potentiate the effects of dopa in the turning model (Ungerstedt and Arbuthnott, unpublished data, see above). Adamantine has been found not to cause a blockade of the membrane pump in the DA and NA neurons, but it must act via another mechanism to potentiate the dopa response ( Goldstein et al., unpublished data). In contrast, diphenylpyraline and dexbrompheniramin may cause a certain blockade of the membrane pump in the DA neurons (Fuxe and Hamberger, unpublished data). These drugs have previously been shown to be potent blockers of the membrane pump in the central NA and especially the 5-HT neurons ( Carlsson and Lindqvist, 1969). When dopa is given together with a peripheral dopa decarboxylase
ASPECTS OF CENTRAL MONOAMINE NEURONS
107
inhibitor there is a marked and rapid fall in the intraneuronal levels of 5-HT (Bartholini et al., 1 W ; Butcher et al., 1970)) and the 5-HT cell bodies become clearly green-fluorescent (Butcher et al., 1970). The main mechanism for this is probably rapid displacement of 5-HT by newly formed DA. The possible role of this released 5-HT is unknown, but it cannot be of critical importance for the therapeutic effects, since a second dose of dopa given when the effects of the first dose have subsided and the 5-HT levels still are low causes marked locomotion (Fuxe et al., unpublished data). In view of the results obtained in rats, it is probable that treatment with dopa in patients results in depletion of brain 5-HT, which also may be of importance for the elicitation of the hyperkinesias. There exists a dense cholinergic innervation of the NCP (Shute and Lewis, 19166), and anticholinergic agents have been used for a long time in the treatment of parkinsonism. The DA and the cholinergic afferents to the NCP are probably antagonistic in function (see review by Randrup and Munkvad, 1968). When the DA receptor activity is low in comparison with the cholinergic receptor activity, as in parkinsonism, the end results will be an increased a-motoneuron activity (Steg, 1966, 1969). In agreement with this hypothesis, it has been found that the increased locomotion found with dopa is potentiated with the help of anticholinergic drugs such as atropine and benztropine (Fuxe et al., unpublished data). The same holds true for this drug combination in treatment of parkinsonism. On theoretical grounds it would seem warranted to combine dopa treatment with at least two drugs, an anticholinergic agent and a DA membrane pump blocker. Benztropine seems to have both these properties (Coyle and Snyder, 1969; Farnebo et al., and Fuxe et al., unpublished). b. Mental Functions (the role of mesolimbic DA neurons will also be discussed), It is now generally accepted that stereotyped behavior induced by apomorphine or by amphetamine [amphetamine probably acts by releasing extragranular CA stores (Carlsson et al., 1966a)b;Fuxe and Ungerstedt, 1968, 1969)] is owing to increased DA receptor activity in the neostriatum (see Randrup and Munkvad, 1968; Fuxe and Ungerstedt, 1969). Such stereotyped behavior is often seen in patients with mental disorders such as schizophrenia, and it has therefore been assumed that an abnormally increased activity in the nigro-neostriatal DA neurons at least partly could be responsible for the psychotic state. This view has become strengthened by the fact that neuroleptic drugs of the phenothiazine type, such as perphenazine and of the butyrophenone type, such as spiroperidol, which mainly block DA receptor sites in the brain (Corrodi and Fuxe, 1969; Anddn et al., un-
108
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
published data) are potent antipsychotic drugs, but at the same time they cause marked Parkinson-like side effects. Spiroperidol has been found to be the most potent blocker of neostriatal DA receptors so far. The rotation obtained by giving amphetamine to rats having a 6-OH-DA induced degeneration of the left nigro-neostriatal DA system is blocked by a dose as low as 0.005 mg/kg (Ungerstedt and Fuxe, unpublished data). Because the dopa-induced increase in the flexor reflex of spinalized rats, which is highly dependent on NA receptor activity ( Andkn et al., 1967a), is not clearly blocked with as high a dose as 10 mg/kg of spiroperidol, the NA receptor sites are probably not blocked with the doses used of this drug. There is little doubt that there exists a correlation with antipsychotic activity, and blockade of neostriatal DA receptors. However, it has not been sufficiently considered that these potent neuroleptic drugs also cause blockade of the DA receptors in the limbic forebrain, which are innervated by the mesolimbic DA neurons. Thus, these DA neurons also show an increase in turnover following treatment with clothiapin or spiroperidol (Corrodi and Fuxe, 1969, unpublished data; see below). It cannot in any way be excluded that part of or the main antipsychotic effect of neuroleptic drugs is mediated via blockade of transmission in the mesolimbic DA neurons. This can be the explanation for the recent findings with pimocide, a new neuroleptic drug (Janssen et al., 1968). This drug is said to give a good antipsychotic effect without causing marked parkinsonian-like side effects. However, it is possible that the lack of parkinsonian-like side effects with pimocide may be owing to the slow onset of action by pimocide compared to that seen with haloperidol or spiroperidol. We have found that pimocide in a dose as low as 0.1 mg/kg blocks DA receptors in the neostriatum and the limbic forebrain, whereas there is no blockade of NA receptors with as high a dose as 20 mg/kg (And& et al., unpublished data). We are now testing if doses from 0.01 to 0.1 mglkg cause a preferential effect of turnover in the mesolimbic DA neurons. Until inter aha these studies are completed, it is not possible to decide whether or not dysfunction in the activity of the mesolimbic DA neurons or the nigro-neostriatal DA neurons is the most important one in relation to mental disorders. It should be pointed out that also in the parts of the limbic system, rich in DA nerve terminals, there is a large input of presumably cholinergic nerve terminals (Shute and Lewis, 1966). Thus, in the limbic system there also may be a balance between dopaminergic and cholinergic activity. With the help of turnover studies it has been possible to obtain some support for this view. Thus, after treatment with oxotremorine, a cholinergic agent, there is an increase in the DA turnover in the two large ascending DA systems. This increase can be blocked with the
ASPECTS OF CENTRAL MONOAMINE NEURONS
109
help of atropine (Corrodi et at., 1967). When anticholinergic hallucinogenic drugs such as ditran and sernyl are given, there is instead a decrease in DA turnover in the two ascending DA systems (Andkn et al., unpublished data). These findings can be interpreted to mean that after oxotremorine there is a compensatory increased release of DA in the neostriatum and the limbic forebrain, possibly induced by nervous feedback onto the DA cell bodies causing increased nervous activity. After ditran and sernyl, on the other hand, there is a compensatory decreased release of DA, possibly induced by nervous feedback. It is thus possible that the hallucinogenic properties of drugs such as ditran are owing to an imbalance in activity between cholinergic and DA neurons innervating the limbic system and/ or the neostriatum. It is clear from the above that we know little about the function of the mesolimbic DA neurons. Studies on rats with bilateral electrocoagulations of neostriatum reveal after treatment with apomorphine in combination with cataprezan, a NA receptor stimulating agent ( Andkn et al., 1970b), a peculiar behavior, which consists of jerky, very rapid movements with periods of complete rest. Because this behavior could not be elicited without apomorphine, it may be dependent on the DA receptor activity in the limbic system (Fuxe and Ungerstedt, 1969). The ascending two systems of DA neurons may thus, play a role in motor functions and in mental functions. c. Function in Thermoregulation. It has recently been found in mice that apomorphine decreases body temperature probably via a central action (Fuxe and Sjoqvist, unpublished data). This effect can be blocked by haloperidol in a dose which mainly blocks central DA receptor sites. These findings are of great interest, since they can suggest a role of the DA neurons in thermoregulation. Hitherto, only NA and 5-HT neurons have been discussed in this respect. d. Autonomic Function. Another finding illustrating the multiple functions of the ascending DA neurons is the decrease in blood pressure (Bolme and Fuxe, unpublished data) observed with potent DA receptor blocking agents such as spiroperidol and pimocide, which do not block NA receptor sites ( Andkn et al., unpublished data; Ungerstedt and Fuxe, unpublished data). Thus, the DA neurons may play a role also in centrd vasomotor mechanisms. In our laboratory ( Ungerstedt, unpublished observations), some results have been obtained indicating that the nigro-neostriatal DA neurons are necessary for normal eating and drinking behavior. Thus, after bilateral 6-OH-DA injections into the substantia nigra causing complete degeneration of the nigro-neostriatal DA neurons the rats will become immobilized and develop a complete adipsia and aphagia and
110
KJEU FUXE, TOMAS HOKFELT, AND URBAN UNGEFLSTEDT
die after 5-7 days. The interpretation given is that the latter effects are secondary to the effects on motor function (akinesia, rigidity). The blockade of eating and drinking found by many authors by lesioning the lateral hypothalamic area may be due to the interruption of the nigro-neostriatal DA pathway.
2. Tubero-lnfundibulur D A Neurons The possible function of this system has been discussed extensively in previous review articles (Fuxe and Hokfelt, 1969, 1970a,b; Fuxe et al., 1970b). All the findings obtained in this laboratory so far support the view that the DA released in the median eminence acts locally on terminals storing luteinizing hormone releasing factor ( LHRF ) to inhibit the release of LHRF from the median eminence. This system also probably participates in mediating the negative feedback action of estrogen and testosterone on gonadotropin secretion, because estrogen and testosterone markedly increase the turnover of the tubero-infundibular DA neurons of castrated rats, resulting in increased release of DA in this area (Fuxe et al., 1967, 1969b). It has also been found recently that synthetic estrogens such as mestranol, ethinyl-estradiol which are used as antifertility steroids, markedly increase the turnover in this system. The blockade of ovulation found with these steroids may at least partly be mediated via activation of the tubero-infundibular DA neurons (Fuxe and Hokfelt, 1970a,b, and unpublished data). The system is also highly sensitive to prolactin, which also markedly increases the turnover in these neurons (Fuxe and Hokfelt, 1970a,b). This effect of prolactin probably explains the marked activation of the system seen in pregnancy, pseudopregnancy, and lactation (Fuxe et al., 1967, 1969c; Fuxe and Hokfelt, 1967). The prolactin secretion from the anterior pituitary is probably controlled indirectly by the central NA neurons, the activation of which increases secretion of prolactin inhibitory factor ( Fwe and Hokfelt, 1970a,b; Fuxe et al., 1970b).In this way, activity changes in NA neurons can, inter alia via prolactin, influence the activity in the tubero-infundibular DA neurons and thereby LH secretion. Of course, the possibility cannot be excluded that the central NA neurons may also directly influence LHRF secretion without involvement of changes in prolactin secretion and in changes of release of DA in the median eminence.
B. NAPATHWAYS 1. Ascending NA Neurons a. Fundion in Behavior and in Wakefulness. For many years antidepressive drugs of the imipramine type have been used in the treatment
ASPECTS OF CENTRAL MONOAMINE NEURONS
111
of depressive states. Some of these drugs such as desipramine and protriptyline have been found to be potent blockers of the membrane pump in the NA neurons (Carlsson et al., 1966b; see GIowinski and Baldessarini, 1966), to be weak blockers of the membrane pump in the 5-HT neurons, and to have no blocking effects at all on the membrane pump of the central DA neurons (Carlsson et al., 1966b, 1969a,b). Many psychiatrists believe that the main effect of these two drugs in patients is an increase in drive, i.e., the patients become activated and alert. It is, therefore, possible that this activating effect of desipramine and protriptyline is owing to the membrane pump blockade in the NA neurons, leading to increased amounts of NA reaching the receptor sites and to an increase in NA receptor activity. This view is supported by the fact that, for example, protriptyline in rats potentiates the effect of dopa combined with peripheral dopa decarboxylase inhibition on exploratory behavior. Increased rearing and frequent walking about the floor of the cage are observed. In a recent study (Fuxe and Ungerstedt, 1969), the evidence supporting the view that exploratory behavior is highly dependent on NA receptor activity has been summarized. A potent dopamine-/3-oxidase inhibitor (FLA 63; Corrodi et al., unpublished data) or a NA receptor blocking agent, phenoxybenzamine A n d h et al., 1967a), have both been found to block markedly the exploratory behavior seen after amphetamine, whereas the stereotyped behavior seen after amphetamine which is mainly dependent on DA receptor activity (see above) is not decreased. In agreement with this view, it has been found that a NA receptor stimulating agent, cataprezan (And6n et al., 1970b), if combined with apomorphine, a DA receptor stimulating agent, will induce marked behavioral hyperactivity (rapid running around and out of the cage) and with marked signs of aggressiveness (defense postures and biting). Furthermore, increased alertness (increased sensitivity to stimuli) seems to appear after cataprezan treatment. Rage behavior induced either by amygdaloid stimulation (Fuxe and Gunne, 1964; Gunne and Lewander, 1966) or by high decerebration (Reis and Fuxe, 1968, 1969) has also been found to be associated with an increased turnover of brain NA. All these findings suggest that these phylogenetically old NA systems may be of importance for the survival of the animal. Marked activation of the NA neurons may be required to meet situations involving defense and attack behavior. Of course, DA receptor activity has to be present, since otherwise no movements can be elicited. It may be (see above) that the limbic DA receptors also play a role in the performance of aggressive behavior. The involvement of neurons such as NA neurons with their enormous collateral networks to trigger off defense-attack reactions makes it possible immediately and concomitantly to influence
112
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
various parts of the central nervous system. Thus, rapid general somatic and autonomic reactions can be immediately elicited if required (see above). It seems logical to assume that increased alertness is mainly due to activation of the dorsal ascending N A pathway, whereas the autonomic signs and the aggressiyeness may mainly be induced by activation of the ventral ascending N A pathuay innervating, for example, the hypothalamus and the limbic system. The descending NA pathway is probably also of importance for this type of behavior, inasmuch as they participate in regulating reflex activity and activity in preganglionic autonomic nerve fibers via an influence on the sympathetic lateral column. Drugs blocking central NA neurotransmission such as dopamine-Poxidase inhibitors and phenoxybenzamine causes sedation ( decreased alertness ) and decreased exploratory behavior. Furthermore, neuroleptic drugs such as chlorpromazine and thioridazine, which have potent blocking actions on NA as well as on DA receptors, also cause sedation (Fuxe et al., unpublished data). These results give further support for the view presented above, that the state of alertness depends on N A receptor actiuity. Carlsson and Lindqvist (1967) have recently found in mice normal exploratory and locomotor activity after selective protection of the DA stores against reserpine-induced amine depletion with the help of repeated doses of m-tyrosine and protriptyline, which block the membrane pump mechanism in the NA but not the DA neurons (Carlsson et al., 196613, 1969a). In rats, such protection experiments are, on the whole, less effective in counteracting reserpine-induced amine depletion and behavioral depression ( Butcher and Fuxe, unpublished data). However, in rats protection of both DA and NA stores leads to considerably less sedation and less decrease in locomotor and exploratory behavior than protection of DA stores alone. Therefore, it may be that in rats central NA neurons are of more importance for these behavioral activities than in mice. On the other hand, it should be pointed out that locomotion, mainly stereotyped behavior, can occur in rats in the absence of any known stores of NA. Thus, it has been found that apomorphine in reserpine-a-methyltyrosine pretreated rats can induce locomotion mainly in the form of stereotyped behavior (mainly sniffing). Exploratory activity, however, cannot be induced and is, thus, as pointed out previously dependent on the activity in NA neurons. For maintenance of conditioned avoidance behavior both central D A and N A neurons probably play an important role. Thus, it has been found that disruption of conditioned avoidance behavior in rats (conditioned lever pressing response on a discriminated avoidance schedule)
ASPECTS OF CENTRAL MONOAMINE NEURONS
113
by H44/68 is connected with signs of increases in both NA and DA turnover in most parts of the brain (Fuxe and Hansson, 1967). In agreement with this it has been found that disulfiram, a dopamine-P-oxidase inhibitor, blocked the dopa reversal of reserpine-induced conditioned avoidance behavior ( Seiden and Paterson, 1968). Furthermore, it has been shown (Butcher and Andh, 1969) that the DA receptor stimulating agent, apomorphine, is less effective than amphetamine, which releases “extragranular” stores of both DA and NA (Carlsson et al., 1 W b ; Fuxe and Ungerstedt, 1968) in restoring lever-pressing in rats on a variable interval schedule of food reinforcement after tetrabenazineinduced depression of that behavior. It is possible that the requirement for N A and not only D A receptor activity in exploratory behavior and conditioned behavioral processes may be the result of decreased alertness in response to the decreased N A receptor activity. A high degree of alertness may be of critical importance, not only in the conditioned behavior but also in exploratory behavior, because high demands are put on the responsiveness of the animal to stimuli. Such a condition does not exist in ordinary locomotion. Accordingly the “minor tranquilizers” such as chlordiazepoxide and diazepam have been found to cause a blockade of the stress-induced NA acceleration of turnover in all parts of the brain plus a reduction of NA turnover in the cortex cerebri and cerebelli compared to normal rats (Corrodi et al., unpublished data). Also in agreement with the above discussion, self-stimulation behavior has been found to be highly dependent on NA receptor activity (Stein and Wise, 1967; Wise and Stein, 1969). Thus, after dopamine-j3-oxidase inhibition the self-stimulation performance is suppressed, and intraventricular injections of 1-NA but not of d-NA, 5-HT or DA can restore self-stimulation. Furthermore, electrical stimulation of the medial forebrain bundle known to cause reward has been found to cause release of NA, as shown in local perfusing experiments on the amygdala and the hypothalamus. b. Autonomic Function. As mentioned above, results have recently been obtained that cataprezan stimulates NA receptor sites in the central nervous system ( AndCn et aE., 1970b). For several years it has been known that this drug is an antihypertensive agent ( Hoefke and Kobinger, 1966). It is, thus, possible that NA neurons participate in central vasomotor regulation. Evidence for this view (Bolme and Fuxe, unpublished data) has recently been obtained by showing that the decrease in blood pressure caused by cataprezan can be blocked by haloperidol in a dose sufficiently high to block NA receptors (1 mglkg) and by phenoxybenzamine. Furthermore, the decrease in blood pressure caused by cataprezan has been found to be potentiated by pretreatment with
114
K JELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
pimocide, a selective blocker of central DA receptors. Thus, probably both noradrenergic and dopaminergic mechanisms participate in central vasomotor mechanisms, and a combination of blockade of DA receptor activity and stimulation of NA receptor activity may result in a pronounced fall in blood pressure (Bolme and Fuxe, unpublished data). c. Neuroendocrine Function. As for the possible role of the central NA neurons in neuroendocrine regulation, this has been discussed in detail in previous reviews (Fuxe and Hokfelt, 1969, 1970a,b; Fuxe et al., 1970a). It is probable that mainly the ventral NA pathway is involved in the regulation of neuroendocrine responses, inasmuch as it primarily innervates the hypothalamus and the limbic system. The dorsal NA pathway, on the other hand, mainly innervates the cortex and the hippocampal formation is probably mainly involved in, for example, regulation of wakefulness (see above). Many findings suggest that central NA neurons may participate in the regulation of prolactin secretion (Coppola et al., 1965; Fuxe and Hokfelt, 1970a,b), probably by increasing secretion of prolactin inhibitory factor from the median eminence. In support of this view is the fact that many drugs blocking central CA neurotransmission cause lactation and pseudopregnancy. There are a number of findings showing that there is an increased NA turnover in connection with a stress-induced increase in adrenocorticotropic hormone ( A C T H ) secretion (see review by Fuxe et al., 1970a). Furthermore, adrenalectomized rats will also have an increased NA turnover compared to controls (Javoy et al., 1968; Fuxe et al., 1970a). This increase in NA turnover is blocked by cortisol (Fuxe et al., 1970a). Furthermore, many drugs interfering with central CA neurotransmission have been found to change ACTH secretion. Thus, it is probable that central NA neurons at least in some situations may play an important role in regulation of corticotropic releasing factor secretion from the hypothalamus. The work of Miiller et al. (1967) suggests that the central N A neurons also participate in regulating growth hormone secretion, because, for example, injections of small amounts of NA intraventricularly leads to increased release of growth hormone releasing factor. In support of the view is the fact that there is an increased turnover of NA after insulin-induced hypoglycemia in young rats ( Hokfelt et al., unpublished data).
2. Descending N A Neurons From the widespread distribution of NA nerve terminals in the posterior and anterior horn and in the intermediate part of the spinal
ASPECTS OF CENTRAL MONOAMINE NEURONS
115
cord, mainly the sympathetic lateral column, it is obvious that the descending NA pathways influence spinal reflexes and autonomic reflexes at various levels. Thus, both the afferent nerve cells in the posterior horn, the interneurons, and the motoneurons in the anterior horn are probably directly influenced. From experiments with nialamide-dopa on spinalized rats (see review by Anden et al., 1969a), it is known that activity in the central NA nerve terminals will increase the naturally evoked flexor reflex markedly. This increase is probably the result of the fact that repetitive activity in the flexor reflex afferents will cause a long-lasting, long-latency discharge in flexor motoneurons ( A n d h et al., 1966d). It has been postulated that the NA neurons produce these changes by inhibiting the short latency effects of activity in flexor reflex afferents (see also And& et al., 1966c), probably by way of an action on interneurons. It may be emphasized that at least some NA neurons innervating the spinal cord also give rise to large ascending axons and to collaterals to the lower brainstem, so that spinal reflex activity may be influenced at the same time as, for example, reflexes at the rhombencephalic level.
C. 5-HTPathways 1. Ascending 5-HT Neurons a. Mental Functions. It has been found that the most potent antidepressive drugs of the imipramine type, imipramine, amitriptyline, and particularly chlorimipramine are able markedly to block predominantly the uptake of 5-HT into the central 5-HT neurons (Carlsson et al., 1968; Fuxe and Ungerstedt, 1968; Carlsson et al., 196913). Inasmuch as these drugs seem to be able to cause an elevation of mood, it may be that the mood-elevating effects of these drugs are related to their ability to block the 5-HT membrane pump. This blockade probably results in an increased 5-HT neurotransmission, because the effects of tryptophan and 5-hydroxytryptophan ( 5-HTP ) on the spinal reflexes are potentiated (see below and Meek et al., 1970). Thus, a decrease in central 5-HT neurotransmission may be an important part in the depression syndrome, and the mood-elevating action of the antidepressant drugs may be caused by increasing 5-HT neurotransmission. In accordance with this view, 5-hydroxyindoleacetic acid ( 5-HIAA ) levels are decreased in the cerebrospinal fluid of depressed patients (Ashcroft and Sharman, 1960; Dencker et al., 1966; Ashcroft et al., 1966), and tryptophan administration also causes an alleviation of depression especially when combined with M A 0 inhibition (see Coppen, 1967; Persson and ROOS, 1967). Furthermore, recently it has been found that dexamethasone treatment
116
K JELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
enhances the effects of tricyclic antidepressants ( McClure and Cleghorn, 1968). This is in agreement with the view given above, because glycocorticoids have been found to increase tryptophan hydroxylase activity ( MacLean, personal communication). In this connection it should also be pointed out that a-ethyltryptamine (monase), which has antidepressive properties ( Robie, 19f3l), is capable of directly stimulating 5-HT receptors in low doses (down to 1 mg/kg) (Meek and Fuxe, unpublished data). Its receptor stimulating effect and not its MA0 inhibiting effect is probably the cause of its antidepressive properties. Thus, many findings support the so called “indolealkylamine theory” to explain the mechanism of depression (see Coppen, 1967).
The manic phase of manic-depressive illness should also be discussed. A potent antimanic agent and also a prophylactic agent against recurrent depression has been found to be lithium (Baastrup and Schou, 1967). Prolonged treatment with lithium has been found to decrease the 5-HT turnover in the central nervous system (Corrodi et al., 1969). This may be due to the fact that lithium ions decrease the release of 5-HT, since lithium chloride given in v i m or added in vitro has been found to diminish the release of tritiated 5-HT from brain slices evoked by mild electrical stimulation (Katz et al., 1968). Thus, it seems possible that lithium therapy may partly exert its beneficial effects by decreasing 5-HT neurotransmission, at least with regard to its antimanic effects. When discussing the possible mental functions of the 5-HT neurons the effects of psychotomimetic drugs on central 5-HT neuro-transmission should also be considered. Evidence has recently been found that lysergic acid diethylamide ( LSD ) directly stimulates 5-HT receptor sites in the brain (see Andkn et al., 1968). Thus, LSD increases markedly the extensor hind limb reflex of the spinal rats independent of presynaptic stores of 5-HT. This reflex is known to be highly dependent on 5-HT receptor activity, ar,d similar results are obtained when 5-HTP is given (see Andkn, 1968). Furthermore, LSD was observed to produce a marked decrease in 5-HT turnover in practically all parts of the brain and the spinal cord. The decreased turnover may have been caused by a nervous feedback onto the 5-HT cell bodies induced by the increased 5-HT receptor activity, resulting in a decreased nervous impulse flow in the 5-HT neurons. It is known that the amine turnover is highly dependent on the nervous impulse flow (see review by Anden et al., 1969b). From extracellular recordings in the raphe areas of the midbrain rich in 5-HT cell bodies, evidence has in fact been observed that LSD causes a decreased firing rate in these neurons (Aghajanian et al., 1968). It cannot as yet, however, be in any way excluded that changes in post-
ASPECTS OF CENTRAL MONOAMINE NEURONS
117
synaptic activity directly in the synapse can influence release from the presynaptic bouton. Thus, both a nemous and a local biochemical feedback may exist. Further studies on the effect of hallucinogenic drugs of the indolealkylamine type of central 5-HT neurotransmission have revealed that psilocybin, dimethyltryptamine (DMT), and to a certain extent tryptamine (but not bufotenine) stimulate 5-HT receptors directly and cause a decrease in 5-HT turnover, which probably is induced by the increased 5-HT receptor activity in a way similar to that described for LSD ( A n d h et al., 1970a). The decreased 5-HT turnover observed after these drugs cannot be explained as a result of MA0 inhibition, because a dose of, for example, pargylin causing the same reduction of 5-HT turnover as, for example, DMT inhibits intraneuronal MA0 in contrast to DMT. Hallucinogenic drugs such as DMT can probably also cause release of extragranular 5-HT, at least after artificial increase of this pool by MA0 inhibition (Fuxe et al., 1968b). However, this presynaptic effect cannot explain the present results, since such an action would rather result in an increased 5-HT turnover and not a decreased 5-HT turnover as was observed. Recently, evidence has also been obtained that hallucinogenic amphetamines ( Snyder et al., 1967, 1968), 4-methoxyamphetamine and especially 2,5-dimethoxy-4-methylamphetamine, can directly stimulate 5-HT receptor sites and cause a decrease in 5-HT turnover (Andkn et al., unpublished data). The increase in knee-jerk activity found in man after LSD, psilocybin, etc. (Isbell et aE., 1956; Isbell, 1959), is probably owing to an increased 5-RT receptor activity in view of the discussion given above. Inasmuch as the effects on the knee-jerk by these drugs are correlated with their hallucinogenic properties, it is possible that the central 5-HT receptor stimulation induced by these drugs is responsible also for the hallucinations caused by these drugs. In view of the discussion given above, overstimulation of central 5-HT receptor sites must be considered as one explanation for the cause of hallucinations found in psychotic states, Thus, not only overstimulation of DA receptors or a disruption of the balance between cholinergic and dopaminergic receptor activity in the neostriatum and/ or the limbic forebrain (see section on central DA neurons) should be considered. From the work of Jouvet’s group (see reviews by Jouvet, 1968, 1969), there is good evidence that the 5-HT neurons induce slow-wave sleep events. Thus, after extensive lesions of the raphe nuclei or after treatment with p-chlorphenylalanine, a blocker of tryptophan hydroxylase (Koe and Weissman, 1967) total sleep is almost completely suppressed.
118
KJEU FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
After p-chlorphenylalanine treatment there is a good correlation between decrease of 5-HT concentrations and decrease of slow-wave sleep. Furthermore, electrical stimulation of the raphe nuclei in the mesencephalon has produced behavioral signs of calmness and an EEG pattern similar to that found in sleep (Kostowski et al., 1989). Sheard and Aghajanian (1968) have also found a lack of habituation to external stimuli after such stimulation. Such electrical stimulations increase brain 5-HIAA levels and cause a decrease of 5-HT levels in the brain ( Aghajanian et al., 1967; Kostowski and Giacolone, 1969). Furthermore, lesions of this area in rats results in marked locomotion and disappearance of the slow-wave sleep pattern (Kostowski et al., 1968, 1969). From these results it is obvious that the sleep disturbances found in depressive states may be due to low 5-HT neurotransmission. Thus, in many respects the NA (see section on function of NA neurons) and 5-HT neurons seem to exert effects, for example, on behavior and wakefulness that are antagonistic to one another. This view is also supported by the fact that the behavioral effects of increased central NA neurotransmission obtained, for example, with help of cataprezan are potentiated by mean of tryptophan hydroxylase inhibition and inhibited by 5-HT receptor stimulation caused by LSD (Fuxe et al., unpublished data). b. Function in Sexual Behavior. From the work of Meyersson (1966) it seems that ascending 5-HT pathways can mediate inhibition of estrous behavior. Thus, the progesterone-induced estrus in estrogen-pretreated ovariectomized rats is markedly inhibited by increased monoamine levels, especially after seIective increases of 5-HT levels ( Meyersson, 1964). Furthermore, it has been found that the antidepressive drugs imipramine and amitriptyline inhibit estrous behavior in doses which do not prevent reserpine-induced sedation or induce exploratory behavior (Meyersson, 1966). These effects on estrous behavior are probably related to the blocking effects these drugs exert on the 5-HT membrane pump. The 5-HT nerve terminals mainly responsible for these effects are probably those lying in the retrochiasmatic area and the preoptic areas which are known to play an important role in the regulation of sexual behavior. c. Neuroendocrine Functions. The role of 5-HT neurons in neuroendocrine regulation has been summarized in previous reviews (Fuxe and Hokfelt, 1970b; Fuxe et at., 1970a,b). The work of Kordon et al. (1968; Kordon, 1969), clearly suggests that central 5-HT mechanisms in the hypothalamus act by inhibiting secretion of luteinizing hormone. Thus, not only sexual behavior but also ovulation is probably inhibited
ASPECTS OF CENTRAL MONOAMINE NEURONS
119
by increased activity in 5-HT neurons. 5-HT neurons may also participate in regulation of ACTH secretion ( Fuxe et al., 1970a).
2. Descending 5-HTNeurons The 5-HT nerve terminals in the spinal cord are found in the largest densities in the lumbal and sacral part of the spinal cord (Fuxe, 1965), where also the highest 5-HT concentrations in the central nervous system are found (And&, personal communication). The 5-HT nerve terminals are found in all parts of the gray matter, anterior horn, posterior horn, and intermediate zone, and they surround both small and large nerve cell bodies. In the acutely spinalized rat, it has been found that treatment with tryptophan or 5 H T P in combination with monoamine oxidase inhibition or with blockade of the 5-HT membrane pump results in a marked potentiation of the extensor hind limb reflex (AndCn, 1968; Meek et al., 1970). Furthermore, after treatment with 5-HTP there is an increased excitability of the a-motoneurons (Anden et al., 1964a), and many of the a-motoneurons are, in fact, surrounded by plexi of 5-HT nerve terminals. With regard to spinal autonomic function, the 5-HT nerve terminals in the sympathetic lateral column may inter alia act to inhibit activity in the sympathoadrenal neurons, since the insulin-induced adrenaline secretion is inhibited by 5-HTP (AndCn et al., 1964b). Ill. Some Conclusions
A. THENIGRO-NEOSTRLATAL DA NEURONS
1. Motor functions: Their degeneration will cause hypokinesia and rigidity. Overstimulation of neostriatal DA receptors causes stereotyped behavior. 2. Mental functions: Experiments especially with neuroIeptic drugs may indicate that normal activity in nigro-neostriatal DA neurons and/or mesolimbic DA neurons are required for normal thought processes. B. THETUBERO-INFUNDIBULAR DA NEURONS These neurons probably act by way of inhibiting the release of LHRF from the median eminence. NA NEURONS C. THECENTRAL
1. Function in wakefulness: Increased NA receptor activity probably results in alertness and increased drive. Possibly NA receptors in the
120
KJELL FUXE, TOMAS HOKFELT, AND URBAN UNGERSTEDT
cortex cerebri are mainly involved. The NA terminals belong mainly to the dorsal NA pathway. 2. Function in emotion: Increased NA receptor activity results in aggression. Possibly NA receptors in the limbic system and the hypothalamus are mainly involved. The NA nerve terminals belong mainly to the ventral NA pathway. 3. Function in behavior: Increased NA receptor activity results in marked locomotor hyperactivity with a strong component of exploratory activity provided DA receptor activity is also present, The NA neurons probably also are essential for conditioned processes as are the DA neurons. 4. Neuroendocrine function: The ventral NA pathway innervating mainly the hypothalamus and the limbic system may participate in the control of prolactin, ACTH, and GH secretion from the anterior pituitary and in the control of oxytocin and antidiuretic hormone secretion from the posterior pituitary. 5. Function in reflex activity: The descending bulbospinal NA neurons participate in the control of somatic and autonomic reflex activity. They decrease transmission in the short latency pathways from the flexor reflex afferents, probably by acting at an interneuronal level, hereby producing an increased flexor reflex.
D. THECENTRAL 5-HT NEURONS 1. Function in mood: There is good evidence that depressive states may partly be the .result of a decreased 5-HT neurotransmission. 2. Function in wakefulness: Destruction of the 5-HT neurons results in insomnia. 3, Function in thought processes: There are indications that high 5-HT receptor activity may cause hallucinations, inasmuch as the psychotomimetic drugs LSD, psilocybine, dimethyltryptamine, and pmethoxyamphetamine are potent stimulators of central 5-HT receptors. 4. Function in behavior: The 5-HT neurons probably inhibit sexual behavior and other types of hyperactive motor performance such as those seen after simultaneous stimulation of DA and NA receptor activity. 5. Neuroendocrine function: The 5-HT neurons may play an important role in inter alia regulation of LH secretion from the anterior pituitary. 6. Function in reflex activity: The descending bulbospinal 5-HT neurons participate in control of autonomic and somatic reflex activity especially in the lumbosacral part. In the spinalized rat the extensor hind limb reflex is markedly increased by an increase in 5-HT receptor activity.
ASPECTS OF CENTRAL MONOAMINE NEURONS
121
ACKNOWLEDGMENT This work has been supported by the Swedish Medical Research Council ( 14X-71504A,05B; 14X-1015-04,05; B70-14X-2887-01; B70-40X-2457-03), by a small Mental Health Grant (1R03 MH16825-01) from National Institute of Health and by grants from 0. och E. Ericssons Stiftelse, M. Bergwalls Stiftelse, Svenska Livforsakringsbolags namnd for medicinsk forskning, and from T. Svenssons Minne. Dr. Arbuthnott was supported by a Fellowship from the Wellcome trust.
REFERENCES Aghajanian, G. K., and Bloom, F. E. (1966a). Science 153, 308. Aghajanian, G. K., and Bloom, F. E. (1966b). J. Pharmacol. ExptZ. Therap. 156, 23. Aghajanian, G. K., and Bloom, F. E. (1967). 3. Pharmucol. Exptl. Therap. 156, 407.